UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 20212023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-40625

Clover Leaf Capital Corp.

(Exact name of registrant as specified in its charter)

Delaware86-2303279
(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer

Identification Number)No.)

c/o Yntegra Capital Investments, LLC

1450 Brickell Avenue, Suite 2520

Miami, FL

33131
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (305) 577-0031

(305) 577-0031

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class:each class:Trading Symbol(s)Name of Each Exchangeeach exchange on Which Registered:which registered:

Units, each consisting of one share of Class A common stock, $0.0001 par valueCommon Stock and one right to receive one-eighth (1/8) of one share of Class A common stockCommon Stock upon the consummation of an initial business combinationBusiness Combination

CLOEU

CLOEU

The Nasdaq Stock Market LLC

Shares of Class A common stock,Common Stock, par value $0.0001 per share

CLOECLOEThe Nasdaq Stock Market LLC
Rights, every eight (8) rights entitlesRights entitling the holder to receive one share of Class A Common Stock upon the consummation of an initial business combinationBusiness CombinationCLOER

CLOER

The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitionthe definitions of “large accelerated filer,” “accelerated filer, “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

The registrant’s shares were not listed on any exchange and had no value as of the last business day of the second fiscal quarter of 2021. The registrant’s units begin trading on the Nasdaq Capital Market on July 20, 2021, and the registrant’s shares of Class A common stock and rights began trading on the Nasdaq Capital Market September 9, 2021. The aggregate market value of the outstanding shares of the registrant’s shares of Class A common stock outstanding, including the shares included in the units,Common Stock, other than shares held by persons who may be deemed affiliates of the registrant, computed by reference to the closing price for the unitsClass A Common Stock on December 31, 2021,June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, as reported on the Nasdaq CapitalStock Market LLC was $140,592,027.24.$17,037,435.

As of April 1, 2022March 21, 2024, there were 14,645,1355,320,507 shares of Class A common stock,Common Stock, par value $0.0001 per share, and 3,457,807 shares1 share of the Company’s Class B common stock,Common Stock, par value $0.0001 per share of the registrant issued and outstanding.

 

 

 

TABLE OF CONTENTS

PAGE

PART I

1
Item 1.BusinessBusiness.1
Item 1A.Risk FactorsFactors.2224
Item 1B.Unresolved Staff CommentsComments.29
23Item 1C.Cybersecurity.29
Item 2.PropertiesProperties.2329
Item 3.Legal ProceedingsProceedings.2329
Item 4.Mine Safety DisclosuresDisclosures.2329
PART II30
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity SecuritiesSecurities.2430
Item 6.[Reserved].2431
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of OperationsOperations.2531
Item 7A.Quantitative and Qualitative Disclosures About Market RiskRisk.2836
Item 8.Financial Statements and Supplementary DataData.2836
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial DisclosureDisclosure.2836
Item 9A.Controls and ProcedureProcedures.2836
Item 9B.Other InformationInformation.2938
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent InspectionsInspections.2938
PART III39
Item 10.Directors, Executive Officers and Corporate GovernanceGovernance.3039
Item 11.Executive CompensationCompensation.3444
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters3544
Item 13.Certain Relationships and Related Transactions, and Director IndependenceIndependence.3646
Item 14.Principal AccountingAccountant Fees and ServicesServices.3848
PART IV49
Item 15.ExhibitsExhibit and Financial Statement SchedulesSchedules.3949
Item 16.Form 10-K SummarySummary.3949

i

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Report (as defined below), including, without limitation, statements under the heading “Management’s“Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933(as defined below) and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act.(as defined below). These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our ability to consummate any acquisition or other business combinationBusiness Combination (as defined below) and any other statements that are not statements of current or historical facts. These statements are based on management’sManagement’s (as defined below) current expectations, but actual results may differ materially due to various factors, including, but not limited to:

our ability to complete our initial business combination;Business Combination, including the Kustom Entertainment Business Combination (as defined below);

our expectations around the performance of the prospective target business or businesses, such as Kustom Entertainment (as defined below);
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;Business Combination;

our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination,Business Combination, as a result of which they would then receive expense reimbursements;

the potential incentive to consummate an initial Business Combination with an acquisition target that subsequently declines in value or is unprofitable for public investors due to the low initial price for the Founder Shares (as defined below) paid by our Sponsor (as defined below) and Initial Stockholders (as defined below);
our potential ability to obtain additional financing to complete our initial business combination;Business Combination;

the ability of our officers and directors to generate a number ofadditional potential acquisition opportunities;opportunities, if needed;

our pool of prospective target businesses;

the ability of our officers and directors to generate a number of potential acquisition opportunities;

our public securities’ potential liquidity and trading;

the lack of a market for our securities;

the use of proceeds not held in the trust accountTrust Account (as defined below) or available to us from interest income on the trust accountTrust Account balance; or

the Trust Account not being subject to claims of third parties;
the impact on the amount held in the Trust Account, our capitalization, principal stockholders and other impacts on our Company (as defined below) or Management Team should we seek to further extend the Combination Period (as defined below) consistent with applicable laws, regulations and stock exchange rules;
our financial performance.performance; or
the other risks and uncertainties discussed in “Item 1A. Risk Factors” below.

Additionally, on January 24, 2024, the SEC (as defined below) adopted the 2024 SPAC Rules (as defined below), which will become effective on July 1, 2024, that will affect SPAC (as defined below) Business Combination transactions. The 2024 SPAC Rules require, among other matters, (i) additional disclosures relating to SPAC Business Combination transactions; (ii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings and Business Combination transactions; (iii) additional disclosures regarding projections included in SEC filings in connection with proposed Business Combination transactions; and (iv) the requirement that both the SPAC and its target company be co-registrants for Business Combination registration statements. In addition, the SEC’s adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act (as defined below), including its duration, asset composition, business purpose, and the activities of the SPAC and its management team in furtherance of such goals. The 2024 SPAC Rules may materially affect our ability to negotiate and complete our initial Business Combination and may increase the costs and time related thereto.

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

ii

Unless otherwise stated in this Report, or the context otherwise requires, references to:

board of directors,” “board” or “directors”2022 Annual Report” are to our Annual Report on Form 10-K for the board of directors offiscal year ended December 31, 2022, as filed with the Company;SEC on April 14, 2023;

common stock”2022 Special Meeting” are to the special meeting of our Class A common stock and our Class B common stock, collectively;stockholders held on October 19, 2022;

Continental”2023 Extension” are to Continental Stock Transfer & Trust Company, trusteeextension of the Combination Period from July 22, 2023 to January 22, 2024, as approved by our trust account (as defined below) and right agent of our public rightsstockholders at the 2023 Special Meeting (as defined below);

DGCL”2023 Extension Note” are to the Delaware General Corporation Law;promissory note in the principal amount of up to $360,000 issued to our Sponsor on July 21, 2023 in connection with the 2023 Extension;

ii

DWAC System”2023 Redemptions” are to the Depository Trust Company’s Deposit/Withdrawal At Custodian System;Redemption (as defined below) of 376,002 Public Shares (as defined below) held by our Public Stockholders (as defined below) that took place in connection with the 2023 Special Meeting;

Exchange Act”2023 Special Meeting” are to the Securities Exchange Actspecial meeting of 1934, as amended;our stockholders held on July 19, 2023;

FINRA”2023 Working Capital Note” are to the Financial Industry Regulatory Authority;promissory note in the principal amount of up to $300,000 issued to our Sponsor on July 24, 2023 for working capital expenses;

founder shares”2024 Extension” are to sharesextension of our Class B common stock initially purchasedthe Combination Period from January 22, 2024 to July 22, 2024, as approved by our sponsor in a private placement prior to our initial public offering, andstockholders at the shares of our Class A common stock issuable upon the conversion thereof as provided herein;2024 Special Meeting (as defined below);

GAAP”2024 Extension Note” are to the accounting principles generally acceptedpromissory note in the United Statesprincipal amount of America;up to $360,000 issued to our Sponsor on January 22, 2024 in connection with the 2024 Extension;

IFRS”2024 Redemptions” are to the International Financial Reporting Standards, as issuedRedemption of 202,360 Public Shares owned by our Public Stockholders that took place in connection with the International Accounting Standards Board;2024 Special Meeting;

initial business combination”2024 SPAC Rules” are to the new rules and regulations for SPACs adopted by the SEC on January 24, 2024, which will become effective on July 1, 2024;

“2024 Special Meeting” are to the special meeting of our stockholders held on January 17, 2024;

“2024 Working Capital Note” are to the promissory note in the principal amount of up to $1,000,000 issued to our Sponsor on January 22, 2024 for working capital expenses;

“Administrative Support Agreement” are to the Administrative Support Agreement, dated July 19, 2021, which we entered into with an affiliate of our Sponsor;

“Amended and Restated Charter” are to our Amended and Restated Certificate of Incorporation, as amended and currently in effect;

“Annual Meeting Requirement” are to requirement pursuant to Nasdaq (as defined below) Listing Rule 5620(a) that companies listed on Nasdaq hold  an annual meeting of shareholders within twelve months of their fiscal year end;

“ASC” are to the FASB (as defined below) Accounting Standards Codification;

“ASU” are to the FASB Accounting Standards Update;

“Audit Committee” are to the audit committee of our Board of Directors (as defined below);

“Board of Directors” or “Board” are to our board of directors;

“Business Combination” are to a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;

Class A Common Stock” are to shares of our Class A common stock, par value $0.0001 per share;

“Class B Common Stock” are to shares of our Class B common stock, par value $0.0001 per share;

“Closing” are to the consummation of the transactions contemplated by the Kustom Entertainment Merger Agreement (as defined below);

iii

“Combination Period” are to the 36-month period, from the closing of the Initial Public Offering (as defined below) to July 22, 2024 (or such earlier date as determined by the Board), as extended by the July 2022 Extension (as defined below), October 2022 Extension (as defined below), 2023 Extension, and 2024 Extension, that we have to consummate an initial business combination redemption time”Business Combination, provided that the Combination Period may be further extended pursuant to an amendment to the Amended and Restated Charter and consistent with applicable laws, regulations and stock exchange rules;

“Common Stock” are to the Class A Common Stock and the Class B Common Stock, together;

“Company,” “our,” “we,” or “us” are to Clover Leaf Capital Corp., a Delaware corporation;

“Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account and right agent of our Public Rights (as defined below);

“Conversion Amendment Proposal” are to the proposal to amend the Amended and Restated Charter to provide for the elective right of holders of shares of Class B Common Stock to convert such shares into shares of Class A Common Stock, on a one-for-one basis at any time prior to the closing of a Business Combination, which was approved by our stockholders at the 2023 Special Meeting;

“Conversion Units” are to units of our Company issuable upon conversion of the unpaid principal amount of the October 2022 Extension Note (as defined below) at the election of our Sponsor;

“Delisting Notice” are to the notice from the Staff (as defined below) of Nasdaq issued to us on March 1, 2024;

“DGCL” are to the Delaware General Corporation Law;

“DWAC System” are to the Depository Trust Company’s Deposit/Withdrawal At Custodian System;

“Effective Time” are to the time of exercisefiling of the Articles of Merger (as defined in the Kustom Entertainment Merger Agreement) for the Merger (as defined below) in form and substance reasonably acceptable to Kustom Entertainment (as defined below) and our public stockholders’ rights to redeem public sharesCompany with the Secretary of State of the State of Nevada in connectionaccordance with our initial business combination;the relevant portions of the Nevada Revised Statutes, or such later time as may be specified in the Articles of Merger;

initial public offering”Exchange Act” are to the Securities Exchange Act of 1934, as amended;

“Excise Tax” are to the U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 as provided for by the Inflation Reduction Act of 2022;

“FASB” are to the Financial Accounting Standards Board;

“FINRA” are to the Financial Industry Regulatory Authority;

“Founder Share Conversion” are to the 3,457,806 shares of Class A Common Stock issued on July 20, 2023, following the approval of the Conversion Amendment Proposal by our stockholders at the 2023 Special Meeting to the Sponsor upon the conversion of an equal number of shares of Class B Common Stock held by the Sponsor as Founder Shares;

iv

“Founder Shares” are to the shares of Class B Common Stock initially purchased by our Sponsor in the Private Placement (as defined below) and the shares of Class A Common Stock that (i) will be issued upon the automatic conversion of the shares of Class B Common Stock at the time of our Business Combination as described herein (for the avoidance of doubt, such Class A Common Stock will not be “Public Shares” (as defined below)) and (ii) were issued in connection with the Founder Share Conversion upon the conversion of an equal number of shares of Class B Common Stock;

“GAAP” are to the accounting principles generally accepted in the United States of America;
“IFRS” are to the International Financial Reporting Standards, as issued by the International Accounting Standards Board;

“Initial Public Offering” or “IPO” are to the initial public offering that waswe consummated by the Company on July 22, 2021;

initial stockholders”Initial Stockholders” are to our sponsorSponsor and any other holders of our founder sharesFounder Shares (or their permitted transferees); prior to our Initial Public Offering;

“Investment Company Act” are to the Investment Company Act of 1940, as amended;

JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

“Maxim” are to Maxim Group LLC, the representative of the underwriters in our initial public offering;

“management” or our “management team” are to our officers and directors;

“Nasdaq” are to the Nasdaq Stock Market;

“PCOAB” are to the Public Company Accounting Oversight Board (United States);

“private placement rights” are to the rights included within the private placement units purchased by our sponsor and the representative in the private placement;

“private placement shares” are to the shares of Class A common stock included within the private placement units purchased by our sponsor and the representative in the private placement;

“private placement units” are to the units issued to our sponsor and the representative in a private placement simultaneously with the closing of our initial public offering, which private placement units are identical to the units sold in the offering, subject to certain limited exceptions as described in the registration statement for our initial public offering;

“public rights” are to our rights sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market);

iii

“public shares” are to shares of our Class A common stock sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market);

“public stockholders” are to the holders of our public shares, including our initial stockholders and management team to the extent our initial stockholders and/or members of our management team purchase public shares, provided that each initial stockholder’s and member of our management team’s status as a “public stockholder” shall only exist with respect to such public shares;

IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on April 7, 2021, as amended, and declared effective on July 19, 2021 (File No. 333-255111);

“JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

“July 2022 Extension” are to extension of the Combination Period from July 22, 2022 to October 22, 2022, as requested by our Sponsor pursuant to our Amended and Restated Charter;

“July 2022 Extension Note” are to the promissory note in the principal amount of $1,383,123 issued to our Sponsor on July 19, 2022, in connection with the July 2022 Extension;

“Kustom Entertainment” are to Kustom Entertainment, Inc., a Nevada corporation;

“Kustom Entertainment Business Combination” are to the transactions and agreements contemplated by the Kustom Entertainment Merger Agreement;

“Kustom Entertainment Merger Agreement” are to the Agreement and Plan of Merger, dated as of June 1, 2023, we entered into with Merger Sub (as defined below), our Sponsor, Kustom Entertainment, and Kustom Entertainment Stockholder (as defined below);

“Kustom Entertainment Registration Statement” are to the Registration Statement on Form S-4 we initially filed with the SEC on October 4, 2023, as amended (File No. 333-274851);

“Kustom Entertainment Stockholder” are to Digital Ally, Inc., a Nevada corporation and the sole stockholder of Kustom Entertainment;

“Management” or our “Management Team” are to our executive officers and directors;

“March 2021 Promissory Note” are to the promissory note in the principal amount of $300,000 issued to our Sponsor on March 4, 2021.

“Marcum” are to Marcum LLP, our independent registered public accounting firm;

“Merger” are to Merger Sub merging with and into Kustom Entertainment, with Kustom Entertainment continuing as the surviving corporation and our wholly-owned subsidiary;

v

“Merger Consideration” are to the aggregate merger consideration to be paid pursuant to the Kustom Entertainment Merger Agreement to the Kustom Entertainment Stockholder at the Effective Time in an amount equal to (i) $125 million, minus (ii) estimated consolidated indebtedness of Kustom Entertainment as of the date and time at which the Closing is actually held.

“Merger Sub” are to CL Merger Sub, Inc., a Nevada corporation and our wholly-owned subsidiary;

“Minimum Public Holders Requirement” are to minimum 300 public holders requirement for Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(3);

“Nasdaq” are to the Nasdaq Stock Market LLC;

“October 2022 Extension” are to extension of the Combination Period from October 22, 2022 to July 22, 2023, as approved by our stockholders at the 2022 Special Meeting;

“October 2022 Extension Note” are to the promissory note in the principal amount of $1,383,123 issued to our Sponsor on October 19, 2022 in connection with the October 2022 Extension;

“Panel” are to the Nasdaq Hearings Panel;

“PCAOB” are to the Public Company Accounting Oversight Board (United States);

“Private Placement” are to the private placement of the Private Placement Units (as defined below) that occurred simultaneously with the closing of our Initial Public Offering;

“Private Placement Rights” are to the rights included within the Private Placement Units purchased by our Sponsor and the Representative in the Private Placement;

“Private Placement Shares” are to the shares of our Class A Common Stock included within the Private Placement Units purchased by our Sponsor, Initial Stockholders and the underwriters of the Initial Public Offering in the Private Placement;

“Private Placement Units” are to the units issued to our Sponsor, Initial Stockholders and the underwriters of the Initial Public Offering in the Private Placement;

“Public Rights” are to our Rights (as defined below) sold as part of the Units (as defined below) in our Initial Public Offering (whether they are purchased in our Initial Public Offering or thereafter in the open market);

“Public Shares” are to the shares of Class A Common Stock sold as part of the Units in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market);

“Public Stockholders” are to the holders of our Public Shares, including our Initial Stockholders and Management Team to the extent our Initial Stockholders and/or the members of our Management Team purchase Public Shares, provided that each Initial Stockholder’s and member of our Management Team’s status as a “Public Stockholder” will only exist with respect to such Public Shares;

vi

“Redemption” are to the opportunity for our Public Stockholders to, in accordance with our organizational documents and the IPO Registration Statement, have their Public Shares redeemed for a pro rata portion of the funds in our Trust Account;

“Registration Rights Agreement” are to the Registration Rights Agreement, dated July 19, 2021, which we entered into with the Sponsor and Initial Stockholders and the holders party thereto;

“Report” are to this Annual Report on Form 10-K for the fiscal year ended December 31, 2021;2023;

Representative” are to Maxim Group LLC, the representative shares”of the underwriters in our Initial Public Offering;

“Representative Shares” are to the 138,312 shares of our Class A common stockCommon Stock issued to the representativeRepresentative and/or its designees;designees upon the consummation of our Initial Public Offering (for the avoidance of doubt, such shares of Class A Common Stock are not “Public Shares”);

rights”Rights” are to our rights, which each entitle the holder to receive one-eighth (1/8) of one share of Class A common stockCommon Stock upon the consummation of an initial business combination,Business Combination, and which rights include the public rightsPublic Rights as well as the private placement rights;Private Placement Rights;

“Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002;

“SEC” are to the U.S. Securities and Exchange Commission;

“Securities Act” are to the Securities Act of 1933, as amended;

sponsor”SPACs” are to special purpose acquisition companies;

“Sponsor” are to Yntegra Capital Investments, LLC, a Delaware limited liability company, an affiliate of Yntegra Capital Management LLC;

trust account”Staff” are to the Listing Qualifications Department of Nasdaq;

“Trust Account” are to the U.S.-based trust account in which an amount of $140,386,985 ($10.15 per unit)Unit) from the net proceeds of the sale of the unitsUnits in our Initial Public Offering and private placement units in the initial public offeringPrivate Placement Units was placed following the closing of the initial public offering;our Initial Public Offering;

units”Trust Agreement” are to the Investment Management Trust Agreement, dated July 19, 2021, which we entered into with Continental, as trustee of the Trust Account;

“Units” are to the units sold in our initial public offering,Initial Public Offering, which consist of one public sharePublic Share and one public right;Public Right; and

we,” “us,” “Company” or “our Company”Working Capital Loans” are to Clover Leaf Capital Corp, a Delaware corporation.funds that, in order to provide working capital or finance transaction costs in connection with an initial Business Combination, the Initial Stockholders or an affiliate of the Initial Stockholders or certain of our directors and officers may, but are not obligated to, loan us.

ivvii

 

PART I

Item 1. Business.

GeneralOverview

We are a blank check company incorporated as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combinationan initial Business Combination with one or more businesses, which we referbusinesses.

The 2024 SPAC Rules may materially affect our ability to throughout this report asnegotiate and complete our initial business combination.Business Combination and may increase the costs and time related thereto.

Initial Public Offering

On July 22, 2021, we consummated our initial public offeringInitial Public Offering of 13,831,230 units.Units. Each unitUnit consists of one share of Class A common stock,Public Share and one rightPublic Right to receive one-eighth (1/8) of a share of Class A common stockCommon Stock upon the consummation of an initial business combination,Business Combination, with every eight (8) rightsPublic Rights entitling the holder thereof to receive one share of Class A common stockCommon Stock at the closing of the business combination.Business Combination. The unitsUnits were sold at a price of $10.00 per unit,Unit, generating gross proceeds to theour Company of $138,312,300.

Simultaneously with the closing of the initial public offering,Initial Public Offering, we completed the private sale of an aggregate of 675,593 units to our sponsorSponsor and the representativeRepresentative in the Private Placement at a purchase price of $10.00 per private placement unit,Private Placement Unit, generating gross proceeds of $6,755,930.

Upon the consummation of our Initial Public Offering, we also issued an additional 138,312 shares of Class A Common Stock, valued at $10.00 per share, to the Representative and/or its designees as Representative Shares.

A total of $140,386,985, comprised of $138,312,300 of the proceeds from the initial public offeringInitial Public Offering and $2,074,685 of the proceeds of the sale of the private placement unitsPrivate Placement Units, was placed in the trust accountTrust Account maintained by Continental, Stock, acting as trustee.

It is the job of our sponsorSponsor and management teamManagement Team to complete our initial business combination.Business Combination. Our management teamManagement Team is led by Felipe MacLean, our President and CEO, and Chris Rebentisch, our COO.CEO. We must complete our initial business combinationBusiness Combination by July 22, 2022, 12 months from the closing of our initial public offering (unless we extend the deadline for our initial business combination, for up to three extensions of three months each, but in no case later than April 22, 2023).2024. If our initial business combinationBusiness Combination is not consummated by July 22, 2022 (or such extended date),2024, then, unless our Board of Directors shall otherwise determine, our existence will terminate, and we will distribute all amounts in the trust account.Trust Account.

BUSINESSExtensions of our Combination Period

We areoriginally had up to 12 months from the closing of our Initial Public Offering, or until July 22, 2022, to consummate an early stage blank check company recently incorporatedinitial Business Combination. However, as requested by our Sponsor and as permitted under our Amended and Restated Charter on July 19, 2022, we extended the Combination Period by an additional three months from July 22, 2022 to October 22, 2022. In connection with the July 2022 Extension, our Sponsor caused to be deposited into the Trust Account an aggregate of $1,383,123 (representing $0.10 per Public Share). The July 2022 Extension was the first of three three-month extensions permitted under our Amended and Restated Charter.

In addition, at the 2022 Special Meeting held on October 19, 2022, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from October 22, 2022 to July 22, 2023, or such earlier date as determined by our Board of Directors. In connection with the October 2022 Extension, Public Stockholders redeemed an aggregate 12,204,072 Public Shares, and our Sponsor loaned to the Company $1,383,123 ($0.85 per Public Share), which was deposited into the Trust Account.

At the 2023 Special Meeting held on July 19, 2023, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from July 22, 2023 to January 22, 2024, or such earlier date as determined by our Board of Directors. In connection with the 2023 Extension, our Sponsor caused to be deposited into the Trust Account up to $360,000 (representing $0.048 per Public Share), which was deposited into the Trust Account.

At the 2024 Special Meeting held on January 17, 2024, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from January 22, 2024 to July 22, 2024, or such earlier date as determined by our Board of Directors. In connection with the 2024 Extension, we issued to our Sponsor the 2024 Extension Note, pursuant to which the Sponsor may cause to be deposited into the Trust Account up to $360,000. As of March 5, 2024, $120,000 of the principal on the 2024 Extension Note has been deposited into the Trust Account.

As a Delaware corporationresult of the July 2022 Extension, October 2022 Extension, 2023 Extension, and formed for2024 Extension, we must complete our initial Business Combination by July 22, 2024.

We may seek to further extend the purpose of effecting a merger,Combination Period consistent with applicable laws, regulations and stock exchange asset acquisition, stock purchase, reorganization amalgamation, recapitalization, reorganizationrules. Such an extension would require the approval of our Public Stockholders, who will be provided the opportunity to redeem all or similar business combination with onea portion of their Public Shares. Such redemptions will likely have a material adverse effect on the amount held in our Trust Account, our capitalization, principal stockholders and other impacts on our Company or more businesses or entities, which we refer to throughout this ReportManagement Team, such as our initial business combination. We have not selected any specific business combination target and have not, nor has anyoneability to maintain our listing on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us.Nasdaq.

While we may pursue a business combination target in any business, industry or geographic region, we have focused our search for cannabis industry businesses that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, we will not invest in, or consummate a business combination with, a target business that we determine has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act (“CSA”).

Under the current legal landscape, examples of the business combination targets that we may pursue in the United State include providers of ancillary services that support the functioning of cannabis activity, but which are not themselves directly plant touching businesses. Such businesses have emerged, driven by the growth of the cannabis industry in sales and footprint, and include the following:

Cultivation Technology: HVAC systems, environmental controls, lighting, automation, enhanced nutrients and soil, grow management software, propagation methods and resource management.

Processing Technology: Safe production capabilities, effective compound isolations, enhanced extraction and manufacturing equipment for increased efficiency and lower production costs.

Testing Technology: Quality assurance and compliance is a state-mandated requirement, from cultivation to the finished good. Reduction in time and cost is an essential new development and competitive advantage.

Consumer Goods Technology: Safety and proper dosing technologies allow for consumer confidence in companies and brands which leads to a loyal customer base.


 

Another areaKustom Entertainment Business Combination

The below subsection describes the material provisions of focusthe Kustom Entertainment Merger Agreement, but does not purport to describe all the terms thereof. This summary of the Kustom Entertainment Merger Agreement is qualified in its entirety by reference to the complete text of the Kustom Entertainment Merger Agreement, a copy of which is filed hereto as Exhibit 2.1 and incorporated by reference herein. Unless otherwise defined herein, the capitalized terms used below have the same meanings given to them in the Kustom Entertainment Merger Agreement. Unless otherwise indicated, this Report does not assume the closing of the Kustom Entertainment Business Combination.

General Terms and Effects

On June 1, 2023, we entered into the Kustom Entertainment Merger Agreement with Merger Sub, the Sponsor, Kustom Entertainment, and the Kustom Entertainment Stockholder.

Pursuant to the Kustom Entertainment Merger Agreement, subject to the terms and conditions set forth therein upon the Closing, Merger Sub will merge with and into Kustom Entertainment, with Kustom Entertainment continuing as the surviving corporation in the Merger and our wholly-owned subsidiary. In the Merger, all of the issued and outstanding capital stock of Kustom Entertainment immediately prior to the Effective Time shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right for the Kustom Entertainment Stockholder to receive the Merger Consideration. Upon consummation of the Kustom Entertainment Business Combination, we will change our name to “Kustom Entertainment, Inc.”

Merger Consideration

The Merger Consideration will be an amount equal to (i) $125 million, minus (ii) the estimated consolidated indebtedness of Kustom Entertainment as of the date and time at which the Closing is actually held (the “Closing Indebtedness”). The Merger Consideration to be paid to the Kustom Entertainment Stockholder will be paid solely by the delivery of new shares of our Class A Common Stock, each valued at $11.14 per share. The Closing Indebtedness (and the resulting Merger Consideration) is based solely on estimates determined shortly prior to the Closing and is not subject to any post-Closing true-up or adjustment.

Representations and Warranties

The Kustom Entertainment Merger Agreement contains a potentialnumber of representations and warranties by each of our Company, Merger Sub, Kustom Entertainment and the Kustom Entertainment Stockholder as of the date of the Kustom Entertainment Merger Agreement and as of the date of the Closing. Many of the representations and warranties are qualified by materiality or Material Adverse Effect. “Material Adverse Effect” as used in the Kustom Entertainment Merger Agreement means with respect to any specified person or entity, any fact, event, occurrence, change or effect that has had or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, combination targetassets, liabilities, results of operations, prospects or condition (financial or otherwise) of such person or entity and its subsidiaries, taken as a whole, or the ability of such person or entity or any of its subsidiaries on a timely basis to consummate the transactions contemplated by the Kustom Entertainment Merger Agreement or the ancillary documents to which it is Specialty Finance. We believe there isa party or bound or to perform its obligations thereunder, in each case subject to certain customary exceptions. Certain of the representations are subject to specified exceptions and qualifications contained in the Kustom Entertainment Merger Agreement or in information provided pursuant to certain disclosure schedules to the Kustom Entertainment Merger Agreement. The representations and warranties made by us, Merger Sub, Kustom Entertainment and the Kustom Entertainment Stockholder are customary for transactions similar to the Kustom Entertainment Business Combination.

Covenants of the Parties

Each party agreed in the Kustom Entertainment Merger Agreement to use its commercially reasonable efforts to effect the Closing. The Kustom Entertainment Merger Agreement also contains certain customary covenants by each of the parties during the period between the signing of the Kustom Entertainment Merger Agreement and the earlier of the Closing or the termination of the Kustom Entertainment Merger Agreement in accordance with its terms (the “Interim Period”), including (1) the provision of access to their properties, books and personnel; (2) the operation of their respective businesses in the ordinary course of business; (3) provision of audited financial statements by Kustom Entertainment; (4) our public filings; (5) no insider trading; (6) notifications of certain breaches, consent requirements or other matters; (7) efforts to consummate the Closing and obtain third-party and regulatory approvals; (8) tax matters and transfer taxes; (9) further assurances; (10) public announcements and (11) confidentiality. Each party also agreed during the Interim Period not to solicit or enter into any inquiry, proposal or offer, or any indication of interest in making an attractive investmentoffer or proposal for an alternative competing transactions, to notify the others as promptly as practicable in writing of the receipt of any inquiries, proposals or offers, requests for information or requests relating to an alternative competing transaction or any requests for non-public information relating to such transaction, and to keep the others informed of the status of any such inquiries, proposals, offers or requests for information. If Kustom Entertainment’s board of directors determines, after consultation with its financial advisors and outside legal counsel, that an unsolicited Acquisition Proposal constitutes a Company Superior Proposal it may, subject to giving Kustom Entertainment an opportunity to focus on those that provide asset-based loans, mainly with real estate. The opportunity ispropose revisions to provide financing and/or sale-leasebackthe Kustom Entertainment Merger Agreement which would cause such Company Superior Proposal to no longer constitute a Company Superior Proposal, cause Kustom Entertainment to terminate the Kustom Entertainment Merger Agreement in order to enter into a definitive agreement relating to such Company Superior Proposal and to pay us the Termination Fee (as defined below). There are also certain customary post-Closing covenants regarding (1) maintenance of specialized industrial real estate assetsbooks and records; (2) indemnification of directors and officers; and (3) use of Trust Account proceeds. We also agreed to seek and use our reasonable best efforts to obtain an extension of our deadline to consummate our initial Business Combination for the regulated cannabis industry. Offering real estate solutions is an attractive alternative to state-licensed operators that have limited access to efficient traditional financing solutions. We believe that the existence of established, creditworthy cannabis companies without access to conventional sources of capital is a compelling business opportunity for the creation of a leading specialty finance company in the cannabis industry.additional six months.

In addition to the above, we may consider pursuing a non-plant touching target business with a focus on e-commerce. The e-commerce revolution has significantly impacted the cannabis industry. The overall growth in the cannabis industry over the past couple of years has increased direct-to-consumer sales platforms and online ordering in those states where legally available. Technologies include existing and developing online platforms and transportation/delivery services that have started to change the industry.

If we target a business with a focus on e-commerce, we would only target a business that limits its activities to those states where such activities are legal. To the extent the target business involves a product that is excluded from Schedule 1 of the U.S. Controlled Substances Act, such as hemp or hemp-derived products, such target company may engage in interstate commerce. E-commerce in the cannabis industry can be distinguished in the following ways:

Marketplaces: “Direct sale” platforms (solely in states and products where it is legally allowed), such as business-to-consumer apps or websites that transact intrastate business directly with the final buyer.

Delivery Services: Online ordering (especially post Covid-19) has set a new consumer behavior trend for the industry. These platforms are not available in every legal state, but California has shown how successful they can be. Online ordering and delivery platforms cost per sale is significantly less than brick and mortar translating to greater margins. We believe that direct-to-consumer sales platforms and online ordering are the future of cannabis retail.

Online Communities or Destinations: “Aggregator” platforms designed to provide consumers with information and education on available products and prices across multiple retailers. Actual sales are conducted by a licensed brick & mortar store (dispensary), but these networks offer exposure to more potential customers. In addition to the above, we may also consider targets that are hemp derived cannabidiol (“CBD”) businesses that are compliant with the U.S. Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), which would include targets engaged in cultivation, manufacturing, processing, branding, transportation, distribution, storage or sale of hemp-derived CBD. Any such targets would only produce products that are derived from “hemp,” as defined in the 2018 Farm Bill, and therefore have a delta- 9 tetrahydrocannabinol (“THC”) concentration of not more than 0.3 percent on a dry weight basis. In addition, any such products must comply with the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) (“FFDCA”) and its implementing regulations, as amended from time to time.

We may also consider entering into a business combination to market or develop products regulated by the FDA, including pharmaceutical applications and treatments that entail compounds found in cannabis. It is unclear how the FDA will respond to the approach taken by a target business we acquire, or whether the FDA will propose or implement new or additional regulations. In addition, such products may be subject to regulation at the state or local levels. Unforeseen regulatory obstacles may hinder our ability to find a target business that can successfully compete in the market for such products. However, recent regulatory movements such as the proposed amendment to the Food Drug & Cosmetic Act may provide the FDA with the flexibility to regulate hemp-based CBD as a dietary supplement and a potential pathway forward for hemp-derived health and wellness products.

The Cannabis Industry

The current trend to legalize different uses and applications of cannabinoid products in the United States, has begun to normalize a situation that had been known to science for many years: that there are numerous benefits from the use of the derived substances of the Cannabis plant. While cannabis is currently illegal under U.S. federal law since it is classified as a Schedule I drug under the CSA, which imposes various criminal penalties, the laws and regulations governing cannabis are still developing including in ways that we may not foresee. For example, the 2018 Farm Bill has taken hemp and hemp-derived cannabinoids out of the most restrictive class of controlled substances under U.S. federal law. Furthermore, numerous U.S. states have legalized the adult use of marijuana, even though its use remains a violation of U.S. federal law.


 

The evolving regulatory landscapeKustom Entertainment Merger Agreement and the Closing thereby require the approval of cannabis is creatingboth our stockholders and the possibilityKustom Entertainment Stockholder. The Kustom Entertainment Stockholder has approved the Kustom Entertainment Business Combination. We agreed, as promptly as practicable after the date of the Kustom Entertainment Merger Agreement, to prepare, with reasonable assistance from the Company, and file with the SEC the Kustom Entertainment Registration Statement in connection with the registration under the Securities Act of the Merger Consideration shares and containing a new legalized industry,proxy statement for both the medicalpurpose of soliciting proxies from our stockholders to approve the Kustom Entertainment Merger Agreement, the Kustom Entertainment Business Combination and adult userelated matters (the “Clover Leaf Stockholder Approval”) at a special meeting of cannabinoid products, understanding that cannabis continuesour stockholders (the “Clover Leaf Stockholder Meeting”) and providing such stockholders an opportunity to, in accordance with the our organizational documents and the IPO Registration Statement, have their Public Shares redeemed (the “Kustom Entertainment Redemption”) and, if necessary, for the issuance of the Merger Consideration to be illegal under U.S. federal law. issued to the Kustom Entertainment Stockholder.

The public perceptionparties also agreed to take all necessary action, so that effective at the Closing, the entire board of this old prohibition, alongsidedirectors of our Company (the “Post-Closing Board”) will consist of five individuals, a majority of whom shall be independent directors in accordance with Nasdaq requirements. Four of the members of the Post-Closing Board (at least one of whom shall be independent directors) will be designated by Kustom Entertainment prior to the Closing and one will be mutually agreed upon by Kustom Entertainment and us and will be independent. At or prior to the Closing, we will provide each of the director designees to the Post-Closing Board with a customary director indemnification agreement, in form and substance reasonably acceptable to such director. The parties also agreed to take all action necessary, so that the individuals serving as chief executive officer and chief financial officer, respectively, of our Company immediately after Closing will be the same individuals as that of Kustom Entertainment immediately prior to the Closing.

During the Interim Period, we may elect to seek subscription agreements with investors relating to a private equity investment in connection with the social supportKustom Entertainment Business Combination (including backstop arrangements) (a “PIPE Investment”) on terms agreeable to us and better government understandingKustom Entertainment, acting reasonably. Kustom Entertainment agreed to cooperate in connection with such PIPE Investment and use its commercially reasonable efforts to cause such PIPE Investment to occur, including having Kustom Entertainment’s senior management participate in any investor meetings and roadshows as reasonably requested by us. We will use commercially reasonable efforts to seek equity financing, whether through a private placement, forward purchase agreement, backstop arrangement or otherwise, that will provide PIPE Investments for a total of this issue, has paved the way for oneat least $10,000,000.

Survival

The representations and warranties of the fastest growing industries in today’s market. This presents a unique opportunityparties terminate as of and do not survive the Closing, and there are no indemnification rights for companies withanother party’s breach. The covenants and agreements of the capital, knowledgeparties shall not survive the Closing, except those covenants and experienceagreements to benefit from this seismic change.be performed after the Closing which covenants and agreements shall survive until fully performed.

This new potential is increased with continual scientific developments that have been unlocking the different propertiesClosing Conditions

The obligations of the cannabis plant, especially for its two main cannabinoids: Cannabinol or “CBD” and Tetrahydrocannabinol or “THC”. The Cannabis Industry today has been growing at a rapid pace, when more and moreparties to complete the Closing are subject to various conditions, including the following mutual conditions of the health and wellness benefits of the use of these cannabinoids gets unlocked by human discovery.parties unless waived:

But this novel industry is still in its infancy, as regulatory changes have been gradually changing the state legalized use of cannabis products, both for its medical use, that mainly use non-psychoactive CBD components, and the social or adult use that have controlled psychoactive THC components.

The cannabis industry can be segmented into the following four main categories:

receipt of the Clover Leaf Stockholder Approval;

THC Market: Medical & Adultreceipt of the Kustom Entertainment Stockholder written consent approving the Kustom Entertainment Business Combination;

expiration of any applicable waiting period under any antitrust laws;

CBD Market: Health & Wellnessreceipt of requisite consents from governmental authorities to consummate the Kustom Entertainment Business Combination, and receipt of specified requisite consents from other third parties to consummate the Kustom Entertainment Business Combination;

Pharmaceutical

Industrialized Hemp: Oil & Fiber Production

In 2018, the U.S. Congress passed the Agriculture Improvement Act of 2018 (also known as the “2018 Farm Bill”), which legalized a significant portion of the hemp industry. With the passage of the 2018 Farm Bill, there has been a significant increase in the availability of hemp-derived products, including products containing CBD. Hemp-derived CBD products are now legally available through mainstream distribution channels and retailers. A wide range of CBD-infused products, including lotions, serums, balms, tinctures, shampoos, soaps and pet treats, can now be found online and at a variety of retailers, such as supermarkets, cosmetic stores, beauty salons and pet supply stores. Consumers are beginning to use hemp-based products to treat a variety of medical conditions, including anxiety, insomnia, pain and inflammation. In aggregate, across all state medical hemp laws in the United States, hemp is legally recognized as a form of therapy or medicine for more than 50 medical conditions. However, even the hemp sector continues to have certain market uncertainty, particularly related to the CBD-infused food and beverage market, as the FDA has asserted that the sale of such products violates the FFDCA.

Currently, state legalized sales are only a fraction of the overall market for cannabis products. This legalized portion has been growing rapidly, and in the United States, more and more states have legalized and regulated the permitted uses of cannabis products. This has also created a new consumer base, on two fronts, both for consumers who now find alternative products for health and wellness reasons, and for those consumers, who have embraced adult use in those states where it is legal.

Due to the current illegality of cannabis at the U.S. federal level and potential for criminal penalties for violations of the CSA, many U.S. private companies in this sector have been dependent on private money or smaller funds, many institutional investors have shied away from deploying capital on them, and, in addition, access to regular banking finance solutions is almost non-existent. In addition to capital and improved management practices, we believe that achieving a successful business combination will also allow us to unlock this value for both the business combination target and our shareholders.

As more states legalize cannabis in the United States and the industry continues to adjust to an evolving regulatory landscape, additional opportunities in ancillary services for the cannabis industry are being created. Examples of such are business to consumer platforms, specialized marketplaces, research and development (both for new technologies and for product development), among others. Our management believes that by selecting the proper target business, we have the opportunity to create one of the leading cannabis companies, by combining institutional quality practices, proper capital allocation and potentially disruptive products and services to this new and evolving industry.

Regulatory Framework in the United States

We seek a target business in the United States that operates in the cannabis industry that is in compliance with all applicable U.S. federal and state laws and regulations. Below is a summary of the regulatory landscape in the United States.


 

the absence of any law or order that would prohibit the consummation of the Merger or other transactions contemplated by the Kustom Entertainment Merger Agreement;

immediately prior to or upon the Closing, after giving effect to the completion of the Kustom Entertainment Redemption, the Company having net tangible assets of at least $5,000,001 unless the Company otherwise is exempt from the provisions of Rule 419 promulgated under the Securities Act;

the members of the Post-Closing Board shall have been elected or appointed as of the Closing; and

 the Kustom Entertainment Registration Statement shall have been declared effective by the SEC.

Legal statusUnless waived by us, the obligations of cannabis,our Company and Merger Sub to consummate the Merger are subject to the satisfaction of the following additional conditions, in addition to customary certificates and other than hempclosing deliverables:

the representations and warranties of Kustom Entertainment being true and correct as of the date of the Kustom Entertainment Merger Agreement and as of the Closing (subject to Material Adverse Effect);

Kustom Entertainment having performed in all material respects its obligations and complied in all material respects with its covenants and agreements under the Kustom Entertainment Merger Agreement required to be performed or complied with on or prior to the date of the Closing;

absence of any Material Adverse Effect with respect to Kustom Entertainment, taken as a whole, since the date of the Kustom Entertainment Merger Agreement which is continuing and uncured;

the Lock-Up Agreement (as defined below) and a non-competition entered into by the Kustom Entertainment Stockholder in favor of the Company and Kustom Entertainment, as well as certain new employment agreements with Kustom Entertainment executives, shall be in full force and effect in accordance with their terms as of the Closing; and
Kustom Entertainment shall own all of the issued and outstanding capital stock of TicketSmarter, Inc.

All but four U.S. statesUnless waived by Kustom Entertainment, the obligations of Kustom Entertainment to consummate the Merger are subject to the satisfaction of the following additional conditions:

the representations and warranties of our Company and Merger Sub being true and correct as of the date of the Kustom Entertainment Merger Agreement and as of the Closing (subject to Material Adverse Effect);

our Company and Merger Sub each having performed in all material respects our obligations and complied in all material respects with our covenants and agreements under the Kustom Entertainment Merger Agreement required to be performed or complied with on or prior to the date of the Closing;

absence of any Material Adverse Effect with respect to our Company or Merger Sub, taken as a whole, since the date of the Kustom Entertainment Merger Agreement which is continuing and uncured;
we shall be in compliance in all material respects with the reporting requirements applicable to us under the Exchange Act immediately prior to the Closing; and

the Common Stock shall not have been suspended from trading as a result of a delisting from Nasdaq and shall have been approved for listing on Nasdaq, subject only to official notice of issuance thereof.


Termination

The Kustom Entertainment Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including:

by mutual written consent of our Company and Kustom Entertainment;

by either our Company or Kustom Entertainment if any of the conditions to Closing have not been satisfied or waived by July 22, 2023 (the “Outside Date”), provided that the Outside Date will be automatically extended for an additional period equal to the shortest of (i) six (6) months and (ii) the period ending on the last day of the Combination Period;

by either our Company or Kustom Entertainment if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by the Kustom Entertainment Merger Agreement, and such order or other action has become final and non-appealable;

by either our Company or Kustom Entertainment of the other party’s uncured breach (subject to certain materiality qualifiers);

by us if there has been an event after the signing of the Kustom Entertainment Merger Agreement that has had a Material Adverse Effect on Kustom Entertainment and its subsidiaries taken as a whole that is continuing and uncured;

by Kustom Entertainment if there has been an event after the signing of the Kustom Entertainment Merger Agreement that has had a Material Adverse Effect on the us and our subsidiaries taken as a whole that is continuing and uncured;
by the us if (i) Kustom Entertainment does not deliver audited financial statements to us by June 30, 2023 or (ii) Kustom Entertainment’s revenue in the fiscal year ending December 31, 2022 calculated in accordance with Kustom Entertainment’s audited financial statements is more than five percent (5%) lower than the revenue in such fiscal year calculated in accordance with Kustom Entertainment’s unaudited financial statements;

by either our Company or Kustom Entertainment if the Clover Leaf Stockholder Meeting is held and the Clover Leaf Stockholder Approval is not received; and

by Kustom Entertainment if the written consent of the Kustom Entertainment Stockholder is revoked in the event Kustom Entertainment accepts a Superior Company Proposal as described above.

If the Kustom Entertainment Merger Agreement is terminated, all further obligations of the parties under the Kustom Entertainment Merger Agreement will terminate and will be of no further force and effect (except that certain obligations related to public announcements, confidentiality, fees and expenses, termination, waiver of claims against the trust, and certain general provisions will continue in effect), and no party will have legalized,any further liability to some extent, cannabisany other party thereto except for medical purposes. Thirty-six states,(i) liability for any willful breach of the District of Columbia, Puerto RicoKustom Entertainment Merger Agreement prior to such termination and Guam have legalized some form of whole-plant cannabis cultivation, sales and use for certain medical purposes (medical states)(ii) in the event that Kustom Entertainment terminates the Kustom Entertainment Merger Agreement pursuant to the Kustom Entertainment Stockholder rescinding its written consent approving the Kustom Entertainment Business Combination, Kustom Entertainment shall pay to the Company an amount equal to $1,750,000 plus all expenses incurred by the Company in connection with the Kustom Entertainment Merger Agreement (the “Termination Fee”). Seventeen of those states

Trust Account Waiver

Kustom Entertainment and the DistrictKustom Entertainment Stockholder agreed that they and their affiliates will not have any right, title, interest or claim of Columbiaany kind in or to any monies in our Trust Account held for our Public Stockholders, and Northern Mariana have also legalized cannabis for adults for non-medical purposes (sometimes referredagreed not to, as adult use)and waived any right to, make any claim against the Trust Account (including any distributions therefrom). Twelve additional states have legalized low-THC/high-CBD extracts for select medical conditions (CBD states).

Under U.S. federal law, however, those activities are illegal. Purchaser Representative

The CSA continues to list cannabis (marijuana, but not including hemp)Sponsor is serving as a Schedule I controlled substance (i.e., deemed to have no medical value), and accordingly, the manufacture (growth), sale or possession of cannabis is federally illegal, even for personal medical purposes. It also remains federally illegal to advertise the sale of cannabis or to sell or advertise the sale of paraphernalia designed or intended primarily for use with cannabis, unless the paraphernalia is traditionally used with tobacco or authorized by federal, state or local law. Entities or persons who knowingly lease or rent a property for the purposes of manufacturing, distributing or using any controlled substances, or merely knows that any of those activities are occurring on land that they control, can also be found liablepurchaser representative under the CSA. Additionally, violatingKustom Entertainment Merger Agreement, and in such capacity will represent the CSA is a predicate crimeinterests of our stockholders after the Closing (other than the Kustom Entertainment Stockholder) with respect to certain post-Closing matters under U.S. anti-money laundering laws.the Kustom Entertainment Merger Agreement and ancillary documents.

Violation of any U.S. federal laws and regulations can result in arrest, criminal charges, forfeiture of property, significant fines and penalties, disgorgement of profits, administrative sanctions, criminal conviction and cessation of business activities, as well as civil liabilities arising from proceedings initiated by either the U.S. government or private citizens. The U.S. government could enforce the federal cannabis prohibition laws even against companies complying with state law. Enforcement in the United States could slow the progress of global legalization, which could negatively impact even cannabis businesses not operating in the U.S. or subject to any U.S. enforcement action.

Legal status of hemp and hemp derivatives

Until recently, hemp (defined by the U.S. government as Cannabis sativa L. with a THC concentration of not more than 0.3% on a dry weight basis) and hemp’s extracts (except mature stalks, fiber produced from the stalks, oil or cake made from the seeds and any other compound, manufacture, salt derivative, mixture or preparation of such parts) were illegal Schedule I controlled substances under the CSA. The 2014 Farm Bill authorized states to establish industrial hemp research programs. The majority of states established programs purportedly in compliance with the 2014 Farm Bill. Many industry participants and even states interpreted the law to include “research” into the commercialization of, and commercial markets for, CBD from hemp, including products containing CBD.

In December 2018, the U.S. government changed hemp’s legal status. The 2018 Farm Bill, removed hemp and extracts of hemp, including CBD, from the CSA schedules. Accordingly, the production, sale and possession of hemp or extracts of hemp, including CBD, no longer violate the CSA. The 2018 Farm Bill did not create a system in which individuals or businesses can grow hemp whenever and wherever they want. There are numerous restrictions. The 2018 Farm Bill allows hemp cultivation under state plans approved by the U.S. Department of Agriculture (“USDA”) or under USDA regulations in states that have legalized hemp but not implemented their own regulations. It also allows the transfer of hemp and hemp-derived products across state lines for commercial or other purposes, even through states that have not legalized hemp or hemp-derived products. Nonetheless, states can still prohibit hemp or limit hemp more stringently than the federal law.

Despite the passage of the 2018 Farm Bill, hemp products’ legal status is complicated further by state and other federal law. The states have a patchwork of different laws on hemp and its extracts, including CBD. Additionally, the FDA claims that the FFDCA significantly limits the legality of hemp-derived CBD products.

It is important to note that the 2018 Farm Bill preserves the authority and jurisdiction of the FDA (pursuant to the FFDCA) to regulate the manufacture, marketing, and sale of food, drugs, dietary supplements, and cosmetics, including products that contain CBD and other cannabinoids. We are focusing our search on businesses in the CBD industry that are compliant with the FFDCA, including the regulations applicable to manufacturing and marketing of certain products, including food, dietary supplements, and cosmetics.

The Dietary Supplement Health and Education Act (the “DSHEA”) amended the FFDCA and established a framework governing the composition, safety, labeling, manufacturing and marketing of dietary supplements in the United States. Generally, under DSHEA, dietary ingredients marketed in the United States prior to October 15, 1994 may be used in dietary supplements without notifying the FDA. By contrast, “new” dietary ingredients (i.e., dietary ingredients not marketed in the United States before October 15, 1994) must be the subject of a new dietary ingredient notification submitted to the FDA, unless the ingredient has been “present in the food supply as an article used for food” and is not “chemically altered.” Any new dietary ingredient notification must provide the FDA with evidence of a “history of use or other evidence of safety” establishing that the use “will reasonably be expected to be safe.” Per the FFDCA, any substance added to a food is subject to premarket review and approval by the FDA, unless the substance is generally recognized, among qualified experts, as safe under the conditions of the substance’s intended use (otherwise known as “GRAS”).


 

WhileRelated Agreements

Lock-Up Agreement

Simultaneously with the 2018 Farm Bill legalized hemp (including its derivatives, extracts,execution and isomers),delivery of the FDA has yet to issue regulations governing hemp products. NotwithstandingKustom Entertainment Merger Agreement, we entered into the lacklock-up agreement, dated as of regulation of hemp products byJune 1, 2023, with the FDA, the FDA has taken the position that neither CBD nor THC can be added to food or marketed as a dietary supplement because CBD (and THC) are active ingredients in FDA-approved drugs (EpidiolexKustom Entertainment Stockholder and Marinol, respectively) and have been the subject of “substantial clinical investigations” before CBD (or THC) were marketed as a food or dietary supplementour Sponsor (the “Drug Exclusion Rule”“Lock-Up Agreement”). The Drug Exclusion Rule, codifiedPursuant to the Lock-Up Agreement, the Kustom Entertainment Stockholder agreed not to, during the period commencing from the Closing and ending on the six (6) month anniversary of the Closing (subject to early release if the closing price of the Common Stock equals or exceeds $12.00 per share for any 20 out of 30 trading days commencing after the Closing and also subject to early release if we consummate a liquidation, merger, share exchange or other similar transaction with an unaffiliated third party that results in 21 U.S.C. § 321(ff) and 21 U.S.C. § 331(ll)all of our stockholders having the right to exchange their equity holdings in the Company for cash, securities or other property): (x) lend, offer, pledge, hypothecate, encumber, donate, assign, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any restricted securities, (y) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the restricted securities, or (z) publicly disclose the intention to do any of the foregoing, whether any such transaction described in clauses (x), provides that an article that(y) or (z) above is an active ingredientto be settled by delivery of restricted securities or other securities, in an FDA-approved drug,cash or has beenotherwise (in each case, subject to certain limited permitted transfers where the subject of substantial clinical investigations that have been instituted and made public, cannot be added to a food or marketed as a dietary supplement. Despiterecipient takes the position taken by the FDA, industry stakeholders assert there are significant arguments against this position, including (i) that CBD and THC in their naturally occurring form are notshares subject to the Drug Exclusion Rule and (ii) CBD was presentrestrictions in the food supplyLock-Up Agreement). Eighty-five percent (85%) of the shares of Class A Common Stock to be received by the Kustom Entertainment Stockholder as Merger Consideration will be subject to the terms of the Lock-Up Agreement.

Sponsor Forfeiture Letter

Simultaneously with the execution and solddelivery of the Kustom Entertainment Merger Agreement, we entered into a letter agreement, dated as of June 1, 2023, with the Sponsor and the Chief Executive Officer of Kustom Entertainment (the “Sponsor Forfeiture Letter”), pursuant to which the Sponsor agreed to forfeit up to 345,780 shares of Class A Common Stock and transfer to the Chief Executive Officer of Kustom Entertainment up to 518,672 shares of Class A Common Stock (the “Earnout Shares”) (such shares of Class A Common Stock having been converted from shares of Class B Common Stock) held by the Sponsor, subject to the earnout provisions contained therein pertaining to the revenue of Kustom Entertainment for the fiscal years of 2023 and 2024, contingent and effective upon the Closing. If the revenue of the business for either of the fiscal years 2023 and 2024 of Kustom Entertainment (the “Earn-Out Period”) achieves certain benchmarks in interstate commercethe applicable fiscal year, 172,890 of the Sponsor’s Earnout Shares shall no longer be subject to forfeiture and the Sponsor shall transfer to the Chief Executive Officer of Kustom Entertainment 259,336 Earnout Shares (the “Earn-Out Payment”); provided, however, that in the event the benchmark revenue is not achieved on or before the end of the applicable fiscal year, then the Earn-Out Payment for such fiscal year shall be zero, and the Sponsor shall, effective immediately, surrender for cancellation and retirement by the Company such amount of Earnout Shares. The Sponsor agreed to forfeit up to an additional 864,452 shares of Class B Common Stock (or shares of Class A Common Stock, if such shares of Class B Common Stock have been converted to shares of Class A Common Stock prior to October 15, 1994. Notably, the FDA does not imposeClosing) (the “Adjustment Shares”), with the same restrictions onpercentage of Adjustment Shares to be forfeited to be equal to the usepercentage of CBD ingredientsthe Common Stock redeemed by the Public in cosmetic products,connection with the Kustom Entertainment Redemption.

The foregoing descriptions of the Lock-Up Agreement and the Drug Exclusion Rule doesSponsor Forfeiture Letter do not applypurport to cosmetic products.be complete and are qualified in their entirety by reference to the complete text of the Lock-up Agreement and the Sponsor Forfeiture Letter, copies of which are filed hereto as Exhibits 10.12 and 10.13, respectively.

In addition, the FFDCA requires a facility that manufactures, packages, and/or labels food and dietary supplements must also establish and follow current Good Manufacturing Practices (“cGMPs”) in compliance with 21 CFR Part 111 (for dietary supplements) and Part 117 (for food). These cGMP requirements and other applicable FFDCA requirements include FDA facility registration, quality control, quality assurance, maintenance of records and documentation, serious adverse event recording and reporting, and compliant packaging and labeling, including absence of drug claims, among other items. The Company will only pursue a target that complies with the foregoing requirements.

To date the FDA has confined its enforcement efforts to issuing warning letters to companies marketing CBD products with disease claims. Any product marketed with claims suggesting that a product is intended to treat, cure, or prevent diseases and ailments will be considered a “drug,” requiring approval by the FDA for its intended use through one of the drug approval pathways. The definition of “drug” under the FFDCA includes, in relevant part, “articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals” as well as “articles intended for use as a component of a drug as defined in the other sections of the definition.” In determining “intended use,” the FDA has traditionally looked beyond a product’s label, including statements made on websites, on social media, or orally by the company’s representatives. The Company will not pursue a target that markets any products with drug claims.

The FDA possesses significant post-market authority to monitor regulated products that have entered interstate commerce to ensure the product continues to adhere to the FFDCA. Enforcement for noncompliance under the FFDCA may be criminal or civil in nature and can include those who aid and abet a violation, or conspire to violate, the FFDCA. Civil remedies under the FFDCA include civil money penalties, injunctions, and seizures. The FDA also has a number of administrative remedies (e.g., warning letters, recalls, import alerts, and debarment). With respect to CBD products, as noted above, the FDA so far has limited its enforcement to sending cease-and- desist letters to companies selling CBD products and making “egregious, over-the-line” claims, such as “cures cancer,” “treats Alzheimer’s Disease” and “treats chronic pain.” The FDA’s additional guidance on CBD, titled, “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” which the FDA has described as a “risk-based enforcement policy” to prioritize enforcement decisions, was submitted to the White House on July 22, 2020. FDA has since withdrawn its draft guidance. It has not yet indicated whether or when a new guidance document will be submitted.

Although criminal prosecutions of cannabis violations are rare under the FFDCA, the FFDCA also subjects individuals to criminal penalties, including fines and imprisonment, for violating certain provisions of the FFDCA. Criminal violations are generally treated as misdemeanors, meaning they are punishable by a fine or imprisonment of a year or less. FFDCA violations may constitute a felony if the violation is a second offense done with the “intent to defraud or mislead.” (21 U.S.C. § 333(a)(2).) For a defendant to act with an “intent to defraud or mislead,” the defendant must intend not only to mislead the product’s ultimate consumer but also the state and federal government regulatory enforcement agencies. The FFDCA provides for a $1,000 fine, imprisonment of up to one year, or both for simple violations and fines of up to $10,000, imprisonment for up to three years, or both, for subsequent convictions or convictions demonstrating intent to defraud or mislead. For misdemeanors not resulting in death, the current maximum fine for an individual is $100,000, while for misdemeanors resulting in death or for FFDCA felonies, the current maximum fine for an individual is $250,000. For organizations, the current maximum fine is $200,000, and for misdemeanors resulting in death or for FFDCA felonies, the current maximum fine is $500,000.


 

In additionFounder Share Conversion

On July 20, 2023, following the approval of the Conversion Amendment Proposal by our stockholders at the 2023 Special Meeting, we issued an aggregate of 3,457,806 shares of Class A Common Stock to the FFDCA,Sponsor upon the conversion of an equal number of shares of Class B Common Stock held by the Sponsor as Founder Shares. The 3,457,806 shares of Class A Common Stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Common Stock before the Founder Share Conversion, including the Sponsor’s agreement not to transfer, assign or sell any target’s advertisingof its Founder Shares until the earlier to occur of: (i) one year after the completion of a Business Combination or (ii) the date on which we complete a liquidation, merger, capital stock exchange or similar transaction that results in our stockholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be subject to regulation byreleased from the Federal Trade Commission (“FTC”) pursuant to the Federal Trade Commission Act. In recent years, the FTC has initiated numerous investigations of dietary and nutritional supplement makers (and their products) based on allegedly deceptive or misleading claims. On December 17, 2020, FTC announced enforcement proceedings against companies making deceptive claims related to CBD products. The six companies targeted by the FTC entered into settlement agreements, and fivelock-up. As a result of the companies paid a fine to FTC. More recently, on May 17, 2021,Founder Share Conversion, the FTC announced its latest law enforcement action against a CBD company that marketed their CBD products with false and/or unsubstantiated claims.2023 Redemptions and the 2024 Redemptions, the Sponsor holds approximately 75.7% of the issued and outstanding shares of Common Stock.

The Cannabis Industry OpportunityBusiness Strategy

Considering the current state of the cannabis industry, we believe that the opportunity is not only driven by a changing regulatory landscape and lack of traditional capital sources, but also by strong sector fundamentals that will allow us to achieve a business combination with accretive value for our shareholders.

Attractive Fundamentals:

The cannabis industry’s current size and growth is surprising considering the inefficiencies that have plagued this market. Potential future favorable changes in the regulatory environment (not limited to potential federal regulation), may accelerate this growth. The industry, in its current state, has achieved significant magnitude as shown by the following data (Source: BDS Analytics):

The global cannabis market, consisting of (i) state legalized cannabis sales in the U.S. (notwithstanding cannabis’ status as a Schedule I controlled substance) and (ii) nationally legalized cannabis sales outside the U.S., saw approximately 45% growth across the board in 2020, with current global forecasts as follows:

Sales exceeded $21 billion in 2020

Sales forecast exceeds $55 billion by 2026

Growth of global sales from 2019 to 2020 represents an increase of 48% over 2019 sales of $14.4 billion

Expected global growth from 2020 to 2026 represents a compound annual growth rate (CAGR) of more than 17%, roughly $6 billion annually.

Aggregate sales in U.S. states where cannabis sales have been legalized accounted for approximately 84% of total global sales in 2020

Five state markets made up 56% of that total (Arizona, California, Colorado, Nevada and Oregon)

Over the next couple of years, it is expected that California, New York, New Jersey, Florida, Ohio, Maryland, Nevada, Massachusetts, Missouri and Arizona will have the highest contribution to growth to bring the U.S. from a $17.6 billion dollar legal system to $41.2 billion in 2026.

Fragmented market:

The cannabis industry is still a highly fragmented industry, the majority of companies are still single state operators.

The top three Multi-State Operators (MSO’s) in the cannabis industry currently represent less than 10% of the industry (measured by sales), with no single company having more than 5% of market participation.

Capital provider’s market:

Access to regular sources of capital has been limited or unavailable to this date, the growth of the companies in this industry is clearly outpacing their available capital to continue growth at its current pace.

Most of the “legacy” owners or those that participated in the initial “wave” of the industry, have been surpassed by their own growth, access to efficient capital sources will also provide them with much needed professional management, standardized processes, M&A advisory and strategic planning.

In addition to all of the above, the potential of eventual federal regulation, as it pertains to the capital markets and banking may boost this opportunity.


Business Strategy

Our business strategy is to identify and complete one or more business combinations with a target operating in the cannabis industryBusiness Combinations that is compliant with all applicable laws and regulations within the jurisdictions in which it is located or operates. We arehave been seeking companies that we believe can efficiently deploy new capital while benefiting from our industry know-how and management team. The goal of our business combination istoBusiness Combination is to achieve revenue growth and to increase profitability. These objectives can be achieved both through acquisitions and/or through organic growth. We expect to lookare looking for targets that can benefit from one or more of the following: investment in research &and development, new technologies and/or additional infrastructure, in order to achieve a dominant position in their market and/or entry in new ones.

While we may pursue a business combinationBusiness Combination target in any business, industry or geographical location (such as the Kustom Entertainment Business Combination), we are focusinghave finished our search for businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate, and, in particular, we will not invest in, or consummate a business combination with, a target business that we determine has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act.laws.

While evaluating any business combinationBusiness Combination, our team believes that the stage of the market should be considered, whether it’s a new, transitioning, or a mature market.

Companies in new and transitioning markets will have a first mover advantage, with significant revenue potential and profit margins. As inexperienced competition enters these markets, supply increases with the resulting sales erosion. If the cyclical nature of the new market strategy is understood and proper practices are applied, our team believes that there is opportunity to capture significant revenues while building a sustainable and established business.

Companies in mature markets experience less volatility and more market/price stability. This stability allows for a traditional approach in managing the business, market growth, operations & forecasting sales.

Entering either a new market or a mature market both have a positive and negative effect, with mature markets typically offeroffering better stability but less growth potential.


Business Combination Criteria

Consistent with our business strategy, we have identified the following general criteria and guidelines that we believe are important in evaluating prospective target businesses. Webusinesses, including Kustom Entertainment. While we have used and will continue to use these criteria and guidelines in evaluating acquisitioninitial Business Combination opportunities, butincluding the Kustom Entertainment Business Combination, we may decide to enter into our initial business combinationBusiness Combination with a target business that doesmeets some, but not meetall of these criteria and guidelines. While we utilize these criteria in evaluating business combination opportunities, we expect that no individual criterion will entirely determine a decision to pursue a particular opportunity.

U.S. Cannabis Companies.    We seek to acquire one or more private companies domiciled in the United States primarily focused on the cannabis sector.

Company Size.Size. We seek to acquire one or more businesses with an enterprise value of $200 million or more, determined in the sole discretion of our officers and directors according to reasonable accepted valuation standards and methodologies. We believe this segment provides the most synergistic opportunities for investment and where we believe we have the strongest network and data to identify opportunities.

Emerging Growth Stories.Stories. We seek to acquire one or more businesses or assets that have (i) a history of, or potential for, outpacing their peers in terms of earnings and industry performance, (ii) a good growth market, (iii) a record of strong growth in sales and (iv) a large target addressable market.

Growth opportunities through capital investment.Opportunities Through Capital Investment. We are seekingseek candidates who will benefit from additional capital investment through a business combinationBusiness Combination with a public vehicle.

Clear competitive advantages.Competitive Advantages. We seek candidates that will benefit not only from the strong fundamentals of the industry, but also that have differentiating elements from its competitors.

Strong revenue growth and Revenue Growth and/or proven brands.Proven Brands. We are seekingseek candidates who have strong revenue growth stories and or proven brands. We seek to partner with the potential target’s management team and expect that the operating and financial abilities of our managementManagement and boardBoard will help the potential target company to unlock opportunities for future growth and enhanced profitability.

Opportunities for Add-On Acquisitions.Acquisitions. We are seekingseek to acquire one or more businesses that we can grow both organically and through acquisitions. In addition, we believe that our ability to source proprietary opportunities and execute such transactions will help the business we acquire grow through acquisition, and thus serve as a platform for further add-on acquisitions.


Benefit from Being a Public Company.Company. We are pursuing a business combinationBusiness Combination with a company that we believe will benefit from being publicly traded and can effectively utilize the broader access to capital and public profile that are associated with being a publicly traded company.

Focus on Risk-Adjusted Return.Return. We intend to acquire one or more companies that we believe can offer attractive risk-adjusted return on investments for our stockholders.

These criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our managementManagement may deem relevant.

In the event that we decide to enter into our initial business combinationBusiness Combination with a target business that doesmeets some, but not meetall of the above criteria and guidelines, we will disclose that the target business doesmeets some but not meetall of the above criteria in our stockholder communications related to our initial business combination,Business Combination, which would be in the form of proxy solicitation materials or tender offer documents that we would file with the SEC.SEC, such as the Kustom Entertainment Registration Statement.


Initial Business Combination

Nasdaq rules require that we must complete one or more business combinationsBusiness Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust accountTrust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account)Trust Account) at the time of our signing a definitive agreement in connection with our initial business combination.Business Combination. Our boardBoard of directorsDirectors will make the determination as to the fair market value of our initial business combination.Business Combination. If our boardBoard of directorsDirectors is not able to independently determine the fair market value of our initial business combination,Business Combination, we will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm with respect to the satisfaction of such criterion. While we consider it unlikely that our boardBoard of directorsDirectors will not be able to make an independent determination of the fair market value of our initial business combination,Business Combination, it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets or prospects. Additionally, pursuant to Nasdaq rules, any initial business combinationBusiness Combination must be approved by a majority of our independent directors. Based on the valuation analysis of our Management and Board of Directors, we have determined that the fair market value of Kustom Entertainment was substantially in excess of 80% of the funds in the Trust Account and that the 80% test was therefore satisfied.

We will have until July 22, 2022 (122024 (36 months from the closing of our initial public offering)Initial Public Offering) to consummate an initial business combination. However, if we anticipate that we may not be able to consummate our initial business combination within 12 months, we may extend the period of time to consummate a business combination by three additional three month periods (for a total of up to 21 months to complete a business combination) without submitting such proposed extensions to our stockholders for approval or offering our public stockholders redemption rights in connection therewith. Pursuant to the terms of our amended and restated certificate of incorporation and the trust agreement dated July 19, 2021 between us and Continental Stock Transfer & Trust Company, in order to extend the time available for us to consummate our initial business combination, our sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account for each additional three month period, $1,383,123 for each additional three month period. In the event that we receive notice from our sponsor five days prior to the applicable deadline of their intent to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the applicable deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the funds had been timely deposited. Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of our initial business combination. If we complete our initial business combination, we will, at the option of our sponsor, repay such loaned amounts out of the proceeds of the trust account released to us or convert a portion or all of the total loan amount into units at a price of $10.00 per unit, which units will be identical to the private placement units. If we do not complete a business combination, we will repay such loans only from funds held outside of the trust account. Furthermore, the letter agreement with our initial stockholders contains a provision pursuant to which our sponsor has agreed to waive its right to be repaid for such loans out of the funds held in the trust account in the event that we do not complete a business combination. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination.


Business Combination. We anticipate structuring our initial business combinationBusiness Combination either (i) in such a way so that the post-transaction company in which our public stockholdersPublic Stockholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses, or (ii) in such a way so that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or stockholders, or for other reasons. However, we will only complete an initial business combinationBusiness Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the “Investment Company Act”.Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target, our stockholders prior to the initial business combinationBusiness Combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the initial business combination.Business Combination. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target.

However, as a result of the issuance of a substantial number of new shares, our stockholders immediately prior to our initial business combinationBusiness Combination could own less than a majority of our outstanding shares subsequent to our initial business combination.Business Combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be taken into account for purposes of Nasdaq’s 80% of net assets test. If the initial business combinationBusiness Combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the transactions and we will treat the target businesses together as the initial business combinationBusiness Combination for purposes of a tender offer or for seeking stockholder approval, as applicable.

Our Business Combination Process

In evaluating prospective business combinations,Business Combinations, such as the Kustom Entertainment Business Combination, we expect to conduct a thorough due diligence review process that will encompass,encompasses, among other things, a review of historical and projected financial and operating data, meetings with management and their advisors (if applicable), on-site inspection of facilities and assets, discussion with customers and suppliers, legal reviews and other reviews as we deem appropriate.

We are not prohibited from pursuing an initial business combinationBusiness Combination with a company that is affiliated with our sponsorSponsor or our officers or directors. InWhile Kustom Entertainment is not affiliated with our Sponsor, executive officers or directors, in the event we do not consummate the Kustom Entertainment Business Combination and we seek to complete our initial business combinationBusiness Combination with a company that is affiliated with our sponsor,Sponsor, officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm that our initial business combinationBusiness Combination is fair to our companyCompany from a financial point of view.


Our officers and directors indirectly own founder sharesFounder Shares and/or private placement units.Private Placement Units. Because of this ownership, our sponsorSponsor and our officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.Business Combination. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combinationBusiness Combination if the retention or resignation of any such officers and directors were to be included by a target business as a condition to any agreement with respect to our initial business combination.Business Combination.

Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combinationBusiness Combination opportunity. Accordingly, if any of our officers or directors becomes aware of a business combinationBusiness Combination opportunity whichthat is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she has honored and will continue to honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We believe, however, that the fiduciary duties or contractual obligations of our officers or directors will not materially affect our ability to complete our initial business combination.Business Combination. Our amendedAmended and restated certificate of incorporation willRestated Charter provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our companyCompany and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation.

Our sponsor,Sponsor, officers and directors may participate in the formation of, or become an officer or director of, any other blank check company prior to completion of our initial business combination.Business Combination. As a result, our sponsor,Sponsor, officers or directors could have conflicts of interest in determining whether to present business combinationBusiness Combination opportunities to us or to any other blank check company with which they may become involved.


Our Management Team

Members of our management teamManagement Team are not obligated to devote any specific number of hours to our matters, but they devote as much of their time as they deem necessary to our affairs and intend to continue doing so until we have completed our initial business combination.Business Combination. The amount of time that any member of our management teamManagement Team devotes in any time period may vary based on whether a target business has been selected for our initial business combinationBusiness Combination and the current stage of the business combinationBusiness Combination process.

We believe our management team’sManagement Team’s operating and transaction experience and relationships with companies provide us with a substantial number of potential business combinationBusiness Combination targets. Over the course of their careers, the members of our management teamManagement Team have developed a broad network of contacts and corporate relationships in various industries. This network has grown through the activities of our management teamManagement Team sourcing, acquiring and financing businesses, our management team’sManagement Team’s relationships with sellers, financing sources and target management teams and the experience of our management teamManagement Team in executing transactions under varying economic and financial market conditions.

Status as a Public Company

We believe our structure makes us an attractive business combinationBusiness Combination partner to target businesses.businesses, such as Kustom Entertainment. As aan existing public company, we offer a target business an alternative to the traditional initial public offering through a merger or other business combinationBusiness Combination with us. Following an initial business combination,Business Combination, we believe the target business would have greater access to capital and additional means of creating management incentives that are better aligned with stockholders’ interests than it would as a private company. A target business can further benefit by augmenting its profile among potential new customers and vendors and aid in attracting talented employees. In a business combinationBusiness Combination transaction with us, the owners of the target business may, for example, exchange their shares of stock in the target business for our shares of Class A common stockCommon Stock (or shares of a new holding company) or for a combination of our shares of Class A common stockCommon Stock and cash, allowing us to tailor the consideration to the specific needs of the sellers. See “Kustom Entertainment Business Combination” above for more information regarding such an exchange in the Kustom Entertainment Business Combination.


Although there are various costs and obligations associated with being a public company, we believe target businesses will find this method a more expeditious and cost effectivecost-effective method to becoming a public company than the typical initial public offering.Initial Public Offering. The typical initial public offeringInitial Public Offering process takes a significantly longer period of time than the typical business combinationBusiness Combination transaction process, and there are significant expenses in the initial public offeringInitial Public Offering process, including underwriting discounts and commissions, marketing and road show efforts that may not be present to the same extent in connection with an initial business combinationBusiness Combination with us.

Furthermore, once a proposed initial business combinationBusiness Combination such as the Kustom Entertainment Business Combination, is completed, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriters’ ability to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring or could have negative valuation consequences. Following an initial business combination,Business Combination, we believe the target business would then have greater access to capital and an additional means of providing management incentives consistent with stockholders’ interests and the ability to use its shares as currency for acquisitions. Being a public company can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.

While we believe that our structure and our management team’sManagement Team’s backgrounds will make us an attractive business partner, some potential target businesses may view our status as a blank check company, such as our lack of an operating history and our ability to seek stockholder approval of any proposed initial business combination,Business Combination, negatively.

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.Financial Position

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.


We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following July 22, 2026, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.

Financial Position

With funds available in the trust accountTrust Account for an initial business combinationBusiness Combination in the amount of $135,546,054 afterapproximately $14,648,926 as of December 31, 2023, before (i) payment of $4,840,931 of deferred underwriting fees, before fees and expenses associated with our initial business combination,Business Combination and (iii) taxes payable on the income earned on the Trust Account, we offer a target business, such as Kustom Entertainment, a variety of options such as creating a liquidity event for its owners, providing capital for the potential growth and expansion of its operations or strengthening its balance sheet by reducing its debt or leverage ratio. Because we are able to complete our initial business combinationBusiness Combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires. However, we have not taken any steps to secure third partythird-party financing and there can be no assurance it will be available to us.


Effecting Our Initial Business Combination

We are not presently engaged in, and we will not engage in, any operations for an indefinite period of time. We intend to effectuate our initial business combinationBusiness Combination using cash from the proceeds of our initial public offeringInitial Public Offering and the private placement of the private placement units,Private Placement, the proceeds of the sale of our shares in connection with our initial business combinationInitial Business Combination (including pursuant to any forward purchase agreements or backstop agreements we may enter into or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing. We may seek to complete our initial business combinationBusiness Combination with a company or business that may be financially unstable or in its early stages of development or growth, which would subject us to the numerous risks inherent in such companies and businesses.

If our initial business combinationInitial Business Combination is paid for using equity or debt securities, or not all of the funds released from the trust accountTrust Account are used for payment of the consideration in connection with our initial business combinationInitial Business Combination or used for redemptions of our Class A common stock,Common Stock, we may apply the balance of the cash released to us from the trust accountTrust Account for general corporate purposes, including for maintenance or expansion of operations of the post-transaction company, the payment of principal or interest due on indebtedness incurred in completing our initial business combination,Initial Business Combination, to fund the purchase of other companies or for working capital.

We may seek to raise additional funds through a private offering of debt or equity securities in connection with the completion of our initial business combination,Business Combination, and we may effectuate our initial business combinationBusiness Combination using the proceeds of such offering rather than using the amounts held in the trust account.Trust Account. In addition, we intend to targetare targeting businesses larger than we could acquire with the net proceeds of our initial public offeringInitial Public Offering and the sale of the private placement units,Private Placement and may as a result be required to seek additional financing to complete such proposed initial business combination.Business Combination. Subject to compliance with applicable securities laws, we would expect to complete such financing only simultaneously with the completion of our initial business combination.Business Combination. In the case of an initial business combinationBusiness Combination funded with assets other than the trust accountTrust Account assets, our proxy materials or tender offer documents disclosing the initial business combinationBusiness Combination would disclose the terms of the financing and, only if required by law, we would seek stockholder approval of such financing. There are no prohibitions on our ability to raise funds privately, or through loans in connection with our initial business combination.Business Combination. At this time, we are not a party to any arrangement or understanding with any third party with respect to raising any additional funds through the sale of securities or otherwise.


Sources of Target Businesses

We anticipate thathave received and may continue to receive a number of proprietary transaction opportunities to originate as a result of the business relationships, direct outreach, and deal sourcing activities of our Management Team. In addition to the proprietary deal flow, target business candidates willhave been and may continue to be brought to our attention from various unaffiliated sources, including investment bankers and investment professionals. Target businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us by calls or mailings. Our officers and directors, as well as our sponsorSponsor and their affiliates, may also bring to our attention target business candidates that they become aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In addition, we expect tomay receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us as a result of the business relationships of our officers and directors and our sponsorSponsor and their affiliates. While we do not presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay a finder’s fee, consulting fee, advisory fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction. We expect to engage a finder only to the extent our managementManagement determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or if finders approach us on an unsolicited basis with a potential transaction that our managementManagement determines is in our best interest to pursue. Payment of finder’s fees is customarily tied to completion of a transaction, in which case any such fee will be paid out of the funds held in the trust account.Trust Account. In no event, however, will our sponsorSponsor or any of our existing officers or directors, or any entity with which our sponsorSponsor or officers are affiliated, be paid any finder’s fee, reimbursement, consulting fee, monies in respect of any payment of a loan or other compensation by the company prior to, or in connection with any services rendered for any services they renderit renders in order to effectuate, the completion of our initial business combinationBusiness Combination (regardless of the type of transaction that it is). None of our sponsor,Sponsor, executive officers or directors, or any of their respective affiliates, will be allowed to receive any compensation, finder’s fees or consulting fees from a prospective business combinationBusiness Combination target in connection with a contemplated initial business combination.Business Combination. We have agreed to pay an affiliate of our sponsorSponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support pursuant to the Administrative Support Agreement and to reimburse our sponsorSponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination.Business Combination. Some of our officers and directors may enter into employment or consulting agreements with the post-transaction company following our initial business combination.Business Combination. The presence or absence of any such fees or arrangements will not be used as a criterion in our selection process of an initial business combinationBusiness Combination candidate.


We are not prohibited from pursuing an initial business combination with an initiala business combination target that is affiliated with our sponsor,Sponsor, officers or directors or making the initial business combinationBusiness Combination through a joint venture or other form of shared ownership with our sponsor,Sponsor, officers or directors. InWhile Kustom Entertainment is not affiliated with our Sponsor, executive officers or directors, in the event we do not consummate the Kustom Entertainment Business Combination and we seek to complete our initial business combinationBusiness Combination with an initial business combinationBusiness Combination target that is affiliated with our sponsor,Sponsor, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm which is a member of FINRA or an independent accounting firm that such an initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.

If any of our officers or directors becomes aware of an initial business combinationBusiness Combination opportunity that falls within the line of business of any entity to which he or she has pre-existing fiduciary or contractual obligations, he or she may be required to present such business combinationBusiness Combination opportunity to such entity prior to presenting such business combinationBusiness Combination opportunity to us. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.

Selection of a Target Business and Structuring of our Initial Business Combination

Nasdaq rules require that we must complete one or more business combinationsBusiness Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust accountTrust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account)Trust Account) at the time of our signing a definitive agreement in connection with our initial business combination.Business Combination. The fair market value of our initial business combinationBusiness Combination will be determined by our boardBoard of directorsDirectors based upon one or more standards generally accepted by the financial community, such as discounted cash flow valuation, a valuation based on trading multiples of comparable public businesses or a valuation based on the financial metrics of M&Amergers and acquisitions transactions of comparable businesses. If our boardBoard of directorsDirectors is not able to independently determine the fair market value of our initial business combination,Business Combination, we will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm with respect to the satisfaction of such criteria. While we consider it unlikely that our boardBoard of directorsDirectors will not be able to make an independent determination of the fair market value of our initial business combination,Business Combination, it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount of uncertainty as to the value of a target’s assets or prospects. We do not intend to purchase multiple businesses in unrelated industries in conjunction with our initial business combination.Business Combination. Subject to this requirement, our managementManagement will have virtually unrestricted flexibility in identifying and selecting one or more prospective target businesses, although we will not be permitted to effectuate our initial business combinationBusiness Combination with another blank check company or a similar company with nominal operations.


In any case, we will only complete an initial business combinationBusiness Combination in which we own or acquire 50% or more of the outstanding voting securities of the target or otherwise acquire a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. If we own or acquire less than 100% of the equity interests or assets of a target business or businesses, the portion of such business or businesses that are owned or acquired by the post-transaction company is what will be taken into account for purposes of Nasdaq’s 80% of net assets test.


To the extent we effect our initial business combinationBusiness Combination with a company or business that may be financially unstable or in its early stages of development or growth, we may be affected by numerous risks inherent in such company or business. Although our managementManagement will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all significant risk factors.

In evaluating a prospective business target, we expect to conduct a thorough due diligence review, which may encompass,encompasses, among other things, meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities, as well as a review of financial and other information that will beis made available to us.

The time required to select and evaluate a target business and to structure and complete our initial business combination,Business Combination, and the costs associated with this process, areis not currently ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target business with which our initial business combinationBusiness Combination is not ultimately completed will result in our incurring losses and will reduce the funds we can use to complete another business combination.Business Combination.

Lack of Business Diversification

For an indefinite period of time after the completion of our initial business combination,Business Combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities that have the resources to complete business combinationsBusiness Combinations with multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. In addition, we are focusing our search for an initial business combinationBusiness Combination in a single industry. By completing our initial business combinationBusiness Combination with only a single entity, our lack of diversification may:

subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination,Business Combination, and

cause us to depend on the marketing and sale of a single product or limited number of products or services.

Limited Ability to Evaluate the Target’s Management Team

Although we intend to closely scrutinize the management of a prospective target business, including the management team of Kustom Entertainment, when evaluating the desirability of effecting our initial business combinationBusiness Combination with that business, and plan to continue to do so if the Kustom Entertainment Business Combination is not consummated and we seek other Business Combination opportunities, our assessment of the target business’ management may not prove to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our management team,Management Team, if any, in the target business cannot presently be stated with any certainty. The determination as to whether any of the members of our management teamManagement Team will remain with the combined company will be made at the time of our initial business combination.Business Combination. While it is possible that one or more of our directors will remain associated in some capacity with us following our initial business combination,Business Combination, including the Kustom Entertainment Business Combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent to our initial business combination. Moreover, we cannot assure you that members of our management team will have significant experience or knowledge relating to the operations of the particular target business.Business Combination.

We cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether any of our key personnel will remain with the combined company will be made at the time of our initial business combination.Business Combination.

Following an initial business combination,Business Combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.


 

Stockholders May Not Have the Ability to Approve Our Initial Business Combination

We may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC. However, we will seek stockholder approval if it is required by law or applicable stock exchange rule (as is the case for Kustom Entertainment as currently contemplated), or we may decide to seek stockholder approval for business or other legal reasons. Presented in the table below is a graphic explanation of the types of initial business combinationsBusiness Combinations we may consider and whether stockholder approval is currently required under Delaware law for each such transaction.

Type of TransactionWhether
Stockholder
Approval Is
Required
Purchase of assetsNo
Purchase of stock of target not involving a merger with the companyNo
Merger of target into a subsidiary of the companyNo
Merger of the companyour Company with a targetYes

Under Nasdaq’s listing rules, stockholder approval would be required for our initial business combinationBusiness Combination if, for example:

we issue shares of Class A common stockCommon Stock that will be equal to or in excess of 20% of the number of shares of our Class A common stockCommon Stock then outstanding;

any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stockCommon Stock could result in an increase in outstanding common shares or voting power of 5% or more; or

the issuance or potential issuance of common stockCommon Stock will result in our undergoing a change of control.

The decision as to whether we will seek stockholder approval of a proposed Business Combination in those instances in which stockholder approval is not required by applicable law or stock exchange rules will be made by us, solely in our discretion, and will be based on business and legal reasons, which include a variety of factors,

including, but not limited to:

the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on us;

the expected cost of holding a stockholder vote;

the risk that the stockholders would fail to approve the proposed Business Combination;

other time and budget constraints of the Company; and

additional legal complexities of a proposed Business Combination that would be time-consuming and burdensome to present to stockholders.

See “Kustom Entertainment Business Combination” above for more information regarding the requisite approvals needed in the Kustom Entertainment Business Combination.


Permitted Purchases of our Securities

If we seek stockholder approval of our initial business combinationBusiness Combination and we do not conduct redemptions in connection with our initial business combinationBusiness Combination pursuant to the tender offer rules, our sponsor, initial stockholders,Sponsor, Initial Stockholders, directors, officers, advisors or their affiliates may purchase sharesPublic Shares or public rightsPublic Rights in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination.Business Combination. There is no limit on the number of sharesPublic Shares our initial stockholders,Initial Stockholders, directors, officers, advisors or their affiliates may purchase in such transactions, subject to compliance with applicable law and Nasdaq rules. However, they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. If they engage in such transactions, they will not make any such purchases when they are in possession of any material nonpublic information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements. None of the funds held in the trust accountTrust Account will be used to purchase shares or public rightsPublic Rights in such transactions prior to completion of our initial business combination.Business Combination.

The purpose of any such purchases of sharesPublic Shares could be to vote such shares in favor of the initial business combinationBusiness Combination and thereby increase the likelihood of obtaining stockholder approval of the initial business combinationBusiness Combination or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination,Business Combination, where it appears that such requirement would otherwise not be met. The purpose of any such purchases of rightsPublic Rights could be to reduce the number of rights, or underlying securities, outstanding. Any such purchases of our securities may result in the completion of our initial business combinationBusiness Combination that may not otherwise have been possible. In addition, if such purchases are made, the public “float” of our shares of Class A common stockCommon Stock or rights may be reduced and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.


Our sponsor,Sponsor, officers, directors and/or their affiliates anticipate that they may identify the stockholdersPublic Stockholders with whom our sponsor,Sponsor, officers, directors or their affiliates may pursue privately negotiated purchases by either the stockholdersPublic Stockholders contacting us directly or by our receipt of redemption requests submitted by stockholdersPublic Stockholders following our mailing of proxy materials in connection with our initial business combination.Business Combination. To the extent that our sponsor,Sponsor, officers, directors, advisors or their affiliates enter into a private purchase, they would identify and contact only potential selling stockholdersPublic Stockholders who have expressed their election to redeem their sharesPublic Shares for a pro-rata share of the trust accountTrust Account or vote against our initial business combination,Business Combination, whether or not such stockholderPublic Stockholder has already submitted a proxy with respect to our initial business combination.Business Combination. Our sponsor,Sponsor, officers, directors, advisors or their affiliates will only purchase sharesPublic Shares if such purchases comply with Regulation M under the Exchange Act and the other federal securities laws.

Any purchases by our sponsor,Sponsor, officers, directors and/or their affiliates who are affiliated purchasers under Rule 10b-18 under the Exchange Act will only be made to the extent such purchases are able to be made in compliance with Rule 10b-18, which is a safe harbor from liability for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. Rule 10b-18 has certain technical requirements that must be complied with in order for the safe harbor to be available to the purchaser. Our sponsor,Sponsor, officers, directors and/or their affiliates will not make purchases of common stockCommon Stock if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent such purchases are subject to such reporting requirements.

See “Kustom Entertainment Business Combination” above for more information regarding such purchases in connection with the Kustom Entertainment Business Combination.


Redemption Rights for Public Stockholders upon Completion of our Initial Business Combination

We will provide our public stockholdersPublic Stockholders with the opportunity to redeem all or a portion of their shares of Class A common stockRedemption opportunities upon the completion of our initial business combinationBusiness Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust accountTrust Account as of two business days prior to the consummation of the initial business combinationBusiness Combination, such as the Kustom Entertainment Business Combination, including interest earned on the funds held in the trust accountTrust Account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares,Public Shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to beTrust Account as of December 31, 2023 was approximately $10.15$11.85 per public share.Public Share. The per-share amount we will distribute to investorsPublic Stockholders who properly redeem their sharesPublic Shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters.underwriters of our Initial Public Offering. Our sponsor,Sponsor, officers and directors have entered into a letter agreementthe Letter Agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares, private placement sharesFounder Shares, Private Placement Shares and public sharesPublic Shares held by them in connection with the completion of our initial business combination.Business Combination.

Manner of Conducting Redemptions

We will provide our public stockholdersPublic Stockholders with the opportunity to redeem all or a portion of their shares of Class A common stockRedemption opportunities upon the completion of our initial business combinationBusiness Combination either (i) in connection with a stockholder meeting called to approve the initial business combinationBusiness Combination, such as the Kustom Entertainment Business Combination, or (ii) by means of a tender offer.offer if the Kustom Entertainment Business Combination is not consummated. The decision as to whether we will seek stockholder approval of a proposed initial business combinationBusiness Combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require us to seek stockholder approval under the law or stock exchange listing requirement. Under Nasdaq rules, asset acquisitions and stock purchases would not typically require stockholder approval while direct mergers with our companyCompany where we do not survive and any transactions where we issue more than 20% of our outstanding common stockCommon Stock or seek to amend our amendedAmended and restated certificate of incorporationRestated Charter would require stockholder approval. If we structure an initial business combinationBusiness Combination with a target company in a manner that requires stockholder approval, we will not have discretion as to whether to seek a stockholder vote to approve the proposed initial business combination.Business Combination. We may conduct redemptions without a stockholder vote pursuant to the tender offer rules of the SEC unless stockholder approval is required by law or stock exchange listing requirements or we choose to seek stockholder approval for business or other legal reasons. To maintain thelistingthe listing for our securities on Nasdaq, we are be required to comply with such rules.

If a stockholder vote is not required and we do not decide to hold a stockholder vote for business or other legal reasons, we will, pursuant to our amendedAmended and restated certificate of incorporation:Restated Charter:

conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and

file tender offer documents with the SEC prior to completing our initial business combinationBusiness Combination which contain substantially the same financial and other information about the initial business combinationBusiness Combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.

Upon the public announcement of our initial business combination,Business Combination, we or our sponsorSponsor will terminate any plan established in accordance with Rule 10b5-1 to purchase shares of our Class A common stockCommon Stock in the open market if we elect to redeem our public sharesPublic Shares through a tender offer, to comply with Rule 14e-5 under the Exchange Act.


In the event we conduct redemptionsRedemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combinationBusiness Combination until the expiration of the tender offer period. In addition, the tender offer will be conditioned on public stockholdersPublic Stockholders not tendering more than a specified number of public sharesPublic Shares which are not purchased by our sponsor,Sponsor, which number will be based on the requirement that we will only redeem our public sharesPublic Shares so long as (after such redemption)Redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combinationBusiness Combination and after payment of underwriters’ fees and commissions (so that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination.Business Combination. If public stockholdersPublic Stockholders tender more shares than we have offered to purchase, we will withdraw the tender offer and not complete the initial business combination.Business Combination.


If, however, stockholder approval of the transaction is required by law or stock exchange listing requirement, or we decide to obtain stockholder approval for business or other legal reasons, we will, pursuant to our amendedAmended and restated certificate of incorporation:Restated Charter:

conduct the redemptionsRedemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and

file proxy materials with the SEC.

In the event that we seek stockholder approval of our initial business combination,Business Combination, we will distribute proxy materials and, in connection therewith, provide our public stockholdersPublic Stockholders with the redemptionRedemption rights described above upon completion of the initial business combination.Business Combination.

If we seek stockholder approval, we will complete our initial business combinationBusiness Combination only if a majority of the outstanding shares of common stockCommon Stock voted are voted in favor of the initial business combination.Business Combination. A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the companyCompany representing a majority of the voting power of all outstanding shares of capital stock of the companyCompany entitled to vote at such meeting. Our initial stockholdersInitial Stockholders will count toward this quorum and pursuant to the letter agreement,Letter Agreement, our sponsor, officersSponsor and directorsInitial Stockholders have agreed to vote their founder shares, private placement sharesFounder Shares, Private Placement Shares and public sharesPublic Shares purchased during or after our initial public offeringInitial Public Offering (including in open market and privately negotiated transactions) in favor of our initial business combination.Business Combination. For purposes of seeking approval of the majority of our outstanding shares of common stockCommon Stock voted, non-votes will have no effect on the approval of our initial business combinationBusiness Combination once a quorum is obtained. As a result, in addition to our initial stockholders’ founder sharesInitial Stockholders’ Founder Shares and the private placement shares,Private Placement Shares, unless otherwise required under applicable law we would not need only 4,848,916, or 35.1%, (assuming all issued and outstanding shares are voted), or 2,424,459, or 17.6%  (assuming only the minimum number of shares representing a quorum are voted),any of the 13,831,230 public sharesPublic Shares sold in our initial public offeringInitial Public Offering to be voted in favor of an initial business combinationBusiness Combination in order to have our initial business combination approved (assuming in each case that the over-allotment option is not exercised).Business Combination approved. We intend to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required, at which a vote shall be taken to approve our initial business combination.Business Combination. These quorum and voting thresholds, and the voting agreements of our initial stockholders,Initial Stockholders, may make it more likely that we will consummate our initial business combination.Business Combination. Each public stockholderPublic Stockholder may elect to redeem its public sharesPublic Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Our amendedAmended and restated certificate of incorporationRestated Charter provides that we will only redeem our public sharesPublic Shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combinationBusiness Combination and after payment of underwriters’ fees and commissions (so that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination.Business Combination. For example, the proposed initial business combinationBusiness Combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred to the target for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions in accordance with the terms of the proposed initial business combination.Business Combination. In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stockCommon Stock that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed initial business combinationBusiness Combination exceed the aggregate amount of cash available to us, we will not complete the initial business combinationBusiness Combination or redeem any shares, and all shares of Class A common stockCommon Stock submitted for redemptionRedemption will be returned to the holders thereof.

Limitation on Redemption upon Completion of our Initial Business Combination if we Seek Stockholder Approval

Notwithstanding the foregoing, if we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 2,074,685, or 15% of the shares sold in our initial public offering, which we refer to as the “Excess Shares.” Such restriction shall also be applicable to our affiliates.

 


 

Ability to Extend Time to Complete Business Combination

We will have until July 22, 2022, 12 months from the closing of our initial public offering, to consummate an initial business combination. However, if we anticipate that we may not be able to consummate our initial business combination within 12 months, we may extend the period of time to consummate a business combination for three additional three month periods (for a total of up to 21 months to complete a business combination) without submitting such proposed extensions to our stockholders for approval or offering our public stockholders redemption rights in connection therewith. Pursuant to the terms of our amended and restated certificate of incorporation and the trust agreement dated July 19, 2021 between us and Continental, in order to extend the time available for us to consummate our initial business combination, our sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account 1,383,123, or $0.10 per public offering share, on or prior to the date of the applicable deadline, for each such three month extension on or prior to the date of the applicable deadline. In the event that we receive notice from our sponsor five days prior to the applicable deadline of their intent to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the applicable deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the funds had been timely deposited. Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of our initial business combination. If we complete our initial business combination, we will, at the option of our sponsor, repay such loaned amounts out of the proceeds of the trust account released to us or convert a portion or all of the total loan amount into units at a price of $10.00 per unit, which units will be identical to the private placement units. If we do not complete a business combination, we will repay such loans only from funds held outside of the trust account. Furthermore, the letter agreement with our initial stockholders contains a provision pursuant to which our sponsor has agreed to waive its right to be repaid for such loans out of the funds held in the trust account in the event that we do not complete a business combination. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination.

 

Redemption of Public Shares and Liquidation if no Initial Business Combination

 

Our amendedAmended and restated certificate of incorporationRestated Charter provides that we will have until July 21, 2022 (or until April 21, 2023,if we extend the period of time to consummate a business combination)22, 2024 to complete our initialInitial business combination.Combination. If we are unable to completehave not completed our initial business combination withinBusiness Combination by July 21, 2022 (or up to April 21, 2023),the end of the Combination Period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust accountTrust Account including interest earned on the funds held in the trust accountTrust Account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,Public Shares, which redemptionRedemption will completely extinguish public stockholders’Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our boardBoard of directors,Directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our rights,Rights, which will expire worthless if we fail to complete our initial business combinationBusiness Combination by July 21, 2022 (or April 21, 2023, if extended).the end of the Combination Period.

 

Our sponsor,Sponsor, officers and directors have entered into a letter agreementthe Letter Agreement with us, pursuant to which they have waived their rights to liquidating distributions from the trust accountTrust Account with respect to any founder sharesFounder Shares and private placement sharesPrivate Placement Shares held by them if we fail to complete our initial business combinationBusiness Combination by July 22, 2021 (or by April 22, 2023, if we extend the periodend of time to consummate a business combinationthe Combination Period. However, if our sponsor,Sponsor, officers or directors acquire public shares,Public Shares, they will be entitled to liquidating distributions from the trust accountTrust Account with respect to such public sharesPublic Shares if we fail to complete our initial business combinationBusiness Combination by July 22, 2021 (or by April 21, 2023, if extended).the end of the Combination Period.


 

Our sponsor,Sponsor, officers and directors have agreed, pursuant to a written agreement with us, that they will not propose any amendment to our amendedAmended and restated certificate of incorporationRestated Charter (i) to modify the substance or timing of our obligation to redeem 100% of our public sharesPublic Shares if we do not complete our initial business combination byBusiness Combination prior to the required timeend of the Combination Period or (ii) with respect to any other provision relating to stockholders’ rights or pre-initialbusiness combinationpre-initial Business Combination activity, unless we provide our public stockholdersPublic Stockholders with the opportunity to redeem their shares of Class A common stockCommon Stock upon approval of any such amendment at a per-shareprice,per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust accountTrust Account including interest earned on the funds held in the trust accountTrust Account and not previously released to us to pay our franchise and income taxes divided by the number of then outstanding public shares.Public Shares. However, we will only redeem our public sharesPublic Shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combinationBusiness Combination and after payment of underwriters’ fees and commissions (so that we are not subject to the SEC’s “penny stock” rules). If this optional redemptionRedemption right is exercised with respect to an excessive number of public sharesPublic Shares such that we cannot satisfy the net tangible asset requirement (described above), we would not proceed with the amendment or the related redemptionRedemption of our public sharesPublic Shares at such time.


 

We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, willwould be funded from amounts remaining out of the approximately $1,350,000$162,933 of proceeds held outside the trust account,Trust Account as of December 31, 2023, although we cannot assure you that there will be sufficient funds for such purpose. We will depend on sufficient interest being earned on the proceeds held in the trust accountTrust Account to pay any franchise and income tax obligations we may owe. However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the extent that there is any interest accrued in the trust accountTrust Account not required to pay franchise and income taxes on interest income earned on the trust accountTrust Account balance, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest to pay those costs and expenses.

 

If we were to expend all of the net proceeds of our initial public offeringInitial Public Offering of unitsUnits and the salePrivate Placement of the private placement units,Private Placement Units, other than the proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account,Trust Account, the per-share redemption amount received by stockholdersPublic Stockholders upon our dissolution would be approximately $10.15.$11.85 as of December 31, 2023 (before taking into account the withdrawal of interest to pay taxes, if any, and up to $100,000 in dissolution expenses). The proceeds deposited in the trust accountTrust Account could, however, become subject to the claims of our creditors which would have higher priority than the claims of our public stockholders.Public Stockholders. We cannot assure you that the actual per-share redemptionRedemption amount received by stockholders will not be substantially less than $10.15.$11.85. Under Section 281(b) of the DGCL, our plan of dissolution must provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient assets. These claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.

 

Although we will have sought and will continue to seek to have all vendors, service providers (other than our independent auditor), prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust accountTrust Account for the benefit of our public stockholders,Public Stockholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the trust accountTrust Account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the trust account.Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account,Trust Account, our managementManagement will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if managementManagement believes that such third party’s engagement would be significantly more beneficial to us than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third partythird-party consultant whose particular expertise or skills are believed by managementManagement to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where managementManagement is unable to find a service provider willing to execute a waiver. Marcum, LLP, our independent registered public accounting firm, and the underwriters of the offering,our Initial Public Offering will not execute agreements with us waiving such claims to the monies held in the trust account.Trust Account.

 

In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust accountTrust Account for any reason. Our sponsorSponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or similar agreement or business combinationBusiness Combination agreement, reduce the amount of funds in the trust accountTrust Account to below the lesser of (i) $10.15 per public sharePublic Share and (ii) the actual amount per public sharePublic Share held in the trust accountTrust Account as of the date of the liquidation of the trust account,Trust Account, if less than $10.15 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust accountTrust Account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of our initial public offeringInitial Public Offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked our sponsorSponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsorSponsor has sufficient funds to satisfy its indemnity obligations and believe that our sponsor’sSponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsorSponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

 


 

 

In the event that the proceeds in the trust accountTrust Account are reduced below (i) $10.15 per public sharePublic Share or (ii) such lesser amount per public sharePublic Share held in the trust accountTrust Account as of the date of the liquidation of the trust account,Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and our sponsorSponsor asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsorSponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our sponsorSponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. We have not asked our sponsorSponsor to reserve for such indemnification obligations and we cannot assure you that our sponsorSponsor would be able to satisfy those obligations. Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemptionRedemption price will not be less than $10.15 per public share.Public Share.

 

We seek to reduce the possibility that our sponsorSponsor has to indemnify the trust accountTrust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than our independent auditor), prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account.Trust Account. Our sponsorSponsor will also not be liable as to any claims under our indemnity of the underwriters of our initial public offeringInitial Public Offering against certain liabilities, including liabilities under the Securities Act. WeAs of December 31, 2023 have access to up to approximately $1,350,000$262,933 from the proceedsfunds held outside of our initial public offeringthe Trust Account with which to pay any such potential claims (including costs and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000). In the event that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, stockholders who received funds from our trust accountTrust Account could be liable for claims made by creditors.

 

Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. The pro-rata portion of our trust accountTrust Account distributed to our public stockholdersPublic Stockholders upon the redemption of our public sharesPublic Shares in the event we do not complete our initial business combinationBusiness Combination by July 22, 2021 (or by April 22, 2023, if we extend the periodend of time to consummate a business combination)the Combination Period may be considered a liquidating distribution under Delaware law. If the corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro-rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.

 

Furthermore, if the pro-rata portion of our trust accountTrust Account distributed to our public stockholdersPublic Stockholders upon the redemption of our public sharesPublic Shares in the event we do not complete our initial business combinationBusiness Combination within the specified time is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful (potentially due to the imposition of legal proceedings that a party may bring or due to other circumstances that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. If we are unable to complete our initial business combinationBusiness Combination by July 22, 2021 (or by April 22, 2023 if we extend the period of time to consummate a business combination),2024, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust accountTrust Account including interest earned on the funds held in the trust accountTrust Account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,Public Shares, which redemptionRedemption will completely extinguish public stockholders’Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,Redemption, subject to the approval of our remaining stockholders and our boardBoard of directors,Directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly, it is our intention to redeem our public sharesPublic Shares as soon as reasonably possible following our July 22, 2021 (or April 22, 2023)the end of the Combination Period and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary of such date.

 


 

 

Because we are not complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against us within the subsequent 10 years. However, because we are a blank check company, rather than an operating company, and our operations are limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers and auditors) or prospective target businesses. As described above, pursuant to the obligation contained in our underwriting agreement, we have sought and will continue to seek to have all vendors, service providers (other than our independent auditor), prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account.Trust Account. As a result of this obligation, the claims that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending to the trust accountTrust Account is remote. Further, our sponsorSponsor may be liable only to the extent necessary to ensure that the amounts in the trust accountTrust Account are not reduced below (i) $10.15 per public sharePublic Share or (ii) such lesser amount per public sharePublic Share held in the trust accountTrust Account as of the date of the liquidation of the trust account,Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest withdrawn to pay taxes and will not be liable as to any claims under our indemnity of the underwriters of our initial public offeringInitial Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsorSponsor will not be responsible to the extent of any liability for such third-party claims.

 

If we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust accountTrust Account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the trust account,Trust Account, we cannot assure you we will be able to return $10.15 per share to our public stockholders.Public Stockholders. Additionally, if we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover some or all amounts received by our stockholders. Furthermore, our boardBoard of directorsDirectors may be viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, thereby exposing itself and our companyCompany to claims of punitive damages, by paying public stockholdersPublic Stockholders from the trust accountTrust Account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.

 

Our public stockholdersPublic Stockholders will be entitled to receive funds from the trust accountTrust Account only upon the earlier to occur of: (i) the completion of our initial business combination,Business Combination, (ii) the redemption of any public sharesPublic Shares properly tendered in connection with a stockholder vote to amend any provisions of our amendedAmended and restated certificate of incorporationRestated Charter (A) to modify the substance or timing of our obligation to redeem 100% of our public sharesPublic Shares if we do not complete our initial business combination within 12 months fromBusiness Combination by the closingend of our initial public offering (or up to 21 months from the closing of our initial public offering if we extend the period of time to consummate a business combination)Combination Period or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity,Business Combination Activity, and (iii) the redemptionRedemption of all of our public sharesPublic Shares if we are unable to complete our business combination by July 22, 2022 (or April 22, 2023, if we extend the periodend of time to consummate a business combination),the Combination Period, subject to applicable law. In no other circumstances will a stockholder have any right or interest of any kind to or in the trust account.Trust Account. In the event we seek stockholder approval in connection with our initial business combination,Business Combination, a stockholder’s voting in connection with the initial business combinationBusiness Combination alone will not result in a stockholder’s redeeming its shares to us for an applicable pro-rata share of the trust account.Trust Account. Such stockholder must have also exercised its redemptionRedemption rights as described above. These provisions of our amendedAmended and restated certificate of incorporation,Restated Charter, like all provisions of our amendedAmended and restated certificate of incorporation,Restated Charter, may be amended with a stockholder vote.

 

Competition

 

In identifying, evaluating and selecting a target business for our initial business combination,Business Combination, we have encountered and may continue to encounter intense competition from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, and operating businesses seeking strategic business combinations. Many of these entities are well established and have extensive experience identifying and effecting business combinationsBusiness Combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than we do. Our ability to acquire larger target businesses is limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the initial business combinationBusiness Combination of a target business. Furthermore, our obligation to pay cash in connection with our public stockholdersPublic Stockholders who exercise their redemptionRedemption rights may reduce the resources available to us for our initial business combinationBusiness Combination and our outstanding rights,Rights, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.Business Combination.

  


 

 

Employees

 

We currently have three officers. These individuals are not obligated to devote any specific number of hours to our matters, but they devote as much of their time as they deem necessary and intend to continue doing so to our affairs until we have completed our initial business combination.Business Combination. The amount of time they devote in any time period will varyvaries based on whether a target business has been selected for our initial business combination and the stage of the initial business combinationBusiness Combination process we are in. We do not intend to have any full timefull-time employees prior to the completion of our initial business combination.Business Combination.

 

Periodic Reporting and Financial Information

 

Our units,Units, Class A common stockCommon Stock and rightsRights are registered under the Exchange Act and, accordingly, we have reporting obligations, including the requirement that we file annual, quarterlyAnnual, Quarterly and current reportsCurrent Reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reportsAnnual Reports, including this Report, have contained and will contain financial statements audited and reported on by our independent registered public accountants.

 

We will provide stockholders with audited financial statements of the prospective target business as part of the tender offer materials or proxy solicitation materials sent to stockholders to assist them in assessing the target business.business, such as the Kustom Entertainment Registration Statement. In all likelihood, these financial statements will need to be prepared in accordance with, or reconciled to, GAAP, or IFRS, depending on the circumstances, and the historical financial statements may be required to be audited in accordance with the standards of the PCAOB. These financial statement requirements may limit the pool of potential targets we may conduct an initial business combinationBusiness Combination with because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combinationBusiness Combination within the prescribed time frame. We cannot assure you that any particular target business identified by us as a potential business combinationBusiness Combination candidate will have financial statements prepared in accordance with GAAP or that the potential target business will be able to prepare its financial statements in accordance with the requirements outlined above. To the extent that these requirements cannot be met, we may not be able to acquire the proposed target business. While this may limit the pool of potential business combinationBusiness Combination candidates, we do not believe that this limitation will be material.

 

We are required to evaluate our internal control procedures for the fiscal year ending December 31, 20222023 as required by the Sarbanes-Oxley Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to have our internal control procedures audited. A target company may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such business combination.

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.

We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following July 22, 2026, (b) in which we have total annual gross revenue of at least $1.07$1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our shares of Class A common stockCommon Stock that areis held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30th.

 


 

 

Item 1A.  Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However, belowthe following is a partial list of material risks, uncertainties and other factors that could have a material effect on the Companyus and itsour operations:

 

we are a blank check company and an early-stage company with no revenue or basis to evaluate our ability to select a suitable business target;

 

we may not be able to select an appropriate target business or businesses and complete our initial business combinationBusiness Combination, including the Kustom Entertainment Business Combination, in the prescribed time frame;

 

our expectations around the performance of a prospective target business or businesses, such as Kustom Entertainment, may not be realized;

 

we may not be successful in retaining or recruiting required officers, key employees or directors following our initial business combination;Business Combination, including the Kustom Entertainment Business Combination;

 

our officers and directors may have difficulties allocating their time between theour Company and other businesses and may potentially have conflicts of interest with our business or in approving our initial business combination;Business Combination;

 

we may not be able to obtain additional financing to complete our initial business combinationBusiness Combination or reduce the number of shareholdersstockholders requesting redemption;

 

we may issue our shares to investors in connection with our initial business combinationBusiness Combination at a price that is less than the prevailing market price of our shares at that time;

 

youour stockholders may not be given the opportunity to choose the initial business target or to vote on the initial business combination;Business Combination;

 

trust accountTrust Account funds may not be protected against third party claims or bankruptcy;

 

an active market for our public securities’securities may not develop and youour stockholders will have limited liquidity and trading;

 

the availability to us of funds from interest income on the trust account balance may be insufficient to operate our business prior to the business combination;

our financial performance following a business combinationBusiness Combination with an entity may be negatively affected by their lack of an established record of revenue, cash flows and experienced management;

there may be more competition to find an attractive target for an initial business combination,Business Combination, which could increase the costs associated with completing our initial business combination;Business Combination and may result in our inability to find a suitable target;

 

changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination;Business Combination;

 

if we do not consummate the Kustom Entertainment Business Combination, we may attempt to simultaneously complete business combinationsBusiness Combinations with multiple prospective targets, which may hinder our ability to complete our initial business combinationBusiness Combination and give rise to increased costs and risks that could negatively impact our operations and profitability;

 

we may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after the initial public offering,Initial Public Offering, which may include acting as a financial advisor in connection with an initial business combinationInitial Business Combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred underwriting commissions that will be released from the trust accountTrust Account only upon a completion of an initial business combination.Business Combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after the initial public offering,Initial Public Offering, including, for example, in connection with the sourcing and consummation of an initial business combination;Business Combination;

 


we may attempt to complete our initial business combinationBusiness Combination with a private company about which little information is available, such as Kustom Entertainment, which may result in a business combinationBusiness Combination with a company that is not as profitable as we suspected, if at all;

 


since our initial stockholdersInitial Stockholders will lose their entire investment in us if our initial business combinationBusiness Combination is not completed (other than with respect to any public sharesPublic Shares they may acquire during or after the initial public offering)Initial Public Offering), and because our sponsor,Sponsor, officers and directors may profit substantially even under circumstances in which our public stockholdersPublic Stockholders would experience losses in connection with their investment, a conflict of interest may arise in determining whether a particular business combinationBusiness Combination target is appropriate for our initial business combination;Business Combination;

 

changes in laws or regulations or how such laws or regulations are interpreted or applied, or a failure to comply with any laws or regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations;

the value of the founder sharesFounder Shares following completion of our initial business combinationBusiness Combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our common stockCommon Stock at such time is substantially less than $10.00$11.85 per share;

 

 

resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed our initial business combinationBusiness Combination within the required time period,Combination Period, our public stockholdersPublic Stockholders may receive only approximately $10.00$11.85 per share, or less than such amount in certain circumstances, on the liquidation of our trust accountTrust Account and our rightsRights will expire worthless;

we may not be able to complete an initial Business Combination with certain potential target companies if a proposed transaction with the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations, including the Committee on Foreign Investment in the United States. To the best of our knowledge, approximately 47% of the total allocated membership interests in our Sponsor are owned by U.S. persons on a look-through basis and approximately 53% of interests in our Sponsor owned by non-U.S. persons on a look-through basis. Of the approximately 53% of interests in our Sponsor owned by non-U.S. persons, approximately 27% are owned by persons in Sweden, approximately 9% are owned by persons in Bolivia and 3% are owned by a person in Venezuela.;

recent increases in inflation and interest rates in the United States and elsewhere could make it more difficult for us to consummate an initial Business Combination;

market conditions, economic uncertainty or downturns could adversely affect our business, financial condition, operating results and our ability to consummate a Business Combination;

adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions, could adversely affect our business, financial condition or results of operations, or our prospects

military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial condition of potential target companies, which could make it more difficult for us to consummate an initial Business Combination; 

inappropriate  use of the funds withdrawn from the Trust Account for income and other permitted taxes for payment of operating expenses not related to the permitted taxes might result in violation of provisions of the Trust Agreement;

   
 the Excise Tax may be imposed on us in connection with our redemptions of shares in connection with a Business Combination or other stockholder vote pursuant to which stockholders would have a right to submit their shares for redemption;

there is substantial doubt about our ability to continue as a “going concern”; and

we have identified a material weakness in our internal control over financial reporting as of December 31, 2021.2023 regarding the classification of redeemable common stock and timeliness, completeness, accuracy of accruals, and accuracy of provision for franchise and income taxes. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results;results.


We may seek to further extend the Combination Period, which could have a material adverse effect on the amount held in our Trust Account and other adverse effects on our Company.

We may seek to further extend the Combination Period. Such an extension would require the approval of our Public Stockholders, who will be provided the opportunity to redeem all or a portion their Public Shares. Such redemptions will likely have a material adverse effect on the amount held in our Trust Account, our capitalization, principal stockholders and other impacts on our Company or Management Team, such as our ability to maintain our listing on Nasdaq.

If we seek to further extend the Combination Period, such extension would not be in compliance with Nasdaq rules, and unless Nasdaq were to grant us an exemption, will likely lead Nasdaq to suspend trading in or delist our securities.

Our securities are listed on the Nasdaq Capital Market. Nasdaq IM-5101-2 requires that a SPAC complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement, which, in our case, would be July 19, 2024 (the “Nasdaq Deadline”). If we were to seek to further extend the Combination Period beyond July 19, 2024, our Combination Period would extend beyond the Nasdaq Deadline. Consequently, further extension of our Combination Period does not comply with Nasdaq rules. There is a risk that, even if an extension were approved by our stockholders, trading in our securities may be suspended and we may be subject to delisting by Nasdaq. We cannot assure you that (i) Nasdaq will not delist our securities in the event such an extension were approved and we do not complete one or more Business Combinations by the Nasdaq Deadline, (ii) we will be able to obtain a hearing with the Panel to appeal the delisting determination, or (iii) our securities will not be suspended pending the Panel’s decision.

If Nasdaq delists any of our securities from trading and we are unable to list our securities on another national securities exchange, we expect our securities could potentially be quoted on an over-the-counter market. However, if this were to occur, we could face significant material adverse consequences. 

Cyber incidents or attacks directed at us or third parties could result in information theft, data corruption, operational disruption and/or financial loss.

We depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of third parties with whom we may deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early-stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. Any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead to financial loss.

Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial Business Combination, and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements and numerous complex tax laws. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial Business Combination, and results of operations.

On January 24, 2024, the SEC adopted the 2024 SPAC Rules requiring, among other matters, (i) additional disclosures relating to SPAC Business Combination transactions; (ii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings and Business Combination transactions; (iii) additional disclosures regarding projections included in SEC filings in connection with proposed Business Combination transactions; and (iv) the requirement that both the SPAC and its target company be co-registrants for Business Combination registration statements

In addition, the SEC’s adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act, including its duration, asset composition, business purpose, and the activities of the SPAC and its management team in furtherance of such goals.

Compliance with the 2024 SPAC Rules and related guidance may (i) increase the costs of and the time needed to negotiate and complete an initial Business Combination and (ii) constrain the circumstances under which we could affect our ability to complete an initial Business Combination.


If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial Business Combination.

The SEC‘s adopting release with respect to the 2024 SPAC Rules provided guidance relating to the potential status of SPACs as investment companies subject to regulation under the Investment Company Act and the regulations thereunder. Whether a SPAC is an investment company is dependent on specific facts and circumstances and we can give no assurance that a claim will not be made that we have been operating as an unregistered investment company.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including (i) restrictions on the nature of our investments; and (ii) restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial Business Combination.

In addition, we may have imposed upon us burdensome requirements, including: (i) registration as an investment company; (ii) adoption of a specific form of corporate structure; and (iii) reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. We are mindful of the SEC’s investment company definition and guidance and intend to complete an initial Business Combination with an operating business, and not with an investment company, or to acquire minority interests in other businesses exceeding the permitted threshold.

We do not believe that our business activities will subject us to the Investment Company Act. To this end, the proceeds held in the Trust Account were initially invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, on June 26, 2023, we instructed Continental, as trustee of the Trust Account, to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank.

Pursuant to the Trust Agreement, Continental is not permitted to invest in securities or assets other than as described above. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intended to avoid being deemed an “investment company” within the meaning of the Investment Company Act. Our Initial Public Offering was not intended for persons who were seeking a return on investments in government securities or investment securities. The Trust Account is intended solely as a temporary depository for funds pending the earliest to occur of: (i) the completion of our initial Business Combination; (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend our Amended and Restated Charter (x) in a manner that would affect the substance or timing of our obligation to provide for the redemption of the Public Shares in connection with an initial Business Combination or to redeem 100% of our Public Shares if we do not complete our initial Business Combination within the Combination Period; or (y) with respect to any other provision relating to the rights of holders of shares of our Class A Common Stock or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within the Combination Period, our return of the funds held in the Trust Account to our Public Stockholders as part of our redemption of the Public Shares.


We are aware of litigation claiming that certain SPACs should be considered investment companies. Although we believe that these claims are without merit, we cannot guarantee that we will not be deemed to be an investment company and thus subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete an initial Business Combination or may result in our liquidation. If we are unable to complete our initial Business Combination, our Public Stockholders may receive only approximately $10.00 per Public Share upon the liquidation of our Trust Account and our Rights will expire worthless.

We have received the Delisting Notice indicating that we have failed to regain compliance with the Minimum Public Holders Requirement and the Annual Meeting Requirement and which informed us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024. If we cannot regain compliance, our securities will be subject to delisting and the liquidity and the trading price of our securities could be adversely affected.

On August 31, 2023, we received a deficiency letter from the Staff of Nasdaq notifying us that we no longer meet the Minimum Public Holders Requirement. The notification received has no immediate effect on our Nasdaq listing. On October 16, 2023, we submitted to Nasdaq a plan to regain compliance with the Minimum Public Holders Requirement. On October 25, 2023, in response to such compliance plan, the Staff granted us an extension of time to regain compliance with the Minimum Public Holders Requirement. Pursuant to the extension, on or before February 27, 2024, we must have filed with Nasdaq documentation that demonstrated that our Common Stock has a minimum of 300 public holders.

On January 23, 2024, we received a deficiency notice from the Staff of Nasdaq notifying us that we are not in compliance with the Annual Meeting Requirement because we did not hold an annual meeting of stockholders within twelve months of our fiscal year ended December 31, 2022. The notification received had no immediate effect on our Nasdaq listing. In accordance with Nasdaq rules, we had 45 calendar days, or until March 8, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement.

On February 27, 2024, we were not able to demonstrate compliance with the Minimum Public Holders Requirement, and as such, on March 1, 2024, we received the Delisting Notice from the Staff of Nasdaq informing us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel. Because the Staff of Nasdaq issued the Delisting Notice to us on March 1, 2024, we chose to forego submitting a plan of compliance to Nasdaq related to the Annual Meeting Requirement. Because we were unable to demonstrate compliance with the Minimum Public Holders Requirement and did not submit to Nasdaq a plan of compliance related to the Annual Meeting Requirement, our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024.

If Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:

a limited availability of market quotations for our securities;

 

if the funds held outside ofreduced liquidity for our trust account are insufficient to allow us to operate until at least July 22, 2022, our ability to fund our search for a target business or businesses or complete an initial business combination may be adversely affected;securities;

 

a determination that our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt aboutClass A Common Stock are a “penny stock” which will require brokers trading in our abilityClass A Class A Common Stock to continue asadhere to more stringent rules and possibly result in a going concern, since we will cease all operations exceptreduced level of trading activity in the secondary trading market for the purposeour securities;


a limited amount of liquidating if we are unable to complete an initial business combination by July 22, 2022;news and analyst coverage;

 

oura decreased ability to identify a target and to consummate a business combination may be adversely affected by economic uncertainty and volatilityissue additional securities or obtain additional financing in the financial markets,future; and

being subject to regulation in each state in which we offer our securities, including as a result of the military conflict in Ukraine.connection with our initial Business Combination.

 

For the complete list ofadditional risks relating to our operations, other than as set forth above, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, and the(ii) 2022 Annual Report, (iii) Quarterly Reports on Form 10-Q for the quarterly periods ended September 30, 2021, March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, and September 30, 2023, as filed with the SEC on November 26, 2021. We may disclose changes to such factors or disclose additional factors from time to time in2021, May 17, 2022, August 15, 2022, November 14, 2022, May 16, 2023, and November 14, 2023, respectively, and (iii) our future filingsDefinitive Proxy Statements on Schedule 14A, as filed with the SEC.SEC on October 3, 2022, July 7, 2023, and January 3, 2024. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

For risks related to Kustom Entertainment and the Kustom Entertainment Business Combination, please see the Kustom Entertainment Registration Statement at www.sec.gov.

 

Item 1B. Unresolved Staff Comments.

 

Not applicable.

 

Item 1C. Cybersecurity

As a blank check company, we do not have any operations and our sole business activity has been to search for and consummate a Business Combination. However, because we have investments in our Trust Account and bank deposits and we depend on the digital technologies of third parties, we and third parties may be subject to attacks on or security breaches in our or their systems. Because of our reliance on the technologies of third parties, we also depend upon the personnel and the processes of third parties to protect against cybersecurity threats, and we have no personnel or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, the Management Team will report to the Board of Directors and provide updates on the Management Team’s incident response plan for addressing and mitigating any risks associated with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead to financial loss. We have not encountered any cybersecurity incidents since our Initial Public Offering.

Item 2. Properties.

 

Our executive offices are located at 1450 Brickell Avenue, Suite 2520, Miami, FL 33131, and our telephone number is (305) 577-0031. Our executive offices are providedThe cost for our use of this space is included in the $10,000  per month fee we pay to us by an affiliate of our sponsor. Commencing on July 19, 2021, we have agreed to pay an affiliate of our sponsor a total of $10,000 per monthSponsor for office space, utilities and secretarial and administrative support.support, pursuant to the Administrative Support Agreement. We consider our current office space adequate for our current operations.

 

Item 3. Legal Proceedings.

 

To the knowledge of our management team,Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 


 

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

  

 (a)Market Information

 

Our units, public sharesUnits, Public Shares and public rightsPublic Rights are each traded on Thethe Nasdaq StockCapital Market LLC under the symbols CLOEU, CLOE and CLOER, respectively. Our unitsUnits commenced public trading on July 20, 2021, and our public sharesPublic Shares and public rightsPublic Rights commenced separate public trading on September 9, 2021.

On August 31, 2023, we received a deficiency letter from the Staff of Nasdaq notifying us that we no longer meet the Minimum Public Holders Requirement. The notification received has no immediate effect on our Nasdaq listing. On October 16, 2023, we submitted to Nasdaq a plan to regain compliance with the Minimum Public Holders Requirement. On October 25, 2023, in response to such compliance plan, the Staff granted us an extension of time to regain compliance with the Minimum Public Holders Requirement. Pursuant to the extension, on or before February 27, 2024, we must have filed with Nasdaq documentation that demonstrated that our Common Stock has a minimum of 300 public holders.

On January 23, 2024, we received a deficiency notice from the Staff of Nasdaq notifying us that we are not in compliance with the Annual Meeting Requirement because we did not hold an annual meeting of stockholders within twelve months of our fiscal year ended December 31, 2022. The notification received had no immediate effect on our Nasdaq listing. In accordance with Nasdaq rules, we had 45 calendar days, or until March 8, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement.

On February 27, 2024, we were not able to demonstrate compliance with the Minimum Public Holders Requirement, and as such, on March 1, 2024, we received the Delisting Notice from the Staff of Nasdaq informing us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel. Because the Staff of Nasdaq issued the Delisting Notice to us on March 1, 2024, we chose to forego submitting a plan of compliance to Nasdaq related to the Annual Meeting Requirement. Because we were unable to demonstrate compliance with the Minimum Public Holders Requirement and did not submit to Nasdaq a plan of compliance related to the Annual Meeting Requirement, our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024.

 

(b)Holders

 

On April 1, 2022,March 21, 2024, there were 3three holders of record of our units, 2Units, three holders of record of our shares of Class A common stock, 1 record of our shares of Class B common stockCommon Stock, and 1 holdersone holder of record of our rights.Public Rights.

 

(c)Dividends

 

We have not paid any cash dividends on our common stockCommon Stock to date and do not intend to pay cash dividends prior to the completion of our initial business combination.Business Combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination.Business Combination. The payment of any cash dividends subsequent to our initial business combinationBusiness Combination will be within the discretion of our boardBoard of directorsDirectors at such time. In addition, our boardBoard of directorsDirectors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if we incur any indebtedness in connection with our initial business combination,Business Combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 

(d)Securities Authorized for Issuance Under Equity Compensation Plans.

 

None.

 

(e)Recent Sales of Unregistered Securities

 

None.On July 20, 2023, upon the approval of the Conversion Amendment Proposal by our stockholders at the 2023 Special Meeting, we issued an aggregate of 3,457,806 shares of Class A Common Stock to our Sponsor, upon the conversion of an equal number of Class B Common Stock held by the Sponsor in the Founder Share Conversion. The 3,457,806 shares of Class A Common Stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Common Stock before the Founder Share Conversion, including, among others, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination as described in the IPO Registration Statement; consequently, the shares of Class A Common Stock issued in connection with the Founder Share Conversion are not registered under the Securities Act and will remain unregistered until registration is demanded by the Sponsor pursuant to the Letter Agreement we entered into with our Sponsor, officers and directors. Following the Founder Share Conversion, the 2023 Redemptions and the 2024 Redemptions, (i) there were (i) 5,320,507 shares of Class A Common Stock issued and outstanding and one share of Class B Common Stock issued and outstanding, and (ii) the Sponsor held 75.7% of the outstanding Class A Common Stock. For more information on the Founder Share Conversion and the Founder Shares’ transfer restrictions, see “Item 1. Business.”


 

(f)Use of Proceeds from the Initial Public Offering

 

On July 22, 2021, pursuant to the filingFor a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the SEC on September 2, 2021. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement, which was declared effective on July 19, 2021, the Company consummated its initial public offering of 13,831,230 units, including 1,331,230 units issued pursuantStatement. Our specific investments in our Trust Account may change from time to the partial exercise of the underwriters’ over-allotment option. Each unit consists of one share of Class A common stock and a right to receive one-eighth (1/8) of a share of Class A common stock at the closing of the initial business combination. The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $138,312,300. time.

 

A totalOn June 26, 2023, we instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account at Morgan Stanley,  with Continental continuing to act as trustee, until the earlier of $140,386,985the consummation of our initial Business Combination or our liquidation. As a result, following the liquidation of investments in the Trust Account, the remaining proceeds from the initial public offering (which amount includes $4,840,931 of the underwriters’ deferred discountInitial Public Offering and $2,074,685 of the proceeds of the sale of the private placement units) was placed in a U.S.-based trust account at JPMorgan Chase Bank N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. The proceeds held in the trust account may bePrivate Placement are no longer invested by the trustee only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solelyinvested in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act.securities.

 

(g)Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

Item 6. [Reserved]On January 17, 2024, we held the 2024 Special Meeting at which our stockholders approved, the 2024 Extension, which extended the date by which we must consummate a Business Combination from January 22, 2024 to July 22, 2024 (or such earlier date as determined by the Board). In connection with the 2024 Extension, Public Stockholders holding 202,360 Public Shares properly exercised their right to redeem such shares for a pro rata portion of the Trust Account. We paid cash in the aggregate amount of $2,369,636, or approximately $11.71 per share to such redeeming Public Stockholders in the 2024 Redemptions.

 

None.There were no such repurchases of our equity securities by us or an affiliate during the further quarter of the fiscal year covered by the Report.


  

Item 6. [Reserved]

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

ReferencesCautionary Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the “Company,” “us,” “our”beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or “we” referoral forward-looking statements attributable to Clover Leaf Capital Corp., a Delaware corporation. us or persons acting on our behalf are qualified in their entirety by this paragraph.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our auditedthe financial statements and relatedthe notes included herein.

Cautionary Note Regarding Forward-Looking Statements

This Report includes forward-looking statements within the meaning of Section 27A of the Securities Act), and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact includedthereto contained elsewhere in this Report. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company recently incorporated in the State of Delaware for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similaran initial Business Combination with one or more businesses (the “Business Combination”).Combination. We may pursue the initial Business Combination target in any industry or geographic location, and we intend to focuswere focusing our search for a target business engaged in the cannabis industry.

 

The registration statement for our initial public offeringIPO Registration Statement was declared effective on July 19, 2021 (the “Effective Date”).2021. On July 22, 2021, we consummated our initial public offeringInitial Public Offering of 13,831,230 Units at $10.00 per unit,Unit, and the sale of 675,593 units,Units, at a price of $10.00 per unit,Unit, in a private placementthe Private Placement to our Sponsor and Maxim, the representative of the underwriters (the “Representative”),Representative that closed simultaneously with the initial public offering.Initial Public Offering. On July 22, 2021, the underwriters of the Initial Public Offering partially exercised their over-allotment option and purchased 1,331,230 of their full 1,875,000 unitsUnits available and subsequently forfeited the remainder of their option as of July 28, 2021. Our managementManagement has broad discretion with respect to the specific application of the net proceeds of the initial public offeringInitial Public Offering and sale of the private placement units,Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating aan initial Business Combination.

 

Transaction costs amounted to $9,562,126, consisting of $2,766,246 of underwriting commissions, $4,840,931 of deferred underwriting commissions, $1,383,123 of fair value of the representative sharesRepresentative Shares, and $571,826 of other cash offering costs.


Recent Developments

2024 Special Meeting and 2024 Extension

On January 17, 2024, we held the 2024 Special Meeting. At the 2024 Special Meeting, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from January 22, 2024 to July 22, 2024, or such earlier date as determined by the Board of Directors.

In connection with the 2024 Special Meeting, Public Stockholders holding 202,360 Public Share properly exercised their right to redeem such shares for a pro rata portion of the funds in our Trust Account. As a result, approximately $2,374,149 (approximately $11.73 per share) was removed from the Trust Account to pay such holders.

Following the approval and implementation of the 2024 Extension, on January 22, 2024, we issued the 2024 Extension Note in the aggregate principal amount of up to $360,000 to our Sponsor, pursuant to which the Sponsor agreed to loan to us up to $360,000 to deposit into the Trust Account for each Public Share held by our Public Stockholders that was not redeemed in the 2024 Redemption. The 2024 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of our initial Business Combination, or (b) the date of our liquidation.

On January 22, 2024, we deposited $60,000 into the Trust Account, and will continue to deposit $60,000 into the Trust Account for each additional calendar month (promptly following the 2nd of each calendar month), or portion thereof, that is needed by us to complete an initial Business Combination until July 22, 2024, and such amount will be distributed either to: (i) all of the holders of Public Shares upon our liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of the Initial Business Combination. As of March 21, 2024, $180,000 of the principal on the 2024 Extension Note has been deposited into the Trust Account.

On January 22, 2024, we issued the 2024 Working Capital Note in the principal amount of up to $1,000,000 to our Sponsor. The 2024 Working Capital Note was issued in connection with up to $1,000,000 of advances our Sponsor has made or may make in the future to us for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) the date of the consummation of our initial Business Combination or (ii) the date of our liquidation. As of March 5, 2024, a total of $525,000 had been drawn down on the 2024 Working Capital Note.

Nasdaq Compliance—Minimum Public Holders Requirement and Annual Meeting Requirement

On August 31, 2023, we received a deficiency letter from the Staff of Nasdaq notifying us that we no longer meet the Minimum Public Holders Requirement. The notification received has no immediate effect on our Nasdaq listing. On October 16, 2023, we submitted to Nasdaq a plan to regain compliance with the Minimum Public Holders Requirement. On October 25, 2023, in response to such compliance plan, the Staff granted us an extension of time to regain compliance with the Minimum Public Holders Requirement. Pursuant to the extension, on or before February 27, 2024, we must have filed with Nasdaq documentation that demonstrated that our Common Stock has a minimum of 300 public holders.

On January 23, 2024, we received a deficiency notice from the Staff of Nasdaq notifying us that we are not in compliance with the Annual Meeting Requirement because we did not hold an annual meeting of stockholders within twelve months of our fiscal year ended December 31, 2022. The notification received had no immediate effect on our Nasdaq listing. In accordance with Nasdaq rules, we had 45 calendar days, or until March 8, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement.

On February 27, 2024, we were not able to demonstrate compliance with the Minimum Public Holders Requirement, and as such, on March 1, 2024, we received the Delisting Notice from the Staff of Nasdaq informing us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel. Because the Staff of Nasdaq issued the Delisting Notice to us on March 1, 2024, we chose to forego submitting a plan of compliance to Nasdaq related to the Annual Meeting Requirement. Because we were unable to demonstrate compliance with the Minimum Public Holders Requirement and did not submit to Nasdaq a plan of compliance related to the Annual Meeting Requirement, our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024.

Indemnification Agreement with Kustom Entertainment and Digital Ally

On February 1, 2024, we entered in an indemnification agreement with Kustom Entertainment and the Kustom Entertainment Stockholder, pursuant to which, Kustom Entertainment and Kustom Entertainment Stockholder agreed to indemnify us and our officers and directors for liabilities incurred in connection with Kustom Entertainment Stockholder disclosure incorporated by reference into the Kustom Entertainment Registration Statement.

Kustom Entertainment Business Combination

On June 1, 2023, we entered into a Kustom Entertainment Merger Agreement with Merger Sub, the Sponsor, Kustom Entertainment, and the Kustom Entertainment Stockholder.

Pursuant to the Kustom Entertainment Merger Agreement, subject to the terms and conditions set forth therein upon the Closing, Merger Sub will merge with and into Kustom Entertainment, with Kustom Entertainment continuing as the surviving corporation in the Merger and our wholly-owned subsidiary. In the Merger, all of the issued and outstanding capital stock of Kustom Entertainment immediately prior to the Effective Time shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right for the Kustom Entertainment Stockholder to receive the Merger Consideration. Upon consummation of the Kustom Entertainment Business Combination, we will change our name to “Kustom Entertainment, Inc.”

On October 4, 2023, we issued a press release announcing that we had submitted to EDGAR, the SEC’s online portal, the Kustom Entertainment Registration Statement, which includes a preliminary proxy statement/prospectus, with respect to the Kustom Entertainment Business Combination.


For a full description of the Kustom Entertainment Merger Agreement and the proposed Kustom Entertainment Business Combination, please see “Item 1. Business.”

Extensions of Our Combination Period

 

We will have onlyoriginally had up to 12 months from the closing of our Initial Public Offering, or until July 22, 2022, to consummate an initial Business Combination. However, as requested by our Sponsor and as permitted under our Amended and Restated Charter, on July 19, 2022, we extended the initial public offeringCombination Period by an additional three months from July 22, 2022 to completeOctober 22, 2022. In addition, at the 2022 Special Meeting held on October 19, 2022, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from October 22, 2022 to July 22, 2023, or such earlier date as determined by our Board of Directors. Thereafter, at the 2023 Special Meeting held on July 19, 2023, our stockholders approved an amendment to our Amended and Restated Charter to extend the Combination Period from July 22, 2023 to January 22, 2024, or such earlier date as determined by our Board of Directors.

Founder Share Conversion

On July 20, 2023, upon the approval of the Conversion Amendment Proposal by our stockholders at the 2023 Special Meeting. we issued an aggregate of 3,457,806 shares of our Class A Common Stock to our Sponsor upon the Founder Share Conversion. The 3,457,806 shares of Class A Common Stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Common Stock before the Founder Share Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights, and the obligation to vote in favor of an initial Business Combination or we may extendas described in the periodIPO Registration Statement. Following the Founder Share Conversion, there were 5,522,867 shares of time to complete the initial Business Combination by three additional three-month periods (the “Combination Period”). Pursuant to the termsClass A Common Stock issued and outstanding and 1 share of Class B Common Stock issued and outstanding. As a result of the Founder Share Conversion, our amendedSponsor held approximately 73.0% of our issued and restated certificate of incorporation and the trust agreement to be entered into between the Company and Continental Stock Transfer & Trust Company, in order to extend the time available for us to consummate the initial Business Combination, the Sponsor or its affiliates or designees, upon five days advance notice prior to the applicable deadline, must deposit into the trust account for each additional three month period, $1,383,123 ($0.10 per share on or prior to the date of the applicable deadline) for each additional three month period. Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of an initial business combination. If we complete an initial business combination, it will, at the option of the Sponsor, repay such loaned amounts out of the proceeds of the trust account released to us or convert a portion or all of the total loan amount into units at a price of $10.00 per unit.outstanding Class A Common Stock.

 

Results of Operations

 

Our entire activity since inception up to December 31, 20212023 relates to our formation, the initial public offeringInitial Public Offering, and, since the closing of the initial public offering,Initial Public Offering, a search for aan initial Business Combination candidate. We will not be generating any operating revenues until the closingClosing and completion of our initial Business Combination, at the earliest.

 

For the year ended December 31, 2023, we had a net loss of $849,368, which consisted of formation and operating costs of $1,586,541 and provision for income taxes of $196,591, offset by interest earned on investments held in Trust Account of $737,057 and interest earned on cash held in bank of $116.


 

For the period from February 25, 2021 (inception) toyear ended December 31, 20212022, we had a net lossincome of $834,087,$60,237, which consisted of $851,777 in formation and operating costs of $ 1,291,228 and provision for income taxes of $185,423, offset by $47 in interest income from the operating bank account and interest income of $17,643 from marketable securitiesearned on investments held in our trust account.Trust Account of $1,195,135, interest earned on cash held in bank of $69 and recovery of previously incurred costs of $341,684.

 

Factors That May Adversely Affect our Results of Operations

Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. We cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.

Liquidity, Capital Resources, and Going Concern

 

As of December 31, 2021,2023 and 2022, we had $680,302 in cash of $162,933 and $303,449, respectively, and working capital deficit of $4,493,502 and working capital of $418,498.$2,882,521, respectively. Prior to the completion of the initial public offering,Initial Public Offering, our liquidity needs had been satisfied through a payment from our Sponsor of $25,000 for the founder sharesFounder Shares to cover certain offering costs and the loan under an unsecured promissory note from our sponsorSponsor of $300,000.

In addition, on July 18, 2022, we issued the July 2022 Extension Note to our Sponsor in the principal amount of $1,383,123, pursuant to which our Sponsor loaned us $1,383,123 ($0.10 per Public Share after Redemptions) to deposit into the Trust Account for each Public Share that was not redeemed in connection with the July 2022 Extension. At the election of our Sponsor, up to $1,383,123 of the unpaid principal amount of the July 2022 Extension Note may be converted into Conversion Units, of which the total Conversion Units so issued shall be equal to: (i) the portion of the principal amount of the July 2022 Extension Note being converted divided by (ii) the conversion price of ten dollars ($10.00), rounded up to the nearest whole number of Units.

On October 19, 2022, we issued the October 2022 Extension Note to our Sponsor in the principal amount of $1,383,123, pursuant to which our Sponsor loaned us $1,383,123 to deposit into the Trust Account for each Public Share that was not redeemed in connection with the October 2022 Extension. The October 2022 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of an initial Business Combination, or (b) the date of our liquidation.


On July 21, 2023, the Company issued the 2023 Extension Note in the aggregate principal amount of up to $360,000 to the Sponsor, pursuant to which the Sponsor agreed to loan to the Company up to $360,000 to deposit into the Trust Account for the Public Stockholders that did not redeem Public Shares in the2023 Redemptions. The 2023 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of our initial Business Combination, or (b) the date of our liquidation.

On July 21, 2023, we issued the 2023 Working Capital Note in the principal amount of up to $300,000 to our Sponsor. The 2023 Working Capital Note was issued in connection with advances our Sponsor may make in the future to us as Working Capital Loans. The 2023 Working Capital Note is non-interest bearing and payable upon the earlier of (i) completion of our initial Business Combination or (ii) the date that our winding up is effective. We drew $300,000 under the 2023 Working Capital Note, which was outstanding as of December 31, 2023.

On June 26, 2023, we instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account at Morgan Stanley with Continental continuing to act as trustee, until the earlier of the consummation of our initial Business Combination or our liquidation. As a result, following the liquidation of investments in the Trust Account, the remaining proceeds from the Initial Public Offering and Private Placement are no longer invested in U.S. government securities or money market funds invested in U.S. government securities.

At various dates in the fourth quarter of 2023, the Sponsor advanced to us $415,000 for our working capital needs. On January 22, 2024, we issued the 2024 Working Capital Note in the principal amount of up to $1,000,000 to our Sponsor. The 2024 Working Capital Note was issued in connection with advances our Sponsor may make in the future to us as Working Capital Loans. The 2024 Working Capital Note is non-interest bearing and payable upon the earlier of (i) completion of the initial Business Combination or (ii) the date of our winding up is effective. The funds advanced in the fourth quarter of 2023 were considered advanced under terms of this note and were outstanding as of December 31, 2023.

 

In addition, in order to finance transaction costs in connection with aan initial Business Combination, our sponsorSponsor or an affiliate of our sponsorSponsor or certain of our officers and directors may, but are not obligated to, provide us working capital loans. AsWorking Capital Loans. $715,000 and $0 were outstanding under any Working Capital Loans as of December 31, 2021, there were no amounts outstanding under any working capital loans.2023 and 2022, respectively.

 

Until the consummation of aan initial Business Combination, we will be usingcontinue to use the funds not held in the trust accountTrust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating, and consummating the initial Business Combination. We will need to raise additional capital through loans or additional investments from our sponsor, shareholders,Sponsor, stockholders, officers, directors, or third parties. Our sponsor,Sponsor, officers, and directors may, but are not obligated to, loan us funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.

 

Going Concern

We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Account Standards Update (“ASU”)FASB ASU Topic 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” We have until July 22, 20222024 to consummate aan initial Business Combination. It is uncertain that we will be able to consummate aan initial Business Combination by this time. If aan initial Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. These conditions raise substantial doubt about our ability to continue as a going concern. TheseThe financial statements and notes thereto contained elsewhere in this Report do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern and also do not include any adjustment that might result from the outcome of this uncertainty about should aan initial Business Combination not occur.

 

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2023 and 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.


Contractual Obligations

Administrative Support Agreement

We do not have any long-term debt, capital lease obligations, operating lease obligations, or long-term liabilities, other than an agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space, utilities and administrative support, pursuant to the Administrative Support Agreement. Upon completion of our initial Business Combination or our liquidation, we will cease paying these monthly fees.

Registration Rights

The holders of the Founder Shares, Private Placement Units, and securities that may be issued upon conversion of Working Capital Loans and extension loans will have registration rights to require us to register a sale of any of the securities held by them pursuant to the Registration Rights Agreement. These holders will be entitled to make up to three demands, excluding short-form registration demands, that we register such securities for sale under the Securities Act. In addition, these holders will have “piggyback” registration rights to include their securities in other registration statements filed by us. Notwithstanding the foregoing, the underwriters of the Initial Public Offering may not exercise their demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the IPO Registration Statement and may not exercise their demand rights on more than one occasion.

Underwriting Agreement

The underwriters had a 30-day option to purchase up to 1,875,000 additional Units to cover any over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On July 22, 2021, the underwriters partially exercised their over-allotment option and purchased an additional 1,331,230 Units and forfeited the remainder of their over-allotment option as of July 28, 2021.

The underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the Initial Public Offering held in the Trust Account upon the completion of the initial Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies and Estimates

 

The preparation of the financial statements in conformity with US GAAP requires managementManagement to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have identified the following as our critical accounting policies:

 

Class A Common Stock Subject to Possible Redemption

 

All of the 13,831,230 Class A common stockCommon Stock sold as part of the unitsUnits in the initial public offeringInitial Public Offering contain a redemption feature which allows for the redemptionRedemption of such public sharesPublic Shares in connection with our liquidation, if there is a stockholder vote or tender offer in connection with the initial Business Combination and in connection with certain amendments to our amendedAmended and restated certificate of incorporation.Restated Charter. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in FASB ASC 480-10-S99, redemptionTopic 480-10-S99. Redemption provisions not solely within our control require common stockCommon Stock subject to redemption to be classified outside of permanent equity.

 

If it is probable that the equity instrument will become redeemable, we have the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately.

 


Net Loss(Loss) Income Per Common Share

 

We comply with accounting and disclosure requirements of FASB ASC Topic 260, Earnings“Earnings Per Share.Share”. Net loss(loss) income per share is computed by dividing net loss(loss) income by the weighted average number of shares of common stockCommon Stock outstanding during the period. We have two classes of shares, redeemable common stockCommon Stock and non-redeemable common stock.Common Stock. Our redeemable common stockCommon Stock is comprised of shares of Class A sharesCommon Stock sold in the initial public offering.Initial Public Offering. Our non-redeemable shares are comprised of shares of Class B sharesCommon Stock purchased by theour Sponsor as well as shares of Class A sharesCommon Stock sold inas part of the private placement unitsPrivate Placement Units and representative shares.the Representative Shares. Earnings and losses are shared pro rata between the two classes of shares. Our statementstatements of operations appliesally the two-class method in calculating net loss(loss) income per share. Basic and diluted net loss(loss) income per common share for redeemable common stockCommon Stock and non-redeemable common stockCommon Stock is calculated by dividing net loss,(loss) income, allocated proportionally to each class of common stock,Common Stock, attributable to us by the weighted average number of shares of redeemable and non-redeemable stock outstanding.

 

The calculation of diluted loss(loss) income per share of common stockCommon Stock does not consider the effect of the rights issued in connection with the initial public offeringInitial Public Offering since exercise of the rights is contingent upon the occurrence of future events and the inclusion of such rights would be anti-dilutive. Accretion of the carrying value of Class A common stockCommon Stock to redemption value is excluded from net loss(loss) income per redeemable share because the redemption value approximates fair value. As a result, diluted loss(loss) income per share is the same as basic loss(loss) income per share for the periodperiods presented.

 

Off-Balance Sheet Financing Arrangements


 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space, utilities and administrative support. Upon completion of our Business Combination or our liquidation, we will cease paying these monthly fees.

Registration Rights

The holders of the founder shares, private placement units and securities that may be issued upon conversion of Working Capital Loans and extension loans will have registration rights to require us to register a sale of any of its securities held by them pursuant to a registration rights agreement. These holders will be entitled to make up to three demands, excluding short form registration demands, that we register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the registration statement of which the initial public offering forms a part and may not exercise their demand rights on more than one occasion.

Underwriting Agreement

The underwriters had a 30-day option to purchase up to 1,875,000 additional units to cover any over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. On July 22, 2021, the underwriters partially exercised their over-allotment option and purchased an additional 1,331,230 units and forfeited the remainder of their over-allotment option as of July 28, 2021.

The underwriters are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the initial public offering held in the trust account upon the completion of the initial Business Combination subject to the terms of the underwriting agreement.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU No.Topic 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”),. which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. We are reviewing what impact, if any, adoption will have on the Company’sour financial position, results of operations, or cash flows.

 

In December 2023, the FASB issued ASU Topic 2023-09, “Income Taxes” (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. Our Management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.


 

Our Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

 

JOBS Act

 

The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation relatedcompensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO’sChief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offeringInitial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

Factors That May Adversely Affect Our Results of Operations

Our results of operations and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk.

 

Not required forWe are a smaller reporting companies.

company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 8. Financial Statements and Supplementary Data.

 

Reference is made to pages F-1 through F-18F-22 comprising a portion of this Report. Report, which are incorporated herein by reference.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.


Under the supervision and with the participation of our management,Management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying Officers”),Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e)13a-15I and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective as of December 31, 2021the end of the period covered by this Report, due to the restatement of our July 22, 2021 balance sheet included in the Form 8-K filed in connection with our IPO, regarding the classification of redeemable common stock, as described below which constitutes a material weakness in our internal control over financial reporting for complex financial instruments. to:

(i)the restatement of our July 22, 2021 balance sheet included in the Current Report on Form 8-K filed with the SEC on July 28, 2021 in connection with our Initial Public Offering, regarding the classification of redeemable Common Stock, as described below, which constitutes a material weakness in our internal control over financial reporting for complex financial instruments.

(ii)material weaknesses in internal controls related to timeliness, completeness and accuracy of accruals, identified as of September 30, 2022.

(iii)material weakness in internal controls related accuracy of the provision for franchise and income taxes, identified as of December 31, 2022.

(iv)a material weakness in internal controls over the financial reporting process which failed to identify a material out of period adjustment that resulted in the revision of previously issued financial statements, identified as of September 30, 2023.

(v)a material weakness in internal controls related to the compliance with the provisions of the Trust Agreement related to the use of funds withdrawn from the Trust Account for payment of our tax liabilities, identified as of December 31, 2023.

In light of this material weakness, we performed additional analysis as deemed necessaryhave enhanced our processes to ensureidentify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements including making greater use of third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. We believe our efforts will enhance our controls relating to accounting for complex financial transactions and instruments and internal controls related to timeliness, completeness and accuracy of accruals, but we can offer no assurance that our auditedcontrols will not require additional review and modification in the future as industry accounting practice may evolve over time.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Management’s Annual Report on Internal Control over Financial Reporting

As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our Management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements were preparedfor external reporting purposes in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that theGAAP. Our internal control over financial statements included in this Report present fairly in all material respects our financial position, results of operationsreporting includes those policies and cash flows for the period presented.procedures that:

(1)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our Company,

(2)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our Management and directors, and

(3)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 


 

 

Regarding the restatementsBecause of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any evaluation of effectiveness to the Company’s balance sheet included on the Company’s Form 8-K, this was necessitated by the fact that the Company’s Common stock features certain redemption rights thatfuture periods are considered to be outside of the Company’s control and subject to the occurrencerisk that controls may become inadequate because of uncertain future events. Accordingly,changes in conditions, or that the Company concluded that its Common stock subject to possible redemption should be presented at redemption valuedegree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting as temporary equity, outsideof December 31, 2023. In making these assessments, Management used the criteria set forth by the Committee of Sponsoring Organizations of the Stockholders’ equity sectionTreadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments and those criteria, Management determined that we did not maintain effective internal control over financial reporting as of the Company’s balance sheet. The Company had previously classified a portionDecember 31, 2023 due to incorrect classification of theclassification of redeemable common stock in permanent equity. The Company restated its financial statements to classify all redeemable common stock as temporary equity.Common Stock and timeliness, completeness and accuracy of accruals and accuracy of provision for franchise and income taxes. 

 

It is noted thatManagement has implemented remediation steps to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex transaction instruments, internal controls related to timeliness, completeness and accuracy of accruals, and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the non-cash adjustmentsrequisite experience and training to the financial statement do not impact the amounts previously reported for our cash and cash equivalents or total assets. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our audited financial statements were prepared in accordance with U.S. generally acceptedsupplement existing accounting principles.

Management’s Annual Report on Internal Controls over Financial Reportingprofessionals.

 

This Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our internal controls from our independent registered public accounting firm due to a transition period established byour status as an emerging growth company under the rules of the SEC for newly public companies.JOBS Act.

 

Changes in Internal Control over Financial Reporting

 

Other than as set forthdiscussed above, there washave been no change inchanges to our internal control over financial reporting that occurred during the fiscal year ended December 31, 2021 covered by this Report2023 that has materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information.

Trading Arrangements

During the quarterly period ended December 31, 2023, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Additional Information

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

Not applicable.

 


 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

Directors and Executive Officers

 

As of the date of this Report, our directors and officers are as follows:

 

Name Age Position
Felipe MacLean 3740 Chairman of the Board, President and Chief Executive Officer
Chris RebentischLuis A. Guerra 3850 Chief Financial Officer and Treasurer
Markus Puusepp41Chief Operating Officer and Secretary
Luis A. GuerraPer Bjorkman 4656 Chief Financial Officer and TreasurerDirector
Per BjorkmanMarcos Angelini 52 Director
Marcos AngeliniLuis Derechin 4955 Director
Ambassador Manuel Rocha70 Director

 

The experience of our directors and executive officers is as follows:

 

Felipe MacLean, our President and CEO since inception and our Chairman of the Board since April 2021, is a successful self-made entrepreneur with over 15 years of experience capitalizing on complex, high-yield transactions in various industries across the globe. Mr. MacLean applied his financial and operational expertise in building vertically integrated businesses in the agriculture, seafood, and edible oil sectors. He is athe founder and CEO of Yntegra Group, a family office and multi-service provider that specializes in high yield transactions that has managed over $1 billion in commodities trading activity and placement of over $100 million in private equity investments. In 2017, Mr. MacLean started his venture in the cannabis industry founding Solace Holdings and leading an investment of over $50 million. Solace Holdings is today one of the most renowned cultivation, extraction and manufacturing facilities in the Nevada market, with leading product categories on its portfolio and doubling sales year over year. Mr. MacLean’s involvement was crucial forto the success of Solace Holdings, success, supported by his clear understanding of the cannabis industry opportunities and challenges. We believe Mr. MacLean is well qualified to serve as our Chairman and CEO due to his extensive knowledge in the cannabis industry, asindustry. As an early investor in the field, he has lived through the multiple regulatory cycles and growth facets of this developing industry. His experience has proven instrumental in creating a successful large-scale profitable cannabis operation.

 

Chris Rebentisch, our COO, has been responsible for Business Development for Spectrum Leaf Latam, LLC since December 2020, an innovative house of CBD wellness brands for the US and Latin American markets. Previously, he was the founder and creator of Canna Hemp™ and the President and CEO of 1933 Industries (TGIFF), Canna Hemp™’s parent company from June 2018 to June 2020. Mr. Rebentisch founded Infused Mfg LLC in August of 2016 and launched the Canna Hemp™ brand in June 2017, after personally developing and crafting each product with the belief in the natural healing properties of cannabis. Mr. Rebentisch is a seasoned cultivator and advocate for the industry in the State of Nevada. He began cultivating medical cannabis in April 2011 as a state licensed caregiver until April 2016, when Mr. Rebentisch turned his focus to hemp. Mr. Rebentisch’s depth of knowledge and expertise has made him a respected influencer in the field, where he is often invited to speak to academia and health care professionals about the viable applications of cannabis pharmacology as it applies to pain management and rehabilitation. We believe Mr. Rebentisch is well qualified to serve as our COO due to his extensive knowledge as a hands-on cannabis entrepreneur, in addition to being a recognized expert in cannabis. He brings valuable input and in-depth knowledge of all the verticals in the cannabis business.

Luis A. Guerra,, our CFO and Treasurer since April 2021, was one of the founders of Bulltick Capital Markets, a regional investment bank in the US, Europe and Latin America whichthat became one of the top 10 brokers and trading firms with the highest volume traded in Latin America ADRs (American Depositary Receipts) on the NYSE.Nasdaq. He was a co-managing partner of the firm and member of its Management Committee, directly responsible for all securities brokerage, electronic trading, and capital markets operations, from March 2000 to February 2011. He grew the firm’s brokerage and trading operations from a start-up to one of the largest regional investment banks in Latin America. Since November 2018, Mr. Guerra has served as co-founder and Managing Director of VitaxVI tax Partners, a private investment vehicle with a focus on private equity and structured finance. Since December 2019, he has also served as part of the Advisory Board of Welz, a European based private equity real estate Investment Manager, where he advises on their investment portfolio. He is a seasoned capital markets professional thatwho brings experienced and structured financial reporting. We believe Mr. Guerra is well qualified to serve as our CFO due to his capital markets and financial background, he has ample experience dealing with regulated entities both in the US and internationally, in addition to hisand knowledge as a former senior executive at an investment bank and asset management business.

Markus Puusepp, our COO and Secretary since July 2022, has been employed as Chief Strategy Officer of SHL Medical AG (“SHL”) since 2017. SHL is a global solution provider in the design, development and manufacturing of advanced drug delivery systems. Mr. Puusepp previously spent over seven years in Hong Kong and Beijing within the private equity and medtech industries. Prior to that, he worked in investment banking in Sweden, as well as management consulting. Additionally, Mr. Puusepp has held several directorships, including as a board member for Spowdi since October 2020, a non-executive board member of QulO since October 2018, a board member of Pharmaero ApS since February 2018 and as a Chairman of Innovation Zed since February 2018. He received his Master’s in Business Administration from Stockholm University in 2008. We believe Mr. Puusepp is well qualified to serve as our COO due to his experience, integrity, and track records across multiple industries.

 


 

 

Per Bjorkman ishas served as one of our Independent Directors.independent directors since July 2021. Since August 2020, he has served as Director of Business Development at SHL Healthcare, one of the world’s leading contract manufacturers and suppliers of MedTech solutions for home, hospital and long-term care use. As a customer-centric company, SHL offers a range of services, robust manufacturing capabilities and dedicated project management teams to best translate customer specifications into quality products. Prior to this role, he served as Managing Director of SHL Technologies & Group Ventures from January 2014 to December 2019. Mr. Bjorkman is a seasoned expert in the cannabis and healthcare industry. From October 2017 to July 2020, he served as Co-CEO of Solace Holdings in Nevada, a cGMP certified, vertically integrated THC tetrahydrocannabinol and CBDcannabidiol cannabis company, focusing on the cultivation and manufacturing of leading cannabis consumer branded goods. Mr. Bjorkman holds a bachelor’s degree in Business Administration from the European University and was part of the Leadership and Strategic Execution Program at INSEAD in France. We believe Mr. Bjorkman is well qualified to serve as a director due to his extensive knowledge in the mainstream medical and pharmaceutical industry, and its potential application to the cannabis field, in addition to having managed a successful cannabis growing and production facility in the US.

 

Marcos Angelini ishas served as one of our Independent Directors.independent directors since July 2021. He currently serveshas served as the President of Red Bull Latin America since April 2017. Since August 2020, he started ashas been an equity investor and is a member of the advisory board to YVY Brazil. Prior to these roles, from May 2016 to February 2017, Mr. Angelini was the CEO of Facebook in Brazil, where he oversaw the media giantgiant’s operations in the largest country in Latin America. Mr. Angelini has 24 years of international experience in marketing, innovation, media, advertising and general management. From January 1996 to March 2016, he worked at Unilever, initially in marketing, rising to Brand VP and later Vice President for Latin America. At Unilever, he had responsibility for numerous products for global client subsidiaries throughout the world. He was recognized by Meio & Mensagem as one of the top 10 Marketing Executives of 2015 and as one of the top 10 Media Executives of Brazil in 2016. Mr. Angelini received his MBA from the University of Durham and completed a Business Executive Program at Stanford University. We believe Mr. Angelini is well qualified to serve as a director due to his extensive experience working as a senior executive with internationally recognized brands such as Redbull and Facebook, and his ample consumer brands knowledge as a senior level global marketing manager at Unilever.

 

Ambassador Manuel RochaLuis Derechin has served as one of our independent directors since December 2023. Heis one of our Independent Directors. Before moving to Miami in 2002, he spent well over two decades as a US diplomat. His last postMexico’s most experienced technology entrepreneurs. In 2001, Mr. Derechin co-founded JackBe, which was as US Ambassador to Bolivia from July 2000 to August 2002. His Foreign Service career included assignments in the Dominican Republic, Italy, Honduras, Argentina and Cuba. Importantly, he was also Director of Inter-American Affairs in the National Security Council at the White House. Making the transition to the private sector, he worked for two law firms, established his own business development company bringing business opportunities from China to the Western Hemisphere, worked for a private equity firm based in Argentina, and headed Corporate Affairs for Arcos Dorados, which owns most of the McDonald’s restaurants in Latin America. All of this before serving as President of BARRICK Gold’s subsidiary in the Dominican Republic from September 2012 to April 2018, which represented the largest foreign direct investment in the country exceeding 5 billion dollars. Since May 2018, he has served as the SVP for Global Corporate Affairs for XCOAL, one of the largest exportersfirst companies in Mexico as well as Latin America to raise funding from U.S. venture capital. In 2014, JackBe was acquired by Software AG, and its technology became the cornerstone of US origin coals forthe German multinational’s push into data management and visualizations. After JackBe, Luis has founded a number of additional companies, including PointWorthy, a venture that allows Citibank and Hilton loyalty point holders to use their points to execute cash donations to any of the more than one million philanthropic causes in integrated steel mills, cement plants,the United States. Mr. Derechin studied engineering at UCSD and power plants throughout the world. He graduated cum laude from Yale University, earned a master’s degree in Public Administration from Harvard University and a Master’s in International Relations from Georgetown University.We believebusiness at Instituto Tecnologico Autónomo de México (ITAM). Mr. RochaDerechin is well qualified to serve as a director due to his ample resourcesextensive experience in venture capital and network astechnology.

Family Relationships

No family relationships exist between any of our directors or executive officers.

Involvement in Certain Legal Proceedings

There are no material proceedings to which any director or executive officer, or any associate of any such director or officer is a senior level, former State Department official, in additionparty adverse to his experience runningour Company, or has a large multinational operation. He is an expert negotiator who will bring valuable input in a highly regulated industry like cannabis.material interest adverse to our Company.

 

Number and Terms of Office of Officers and Directors

 

We have four directors. Our boardBoard of directorsDirectors is divided into two classes with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a two-year term. In accordance with Nasdaq corporate governance requirements, we arewere not required to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq. The term of office of the first class of directors, consisting of Manuel RochaLuis Derechin and Marcos Angelini, will expire at our first annual meeting of stockholders. The term of office of the second class of directors, consisting of Felipe MacLean and Per Bjorkman, will expire at the second annual meeting of stockholders.

 

On January 23, 2024, we received a deficiency notice from the Staff of Nasdaq notifying us that we are not in compliance with the Annual Meeting Requirement because we did not hold an annual meeting of stockholders within twelve months of our fiscal year ended December 31, 2022. The notification received had no immediate effect on our Nasdaq listing. In accordance with Nasdaq rules, we had 45 calendar days, or until March 8, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement. On March 1, 2024, we received the Delisting Notice from the Staff of Nasdaq informing us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024.


 

Our officers are appointed by the boardBoard of directorsDirectors and serve at the discretion of the boardBoard of directors,Directors, rather than for specific terms of office. Our boardBoard of directorsDirectors is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our officers may consist of a Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Vice Presidents, Secretary, Treasurer, Assistant Secretaries and such other offices as may be determined by the boardBoard of directors.Directors.

 

Nasdaq listing standards require that a majority of our board of directors be independent. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Messrs. Angelini, Bjorkman and Ambassador Rocha are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.


 

Committees of the Board of Directors

 

Our boardBoard of directorsDirectors has two standing committees: an audit committeethe Audit Committee and a compensation committee.committee (the “Compensation Committee”). Subject to phase-in rules and a limited exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent directors.

 

Audit Committee

 

Marcos Angelini, Manuel RochaLuis Derechin and Per Bjorkman serve as members of our audit committee,Audit Committee, and Marcos Angelini chairs the audit committee.Audit Committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee,Audit Committee, all of whom must be independent. Each of Marcos Angelini, Manuel Rocha,Luis Derechin, and Per Bjorkman meets the independent director standard under Nasdaq listing standards and under Rule 10-A-3(b)(1) of the Exchange Act.

 

Each member of the audit committeeAudit Committee is financially literate, and our boardBoard of directorsDirectors has determined that Marcos Angelini qualifies as an “audit committee financial expert” as defined in applicable SEC rules.

 

We have adopted an audit committeeAudit Committee charter, as amended and restated. which details the principal functions of the audit committee,Audit Committee, including:

 

the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm engaged by us;

 

pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;

 

setting clear hiring policies for employees or former employees of the independent registered public accounting firm, including but not limited to, as required by applicable laws and regulations;

 

setting clear policies for audit partner rotation in compliance with applicable laws and regulations;

 

obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures, (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues and (iii) all relationships between the independent registered public accounting firm and us to assess the independent registered public accounting firm’s independence;

 

reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and

 

reviewing with management,Management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board,FASB, the SEC or other regulatory authorities.authorities; and

 

advising the Board and any other Board committees if the clawback provisions of Rule 10D-1 under the Exchange Act (the “Rule”) are triggered based upon a financial statement restatement or other financial statement change, with the assistance of Management and to the extent that our securities continue to be listed on an exchange and subject to the Rule.


 

 

Compensation Committee

 

Per Bjorkman, Marcos Angelini and Manuel RochaLuis Derechin serve as the members of our compensation committee.Compensation Committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least two members of the compensation committee,Compensation Committee, all of whom must be independent. Per Bjorkman, Marcos Angelini and Manuel RochaLuis Derechin are independent, and Per Bjorkman will chairchairs the compensation committee.Compensation Committee.

 

We have adopted a compensation committeeCompensation Committee charter, as amended and restated, which details the principal functions of the compensation committee,Compensation Committee, including:

 

reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officers’ compensation, if any is paid by us, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;

 

reviewing and approving on an annual basis the compensation, if any is paid by us, of all of our other officers;

 

reviewing on an annual basis our executive compensation policies and plans;

 

implementing and administering our incentive compensation equity-based remuneration plans;

 

assisting managementManagement in complying with our proxy statement and annual report disclosure requirements;

 

approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;

 

if required, producing a report on executive compensation to be included in our annual proxy statement; and

 

reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.directors;

advising the Board and any other Board committees if the clawback provisions of the Rule are triggered based upon a financial statement restatement or other financial statement change, with the assistance of Management and to the extent that our securities continue to be listed on an exchange and subject to the Rule.

 

Notwithstanding the foregoing, as indicated above, other than the payment to an affiliate of our sponsorSponsor of $10,000 per month for up to 12 months (or up to 21 months), for office space, utilities and secretarial and administrative support, pursuant to the Administrative Support Agreement, and reimbursement of expenses, no compensation of any kind, including finders, consulting or other similar fees, has been or will be paid to any of our existing stockholders, officers, directors or any of their respective affiliates, prior to, or for any services they render in order to effectuate the consummation of an initial business combination.Business Combination. Accordingly, it is likely that prior to the consummation of an initial business combination,Business Combination, the compensation committeeCompensation Committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business combination.Business Combination.

 

The Compensation Committee charter also provides that the compensation committeeCompensation Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committeeCompensation Committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.

 


Director Nominations

 

We do not have a standing nominating and corporate governance committee though we intend to form a nominating and corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the boardBoard of directors.Directors.


 

The boardBoard of directorsDirectors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. The directors who will participate in the consideration and recommendation of director nominees are Per Bjorkman, Marcos Angelini, and Manuel Rocha.Luis Derechin. In accordance with Rule 5605 of the Nasdaq rules, all such directors are independent. As there is no standing nominating and corporate governance committee, we do not have a nominating and corporate governance committee charter in place.

 

The boardBoard of directorsDirectors will also consider director candidates recommended for nomination by our stockholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special meeting of stockholders). Any stockholder who wishesOur stockholders that wish to nominate a director for election to our boardBoard of directorsDirectors should follow the procedures set forth in our bylaws.

 

We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the boardBoard of directorsDirectors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our stockholders.

 

Code of Ethics

 

We have adopted a Code of Ethics applicable to our directors, officers and employees, which wasis filed, along with our amended and restated audit and compensation committee charters, as exhibits to the registration statement in connection with our initial public offering.Report. You can review these documents by accessing our public filings at the SEC’s web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K.

 

Compliance with Section 16(a) of the Exchange ActInsider Trading Policy

 

Section 16(a)On July 19, 2021, we adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities by directors, officers, and employees, which are reasonably designed to promote compliance with insider trading laws, rules and regulations, and applicable Nasdaq listing standards (the “Insider Trading Policy”).

The foregoing description of the ExchangeInsider Trading Policy does not purport to be complete and is qualified in its entirety by the terms and conditions of the Insider Trading Policy, a copy of which is attached hereto as Exhibit 19 and is incorporated herein by reference


Compensation Recovery and Clawback Policies

Under the Sarbanes-Oxley Act, requiresin the event of misconduct that results in a financial restatement that would have reduced a previously paid incentive amount, we can recoup those improper payments from our executive officers, directors and persons who beneficially own more than 10%officers. The SEC also recently adopted rules which direct national stock exchanges to require listed companies to implement policies intended to recoup bonuses paid to executives if the company is found to have misstated its financial results.

On November 30, 2023, our Board of a registered classDirectors approved the adoption of our equity securitiesthe Executive Compensation Clawback Policy (the “Clawback Policy”), with an effective date of October 2, 2023, in order to filecomply with the final clawback rules adopted by the SEC initial reportsunder the Rule, and the listing standards, as set forth in the Nasdaq Listing Rule 5608 (the “Final Clawback Rules”).

The Clawback Policy provides for the mandatory recovery of ownershiperroneously awarded incentive-based compensation from our current and reports of changes in ownership of our common stock and other equity securities. Theseformer executive officers directors, and greater than 10% beneficial ownersas defined in the Rule (“Covered Officers”) in the event that we are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons. Based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that during the year ended December 31, 2021, all reports applicable to our executive officers, directors and greater than 10% beneficial owners were filed in a timely mannerprepare an accounting restatement, in accordance with Section 16(a)the Final Clawback Rules. The recovery of such compensation applies regardless of whether a Covered Officer engaged in misconduct or otherwise caused or contributed to the requirement of an accounting restatement. Under the Clawback Policy, our Board of Directors may recoup from the Covered Officers erroneously awarded incentive compensation received within a lookback period of the Exchange Act.three completed fiscal years preceding the date on which we are required to prepare an accounting restatement.

 

Item 11. Executive Compensation.

 

Other than disclosed herein, none of our officers has received any cash compensation for services rendered to us. Commencing on July 19, 2021, we have agreed to pay an affiliate of our sponsorSponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support.support, pursuant to the Administrative Support Agreement. Upon the earlier of the completion of our initial business combinationBusiness Combination or our liquidation, we will cease paying these monthly fees. No compensation of any kind, including any finder’s fee, reimbursement, consulting fee or monies in respect of any payment of a loan, has been or will be paid by us to our sponsor,Sponsor, officers and directors, or any affiliate of our sponsorSponsor or officers, prior to, or in connection with any services rendered in order to effectuate, the consummation of our initial business combinationBusiness Combination (regardless of the type of transaction that it is). However, these individuals will beare reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf, such as identifying potential target businesses and performing due diligence on suitable business combinations.Business Combinations. Our audit committee will reviewAudit Committee reviews on a quarterly basis all payments that were made to our sponsor,Sponsor, officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will beBusiness Combination are made using funds held outside the trust account.Trust Account. Other than quarterly audit committeeAudit Committee review of such payments, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with identifying and consummating an initial business combination.Business Combination.

 

After the completion of our initial business combination,Business Combination, directors or members of our managementManagement team who remain with us may be paid consulting or managementManagement fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our stockholders in connection with a proposed initial business combination.Business Combination, such as the Kustom Entertainment Registration Statement. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management.Management. It is unlikely the amount of such compensation will be known at the time of the proposed initial business combination,Business Combination, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the boardBoard of directorsDirectors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our boardBoard of directors.Directors.

 

We do not intend to take any action to ensure that members of our managementManagement team maintain their positions with us after the consummation of our initial business combination,Business Combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination.Business Combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’sManagement’s motivation in identifying or selecting a target business, but we do not believe that the ability of our managementManagement to remain with us after the consummation of our initial business combinationBusiness Combination will be a determining factor in our decision to proceed with any potential business combination.Business Combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.

 


Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The following table sets forth information regarding the beneficial ownership of our common stockCommon Stock as of April 1, 2022March 21, 2024 based on information obtained from the persons named below, with respect to the beneficial ownership of common stock,Common Stock, by:

 

each person known by us to be the beneficial owner of more than 5% of our outstanding common stock;Common Stock;

 

each of our executive officers and directors that beneficially owns our common stock;Common Stock; and

 

all our executive officers and directors as a group.

  

In the table below, percentage ownership is based on 18,102,9425,320,508 shares of our common stock,Common Stock, consisting of (i) 14,645,1355,320,507 shares of our Class A common stockCommon Stock and (ii) 3,457,807 sharesone share of our Class B common stock,Common Stock, issued and outstanding as of December 31, 2020.March 21, 2024. On all matters to be voted upon, except for the election of directors of the board, holders of the shares of Class A common stockCommon Stock and shares of Class B common stockCommon Stock vote together as a single class.class, unless otherwise required by applicable law. Currently, all of the shares of Class B common stockCommon Stock are convertible into Class A common stockCommon Stock on a one-for-one basis.


 

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stockCommon Stock beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement rightsPrivate Placement Rights as these rightsRights are not exercisable within 60 days of the date of this Report.

 

  Class A Common Stock  Class B Common Stock  Approximate 
Name and Address of Beneficial Owner (1) Number of
Shares
Beneficially
Owned
  Approximate
Percentage
of Class
  Number of
Shares
Beneficially
Owned
  Approximate
Percentage
of Class
  Percentage
of Outstanding
Common
Stock
 
Yntegra Capital Investments, LLC(2)  571,859   3.9   3,457,807   100.0   22.6 
Felipe MacLean (2)  571,859   3.9   3,457,807   100.0   22.6 
Chris Rebentisch (3)  -   -   -   -   - 
Luis A. Guerra(3)  -   -   -   -   - 
Per Bjorkman(3)  -   -   -   -   - 
Marcos Angelini(3)  -   -   -   -   - 
Ambassador Manuel Rocha(3)  -   -   -   -   - 
All executive officers, directors and director nominees as a group  571,859   3.9   3,457,807   100.0   22.6 
Other 5% holders                    
Boothbay Fund Management, LLC(4)  1,200,000   9.05   -   -   6.7 
Highbridge Capital Management, LLC(5)  739,116   5.42   -   -   4.1 
MMCAP International Inc. SPC (6)  1,000,000   6.83   -   -   5.6 
Hudson Bay Capital Management LP (7)  1,245,000   8.50   -   -   6.9 
ATW SPAC MANAGEMENT LLC (8)  1,200,000   8.19   -   -   6.7 
Mizuho Financial Group, Inc. (9)  816,476   5.58   -   -   4.6 
  Class A Common Stock  Class B Common Stock    
Name and Address of Beneficial Owner(1) Number of
Shares
Beneficially
Owned
  Approximate
Percentage of
Class
  Number of
Shares
Beneficially
Owned
  Approximate
Percentage of
Class
  Approximate
Percentage of
Outstanding
Common Stock
 
Yntegra Capital Investments, LLC(2)  4,029,665   76.0%  1   100.0   76.0%
Felipe MacLean(2)  4,029,665   76.0%  1   100.0   76.0%
Markus Puusepp(2)               
Luis A. Guerra(3)               
Per Bjorkman(3)               
Marcos Angelini(3)               
Luis Derechin(3)               
All executive officers, directors and director nominees as a group  4,029,665   76.0%  1   100.0   76.0%
Mizuho Financial Group, Inc.(4)  816,476   14.78%        14.78%
RiverNorth Capital Management, LLC (5)  300,000   5.43%          5.43%

 

 

*less than 1%

(1)Unless otherwise noted, the principal business address of each of the following entities or individuals is c/o Yntegra Capital Investments, LLC, 1450 Brickell Avenue, Suite 2520, Miami, FL 33131.Kustom Entertainment, Inc., 14001 Marshall Drive Lenexa, KS 66215.

(2)Represents shares held by Yntegra Capital Investments, LLC, our sponsor.the Company’s Sponsor. Yntegra Capital Management, LLC is the sole managing member of the Sponsor and a U.S. entity. Felipe MacLean, oura U.S. citizen and the Company’s Chairman and Chief Executive Officer, is the sole manager of our sponsorYntegra Capital Management, LLC, and as such, may be deemed to haveshare beneficial ownership of the common stockCommon Stock held directly by our sponsor.Sponsor. Mr. McLean and Markus Puusepp, the Company’s Chief Operating Officer, each own 50% of Yntegra Capital Management, LLC. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

(3)Does not include any shares held by our sponsor.Sponsor. This individual is a member of our sponsorSponsor but does not have voting or dispositive control over the shares held by our sponsor.

(4)According to a Schedule 13G filed with the SEC on July 27, 2021, the listed Class A common shares are owned by one or more private funds, including Boothbay Absolute Return Strategies LP, managed by Boothbay Fund Management, LLC, of which Ari Glass is the Managing Member. The business address of each such person is 140 East 45th Street, 14th Floor, New York, NY 10017.


(5)According to a Schedule 13G filed with the SEC on February 3, 2022, the listed Class A common shares are owned by Highbridge Capital Management, LLC, which is the investment adviser to certain funds and accounts (the “Highbridge Funds”). Highbridge Capital Management, LLC may be deemed to be the beneficial owner of the 793,116 shares of Class A common stock held by the Highbridge Funds. The business address of the listed parties is 277 Park Avenue, 23rd Floor, New York, NY 10172.Sponsor.
(4)(6)According to a Schedule 13G filed with the SEC on July 27, 2021, the listed shares are owned by MMCAP International Inc. SPC (“Fund”), and voting and dispositive powers are shared with MM Asset Management Inc. (“Manager”). The addresses of Fund and Manager are c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, P.O. Box 1348, Grand Cayman, KY1-1108, Cayman Islands and 161 Bay Street, TD Canada Trust Tower Ste 2240, Toronto, ON, M5J 2S1, Canada, respectively.
(7)According to a Schedule 13G filed with the SEC on February 4, 2022, the listed shares are owned by Hudson Bay Capital Management LP (the “Investment Manager”), which serves as the investment manager to HB Strategies LLC and Hudson Bay SPAC Master Fund LP, in whose name the securities are held. As such, the Investment Manager may be deemed to be the beneficial owner of all shares of Class A Common Stock held by HB Strategies LLC and Hudson Bay SPAC Master Fund LP. Mr. Sander Gerber serves as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager. Mr. Gerber disclaims beneficial ownership of these securities. The address of the Investment Manager and Mr. Gerber are 28 Havemeyer Place, 2nd Floor, Greenwich, Connecticut 06830.
(8)According to a Schedule 13G filed with the SEC on February 14, 2022  by Mizuho Financial Group, Inc., a Japanese corporation (“Mizuho”). Mizuho, Mizuho Bank, Ltd. and Mizuho Americas LLC may be deemed to be indirect beneficial owners of the listed Class A commonPublic Shares reported therein, which are directly held by Mizuho Securities USA LLC, their wholly-owned subsidiary. The number of Public Shares held by Mizuho is reported as of December 31, 2021, which does not reflect any redemption of shares are owned by onein the 2023 Redemptions, the 2024 Redemptions, or more separately managed accounts managed by ATW SPAC Management LLC,any other transactions after December 31, 2021. Accordingly, the number of which Antonio Ruiz-Gimenez isPublic Shares and the Managing Member.percentages set forth in the table may not reflect Mizuho’s current beneficial ownership. The principal business address of each such personMizuho is 7969 NW 2nd Street, #401, Miami, Florida 33126.1–5–5, Otemachi, Chiyoda–ku, Tokyo 100–8176, Japan.
(5)(9)According to a Schedule 13G filed with the SEC on February 14, 2022, the listed Class A common shares are owned2024 by Mizuho Financial Group, Inc., Mizuho Bank, Ltd. and Mizuho AmericasRiverNorth Capital Management, LLC, which may be deemed to be indirect beneficial ownersa Delaware limited liability company (“RiverNorth”). The number of said equity securities directlyPublic Shares held by Mizuho Securities USA LLCthe RiverNorth is reported as of December 31, 2023, which is their wholly-owned subsidiary.does not reflect any redemption of shares in the 2024 Redemptions or any other transactions after December 31, 2023. Accordingly, the number of Public Shares and the percentages set forth in the table may not reflect RiverNorth’s current beneficial ownership. The principal business address of Mizuho Financial Group, Inc.RiverNorth is 1–5–5, Otemachi, Chiyoda–ku, Tokyo 100–8176, Japan.360 S. Rosemary Avenue, Ste. 1420, West Palm Beach, Florida 33401.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

None.

 

Changes in Control

 

None. For more information on the Kustom Entertainment Business Combination, please see “Item 1. Business.”


 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

On March 4, 2021, we issued an aggregate of 3,593,750 founder sharesFounder Shares to our sponsorSponsor (135,942 of which were forfeited by our sponsorSponsor because the underwriters’ over-allotment option was not exercised in full) for an aggregate purchase price of $25,000 in cash. The number of founder sharesFounder Shares issued was determined based on the expectation that such founder sharesFounder Shares would represent 20% of the outstanding shares upon completion of our initial public offeringInitial Public Offering (excluding shares included in the private placement unitsPrivate Placement Units or the shares of Class A common stockCommon Stock issuable to Maxim)the Representative). The founder sharesFounder Shares (including the Class A common stockCommon Stock issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder.

 

On April 8, 2021, our Sponsor transferred a membership interest in our Sponsor to each of our three officers and our three independent directors, representing an aggregate 75,000 Founder Shares. The interest of each officer and director relates solely to the number of Founder Shares laid out in their respective agreements. The transferred shares will vest upon our consummation of an initial Business Combination (the “Vesting Date”). If prior to the Vesting Date, any of the grantees ceases to remain in their role, either voluntarily or for a cause, (a “Separation Event”), 100% of the shares granted will be automatically and immediately transferred back to our Sponsor upon such Separation Event.

On July 20, 2023, upon the approval of the Conversion Amendment Proposal by our stockholders at the 2023 Special Meeting, we issued an aggregate of 3,457,806 shares of Class A Common Stock to our Sponsor, upon the conversion of an equal number of Class B Common Stock held by the Sponsor in the Founder Share Conversion. The 3,457,806 shares of Class A Common Stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Common Stock before the Founder Share Conversion, including, among others, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial Business Combination as described in the IPO Registration Statement; consequently, the shares of Class A Common Stock issued in connection with the Founder Share Conversion are not registered under the Securities Act and will remain unregistered until registration is demanded by the Sponsor pursuant to the Letter Agreement we entered into with our Sponsor, officers and directors.

Our sponsorSponsor purchased an aggregate of 571,859 private placement unitsPrivate Placement Units at a price of $10.00 per unit,Unit, for an aggregate purchase price of $5,718,590.$5,718,590 in the Private Placement. The private placement unitsPrivate Placement Units (including the underlying securities) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until after the completion of our initial business combination.Business Combination.

 

If any of our officers or directors becomes aware of an initial business combinationBusiness Combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combinationBusiness Combination opportunity to such other entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.

 

Commencing July 19, 2021, we have agreed to pay an affiliate of our sponsorSponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support.support, pursuant to the Administrative Support Agreement. Upon completion of our initial business combinationBusiness Combination or our liquidation, we will cease paying these monthly fees.

 

Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us up to $300,000 to be used for a portion of the expenses of the offering. These loans were non-interest bearing, unsecured and due at the earlier of September 30, 2021 or the closing of our Initial Public Offering. $173,500 had been advanced on June 30, 2021. The loan was to be repaid upon the closing of our Initial Public Offering out of the offering proceeds. As of December 31, 2021, $0 was outstanding under such loan. The value of our Sponsor’s interest in this transaction corresponds to the principal amount outstanding under any such loan.

In connection with the July 2022 Extension, on July 18, 2022, we issued the July 2022 Extension Note to our Sponsor in the principal amount of $1,383,123, pursuant to which our Sponsor loaned to us $1,383,123 to be deposited into the Trust Account. The July 2022 Extension Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which our initial Business Combination is consummated and (ii) our liquidation. At the election of our Sponsor, up to $1,383,123 of the unpaid principal amount of the July 2022 Extension Note may be converted into Conversion Units. The total Conversion Units so issued shall be equal to: (x) the portion of the principal amount of the July 2022 Extension Note being converted divided by (y) the conversion price of ten dollars ($10.00), rounded up to the nearest whole number of Units.

In connection with the October 2022 Extension, on October 19, 2022, we issued the October 2022 Extension Note to our Sponsor in the principal amount of $1,383,123, pursuant to which our Sponsor loaned to us $1,383,123 to be deposited into the Trust Account. The October 2022 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of our initial Business Combination, or (b) the date of our liquidation.


 

In connection with the 2023 Extension, on July 24, 2023, our Sponsor caused to be deposited into the Trust Account up to $360,000 (representing $0.048 per Public Share), which was deposited into the Trust Account. The 2023 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of our initial Business Combination, or (b) the date of our liquidation.

In connection with the 2024 Extension, on January 22, 2024, our Sponsor caused to be deposited into the Trust Account up to $360,000. The 2024 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of our initial Business Combination, or (b) the date of our liquidation. As of March 21, 2024, $180,000 of the principal on the 2024 Extension Note has been deposited into the Trust Account.

In addition, in order to finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete an initial Business Combination, we would repay such Working Capital Loans. In the event that the initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such Working Capital Loans but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be convertible into Conversion Units at a price of $10.00 per Conversion Unit (which, for example, would result in the holders being issued Conversion Units to purchase 150,000 Units if $1,500,000 of notes were so converted), at the option of the lender. Such Conversion Units would be identical to the Private Placement Units. We do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.

On July 21, 2023, we issued the 2023 Working Capital Note in the principal amount of up to $300,000 to our Sponsor. The 2023 Working Capital Note was issued in connection with advances our Sponsor may make in the future to us as Working Capital Loans. The 2023 Working Capital Note is non-interest bearing and payable upon the earlier of (i) completion of our initial Business Combination or (ii) the date that our winding up is effective. We drew $300,000 under the 2023 Working Capital Note, which was outstanding as of December 31, 2023.

In addition, in order to finance transaction costs in connection with an initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. $715,000 and $0 were outstanding under any Working Capital Loans as of December 31, 2023 and 2022, respectively.

 

Other than the foregoing, no compensation of any kind, including any finder’s fee, reimbursement, consulting fee or monies in respect of any payment of a loan, will be paid by us to our sponsor,Sponsor, officers and directors, or any affiliate of our sponsorSponsor or officers, prior to, or in connection with any services rendered in order to effectuate, the consummation of an initial business combinationBusiness Combination (regardless of the type of transaction that it is). However, these individuals will beare reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf, such as identifying potential target businesses and performing due diligence on suitable business combinations.Business Combinations. Our audit committee will reviewAudit Committee reviews on a quarterly basis all payments that were made to our sponsor,Sponsor, officers, directors or our or their affiliates and will determinedetermines which expenses and the amount of expenses that willare to be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 

Prior to the closing of our initial public offering, our sponsor agreed to loan us up to $300,000 to be used for a portion of the expenses of the offering. These loans are non-interest bearing, unsecured and were due at the earlier of September 30, 2021 or the closing of our initial public offering. $173,500 had been advanced on June 30, 2021. The loan was to be repaid upon the closing of offering out of the offering proceeds. As of December 31, 2021, $0 was outstanding under such loan. The value of our sponsor’s interest in this transaction corresponds to the principal amount outstanding under any such loan.

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such working capital loans may be convertible into private placement-equivalent units at a price of $10.00 per unit (which, for example, would result in the holders being issued units to purchase 150,000 units if $1,500,000 of notes were so converted), at the option of the lender. Such units would be identical to the private placement units. The terms of such working capital loans by our sponsor or its affiliates, or our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

If we anticipate that we may not be able to consummate our initial business combination within 12 months, and subject to our sponsor depositing additional funds into the trust account as set out below, our time to consummate a business combination shall be extended by up to three additional three month periods, for a total of up to 21 months to complete a business combination. This will occur as long as our sponsor or its affiliates or designees, on or prior to the date of the applicable deadline, deposits into the trust account $1,383,123 for each additional three month period. Any such payment would be made in the form of a non-interest bearing loan. If we complete our initial business combination, we will, at the option of the lender, repay such loaned amounts out of the proceeds of the trust account released to us or convert a portion or all of the total loan amount into units at a price of $10.00 per units, which units will be identical to the private placement units. If we do not complete a business combination, we will repay such loans only from funds held outside of the trust account. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination.

After our initial business combination,Business Combination, members of our management teamManagement Team who remain with us may be paid consulting, managementManagement or other fees from the combined company with any and all amounts being fully disclosed to our stockholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our stockholders.stockholders, such as the Kustom Entertainment Registration Statement. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a stockholder meeting held to consider our initial business combination,Business Combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.

 

We will enterhave entered into a registration rights agreementRegistration Rights Agreement with respect to the private placement units,Private Placement Units, the securities issuable upon conversion of working capital loansWorking Capital Loans and extension loans (if any) and the shares of Class A common stockCommon Stock issuable upon exercise or conversion or exercise of the foregoing and upon conversion of the founder shares.Founder Shares.

 

Director Independence

 

Nasdaq listing standards require that a majority of our boardBoard of directorsDirectors be independent. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship whichthat, in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our boardBoard of directorsDirectors has determined that Marcos Angelini, Per Bjorkman and Manuel RochaLuis Derechin are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.

 


 

 

Item 14.14. Principal Accountant Fees and Services.

 

The following is a summary of fees paid or to be paid to Marcum LLP for services rendered.

Audit Fees.

Audit fees consist of fees for professional services rendered for the audit of our year-end financial statements and services that are normally provided by Marcum LLP in connection with regulatory filings. The aggregate fees of Marcum LLP for professional services rendered for the audit of our annual financial statements, review of the financial information included in our FormsQuarterly Reports on Form 10-Q for the respective periods and other required filings with the SEC for the yearyears ended December 31, 20212023 and 2022 totaled approximately $31,930.$195,794 and $115,360, respectively. The aggregate fees of Marcum LLP related to audit services in connection with our initial public offeringInitial Public Offering totaled approximately $49,955. The above amounts include interim procedures and audit fees, as well as attendance at audit committeeAudit Committee meetings.

 

Audit-Related Fees

.

Audit-related fees consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.

Tax Fees. We did not pay Marcum LLPfor any audit-related fees for the years ended December 31, 2023 and 2022.

Tax Fees

Tax fees consist of fees billed for professional services relating to tax compliance, tax planning and tax advice. We paid Marcum $9,293 and $8,755, respectively, for tax services, planning or advice for the periodyears ended December 31, 2021.2023 and 2022.

 

All Other Fees.

All other fees consist of fees billed for all other services. We did not pay Marcum LLP for any other services for the year periodyears ended December 31, 2021.2023 and 2022.

 

Pre-Approval Policy

 

Our audit committeeAudit Committee was formed upon the consummation of our initial public offering.Initial Public Offering. As a result, the audit committeeAudit Committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our audit committeeAudit Committee were approved by our boardBoard of directors.Directors. Since the formation of our audit committee,Audit Committee, and on a going-forward basis, the audit committeeAudit Committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committeeAudit Committee prior to the completion of the audit).


 

 

PART IV

 

Item 15. Exhibit and Financial Statement Schedules.

 

(a)The following documents are filed as part of this Report:

 

(1)Financial Statements

 

 PAGE
Report of Independent Registered Public Accounting Firm PCAOB(PCAOB ID Number 688688)F-2
Balance SheetSheets as of December 31, 20212023 and 2022F-3
StatementStatements of Operations for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-4
StatementStatements of Changes in Stockholders’ Deficit for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-5
StatementStatements of Cash Flows for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-6
Notes to Financial StatementsF-7 to F-22

 

(2)Financial StatementsStatement Schedule

 

All financial statement schedules are omitted because they are not applicable or the amounts are immaterial and not required, or the required information is presented in the financial statements and notes thereto beginning on page F-1 of this Report.

 

(3)Exhibits

 

We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits whichthat are incorporated herein by reference can be inspected on the SEC website at www.sec.gov.www.sec.gov.

 

Item 16. Form 10-K Summary.

 

Not applicable.Omitted at our Company’s option.

 


 

 

CLOVER LEAF CAPITAL CORP.

 

INDEX TO FINANCIAL STATEMENTS

 

 PAGE
Report of Independent Registered Public Accounting Firm PCAOB ID Number 688F-2
Balance SheetSheets as of December 31, 20212023 and 2022F-3
StatementStatements of Operations for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-4
StatementStatements of Changes in Stockholders’ Deficit for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-5
StatementStatements of Cash Flows for the period from February 25, 2021 (inception) throughyear ended December 31, 20212023 and 2022F-6
Notes to Financial StatementsF-7 to F-22

 


F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the ShareholdersStockholders and Board of Directors of

Clover Leaf Capital Corp.Corp.

 

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Clover Leaf Capital Corp. (the “Company”) as of December 31, 2021,2023 and 2022, the related statements of operations, changes in stockholders’ deficit and cash flows for each of the two years in the period from February 25, 2021 (inception) throughended December 31, 2021,2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021,2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period from February 25, 2021 (inception) throughended December 31, 2021,2023, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, to the financial statements, the Company’s ability to execute its business plan is dependent onupon the completionconsummation of a business combination and it lacks the Company’s cash and working capital as of December 31, 2021 are not sufficientfinancial resources it needs to complete its planned activitiessustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. Further, if the Company does not complete a business combination by July 22, 2022,2024, or obtain approval for an extension of this deadline, it will be required to cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about the Company'sCompany’s ability to continue as a going concern. Management'sManagement’s plans with regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

 

These financial statements are the responsibility of the Company'sCompany’s management. Our responsibility is to express an opinion on the Company'sCompany’s financial statements based on our audit.audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB"(“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our auditaudits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditaudits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit,audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company'sCompany’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our auditaudits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our auditaudits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit providesaudits provide a reasonable basis for our opinion.

 

/s/ Marcum llp

 

Marcum llp

 

We have served as the Company’s auditor since 2021.

New York, NY

April 15, 2022
March 21, 2024

 


F-2

 

PART I. FINANCIAL INFORMATION

CLOVER LEAF CAPITAL CORP.

BALANCE SHEET

December 31, 2021SHEETS

 

 December 31, 
 2023  2022 
     
Assets:        
Current assets:        
Cash $680,302  $162,933  $303,449 
Prepaid expenses – current portion  183,663 
Prepaid expenses  122,364   104,876 
Total current assets  863,965   285,297   408,325 
Prepaid expenses – long term portion  97,945 
Investments held in Trust Account  140,404,628   14,648,926   18,276,649 
Total Assets $141,366,538  $14,934,223  $18,684,974 
            
Liabilities, Redeemable Common Stock and Stockholders’ Deficit            
Accrued costs and expenses $442,564  $809,542  $367,408 
Income taxes payable  134,428   137,633 
Excise Tax Payable  42,099    
Deferred income tax     18,790 
Promissory note to Related Party  3,842,015   2,767,015 
Due to related party  2,903   10,000    
Total current liabilities  445,467   4,838,084   3,290,846 
        
Deferred underwriting commissions  4,840,931   4,840,931   4,840,931 
Total Liabilities  5,286,398   9,679,015   8,131,777 
            
Commitments and Contingencies (see Note 7)    
Commitments and Contingencies (see Note 6)        
            
Redeemable Common Stock:            
Class A common stock subject to possible redemption, 13,831,230 Class A common stock shares at redemption value of $10.15 per share  140,386,985 
Class A common stock subject to possible redemption, 1,251,156 and 1,627,158 Class A common stock shares at redemption value of $11.85 and $11.24 per share at December 31, 2023 and 2022, respectively  14,830,241   18,283,387 
            
Stockholders’ Deficit:            
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding         
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 813,905 shares issued and outstanding (excluding 13,831,230 shares subject to possible redemption)  81 
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,457,807 shares issued and outstanding  346 
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 4,271,711 and 813,905 shares issued and outstanding (excluding 1,251,156 and 1,627,158 shares subject to possible redemption) at December 31, 2023 and 2022, respectively  427   81 
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 1 and 3,457,807 shares issued and outstanding December 31, 2023 and 2022, respectively     346 
Accumulated deficit  (4,307,272)  (9,575,460)  (7,730,617)
Total Stockholders’ Deficit  (4,306,845)  (9,575,033)  (7,730,190)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit $141,366,538  $14,934,223  $18,684,974 

 

The accompanying notes are an integral part of these financial statements.

 


F-3

 

 

CLOVER LEAF CAPITAL CORP.

STATEMENTSTATEMENTS OF OPERATIONS

FOR THE PERIOD FROM FEBRUARY 25, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021 

    
Formation and operating costs $851,777 
Loss from operations  (851,777)
     
Other income    
Interest and dividends earned on investments held in trust account  17,690 
Total other income  17,690 
     
Net loss $(834,087)
     
Basic and diluted weighted average of Class A common stock outstanding  7,700,506 
Basic and diluted net loss per share, Class A common stock $(0.08)
Basic and diluted weighted average Class B common stock outstanding  3,189,105 
Basic and diluted net loss per share, Class B common stock $(0.08)
  For the Year Ended December 31, 
  2023  2022 
       
Formation and operating costs $1,586,541  $1,291,228 
Loss from operations  (1,586,541)  (1,291,228)
         
Other income:        
Recovery of previously incurred costs     341,684 
Interest earned on investments held in Trust Account  737,057   1,195,135 
Interest earned on cash held in bank  116   69 
Total other income  737,173   1,536,888 
         
(Loss) Income before provision for income taxes  (849,368)  245,660 
Provision for income taxes  (196,591)  (185,423)
Net (loss) income $(1,045,959) $60,237 
         
Basic and diluted weighted average of redeemable Class A common stock outstanding  1,457,184   12,204,321 
Basic and diluted net (loss) income per share, redeemable Class A common stock  (0.18)  0.00 
Basic and diluted weighted average non-redeemable Class A and Class B common stock outstanding  4,271,712   3,457,807 
Basic and diluted net (loss) income per share, non-redeemable Class A and Class B common stock  (0.18)  0.00 

  

The accompanying notes are an integral part of these financial statements.

 


F-4

 

CLOVER LEAF CAPITAL CORP.

STATEMENTSTATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE PERIOD FROM FEBRUARY 25, 2021 (INCEPTION) THROUGH DecemberYEARS ENDED DECEMBER 31, 20212023 AND 2022

  Class A  Class B  Additional     Total 
  Common Stock  Common Stock  Paid-in  Accumulated  Stockholders’ 
  Shares  Amount  Shares  Amount  Capital  Deficit  Deficit 
Balance as of February 25, 2021 (Inception)  
  $
   
  $
  $
  $
  $
 
Class B common stock issued to initial stockholder     
   3,593,750   359   24,641      25,000 
Sales of 103,734 private placement units through the exercise of the over-allotment  103,734   10      
   1,037,332   
   1,037,342 
Sale of 571,859 private placement units  571,859   57         5,718,531      5,718,588 
Representative shares  138,312   14         1,383,109      1,383,123 
Forfeiture of shares due to over-allotment not exercised in full        (135,943)  (13)  13       
Proceeds allocated to equity rights              760,718      760,718 
Issuance costs allocated to equity rights              (52,593)     (52,593)
Class A share remeasurement to redemption value, net of allocation of rights proceeds and offering costs              (8,871,751)  (3,473,185)  (12,344,936)
Net loss                 

(834,087

)  (834,087)
Balance as of December 31, 2021  813,905  $81   3,457,807  $346  $
  $(4,307,272) $(4,306,845)
  Class A  Class B  Additional     Total 
  Common Stock  Common Stock  Paid-in  Accumulated  Stockholders’ 
  Shares  Amount  Shares  Amount  Capital  Deficit  Deficit 
Balance as of December 31, 2021  813,905   81   3,457,807   346      (4,307,272)  (4,306,845)
Accretion of Class A ordinary shares to redemption amount                 (3,483,582)  (3,483,582)
Net income                 60,237   60,237 
Balance as of December 31, 2022  813,905   81   3,457,807   346      (7,730,617)  (7,730,190)
Conversion of Class B ordinary shares in Class A ordinary shares  3,457,806   346   (3,457,806)  (346)         
Excise tax liability on share redemptions                 (42,099)  (42,099)
Accretion of Class A ordinary shares to redemption amount                 (756,785)  (756,785)
Net loss                 (1,045,959)  (1,045,959)
Balance as of December 31, 2023  4,271,711  $427   1  $  $  $(9,575,460) $(9,575,033)

The accompanying notes are an integral part of these financial statements.


F-5

 

CLOVER LEAF CAPITAL CORP.

STATEMENTSTATEMENTS OF CASH FLOWS

FOR THE PERIOD FROM FEBRUARY 25, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021

  For the Year Ended
December 31,
 
  2023  2022 
       
Cash flows from operating activities:      
Net (loss) income $(1,045,959) $60,237 
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest and dividends earned on investment in Trust  (737,173)  (1,195,135)
Amortization of prepaid expenses     46,557 
Changes in operating assets and liabilities:        
Accrued costs and expenses  442,135   (75,156)
Prepaid expenses  (17,488)  130,175 
Due to related party  10,000   (2,903)
Income taxes payable  (3,205)  137,633 
Deferred income tax  (18,790)  18,790 
Net cash used in operating activities  (1,370,480)  (879,802)
         
Cash Flows from Investing Activities:        
Investment of cash in Trust Account  (360,000)  (2,767,015)
Disposal of trust assets for redemptions  4,209,931   125,587,180 
Withdrawal of trust funds to pay taxes  514,964   502,949 
Net cash provided by Investing Activities  4,364,895   123,323,114 
         
Cash Flows from Financing Activities:        
Proceeds from sale of common stocks to initial stockholders  (4,209,931)  (125,587,180)
Proceeds from issuance of promissory note to related party  1,075,000   2,767,015 
Net cash used in financing activities  (3,134,931)  (122,820,165)
         
Net change in cash  (140,516)  (376,853)
Cash, beginning of the period  303,449   680,302 
Cash, end of the period $162,933  $303,449 
         
Supplemental disclosure of cash flow information:        
Recognition of liability for excise tax on redemptions $42,099  $ 
Class A share accretion to redemption value in excess of purchase price $756,785  $3,483,582 

    
Cash Flows from Operating Activities:   
Net loss $(834,087)
Adjustments to reconcile net loss to net cash used in operating activities:    
Formation costs paid by Sponsor  6,725 
Interest and dividends earned on investment in Trust  (17,643)
Amortization of prepaid expenses  102,892 
Changes in operating assets and liabilities:    
Accrued costs and expenses  442,564 
Due to related party  2,903 
Prepaid expenses  (384,500)
Net cash used in operating activities  (681,146)
     
     
Cash Flows from Investing Activities:    
Investment of cash in Trust Account  (140,386,985)
Net cash used in investing activities  (140,386,985)
     
Cash Flows from Financing Activities:    
Proceeds from Initial Public Offering  135,546,054 
Proceeds from Private placement  6,755,930 
Proceeds from sale of founder shares to initial stockholders  25,000 
Proceeds from issuance of promissory note to related party  130,000 
Payment of promissory note to related party  (174,225)
Payment of deferred offering costs  (534,326)
Net cash provided by financing activities  141,748,433 
     
Net Change in Cash  680,302 
Cash - February 25, 2021 (inception)   
Cash - Ending $680,302 
     
Supplemental disclosure of cash flow information:    
Initial value of Class A common stock subject to possible redemption $140,386,985 
Deferred underwriters commission $4,840,931 
Deferred offering costs paid by promissory note – related party $37,500 
Fair value of representative shares issued $1,383,124 
Forfeiture of shares due to over-allotment not exercised in full $13 

The accompanying notes are an integral part of these financial statements.


F-6

 

CLOVER LEAF CAPITAL CORP.

NOTES TO FINANCIAL STATEMENTS

Note 1—1 — Organization, Business Operation and Going Concern

Clover Leaf Capital Corp. (the “Company”) a blank check company recently incorporated in the State of Delaware for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business(“Business Combination”). The Company may pursue the initial Business Combination target in any industry or geographic location, thelocation. The Company intendsintended to focus its search for a target business engaged in the cannabis industry.

As of December 31, 2021,2023, the Company had not commenced any operations. All activity for the period from February 25, 2021 (inception) through December 31, 20212023 relates to the Company’s formation, and the initial public offering (the “Initial Public Offering” or “IPO”) and the Company’s efforts to pursue an initial Business Combination described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.

The Company’s sponsor is Yntegra Capital Investments, LLC, a Delaware limited liability company (the “Sponsor”).

The registration statementRegistration Statement for the Company’s IPO (the “IPO Registration Statement”) was declared effective on July 19, 2021 (the “Effective Date”).2021. On July 22, 2021, the Company consummated its IPO of 13,831,230 Unitsunits (the “Units” and, with respect to the Company’s Class A common stock, par value $0.0001 (“Class A Common Stock”) included in the Units being offered, the “public shares”“Public Shares”) at $10.00 per Unit, which is discussed in Note 3 (the “Initial(“The Initial Public Offering”), and the sale of 675,593 Units which is discussed in Note 4 (the “Private(“The Private Placement”), at a price of $10.00 per Unit,private placement unit (“Private Placement Units”), in a private placement (the “Private Placement”) to the Sponsor and Maxim Group LLC (“Maxim”(the “Representative”), the representative of the underwriters, that closed simultaneously with the IPO. On July 22, 2021, the underwriters partially exercised their over-allotment option and purchased 1,331,230 of their full 1,875,000 unitsUnits available and subsequently forfeited the remainder of their option as of July 28, 2021. The Company’s managementexecutive officers and directors (“Management”) has broad discretion with respect to the specific application of the net proceeds of the IPO and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating aan initial Business Combination.

Transaction costs amounted to $9,562,126 consisting of $2,766,246 of underwriting commissions, $4,840,931 of deferred underwriting commissions, $1,383,123 of the fair value of the representative shares138,312 Class A Common Stock issued to the Representative and/or its designees upon the consummation of the IPO (“Representative Shares”), and $571,826 of other cash offering costs.

The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into aan initial Business Combination. However, the Company will only complete aan initial Business Combination if the post-Businesspost-initial Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect aan initial Business Combination.

Following the closing of the IPO on July 22, 2021, $140,386,985 ($10.15 per Unit) from the net proceeds sold in the IPO, including the proceeds of the sale of the Private Placement Units, will be held in a Trust Accounttrust account (“Trust Account”), with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee, and will beuntil July 6, 2023 were invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasuryDepartment of the Treasury (“Treasury”) obligations. Except with respect to interest earned on the funds held in the trust accountTrust Account that may be released to pay the Company’s franchise and income taxes, if any, the funds held in the trust accountTrust Account will not be released from the trust accountTrust Account until the earliest to occur of: (1) the completion of an initial Business Combination; (2) the redemption of any public sharesPublic Shares properly submitted in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation, as amended and restated certificate of incorporationcurrently in effect (the “Amended and Restated Charter”) (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public sharesPublic Shares if the Company does not complete an initial Business Combination within 12 months from the closing of the IPO (or up to 21 months if the Company extends theapplicable period of time to consummate an initial Business Combination) or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3) the redemption of the public sharesPublic Shares if the Company has not completed an initial Business Combination within 12 months from the closing of the IPO (or up to 21 months if the Company extends theapplicable period, of time to consummate an initial Business Combination), subject to applicable law.


The Company will provide its public stockholdersPublic Stockholders with the opportunity to redeem all or a portion of their public sharesPublic Shares upon the completion of the initial Business Combination either (1) in connection with a stockholder meeting called to approve the initial Business Combination or (2) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require it to seek stockholder approval under applicable law or stock exchange listing requirement. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public sharesPublic Shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes, divided by the number of then issued and outstanding public shares,Public Shares, subject to the limitations described herein.

F-7

The shares of Class A Common Stock and Class B common stock, par value $0.0001 per share (the “Class B Common Stock” and together with the Class A Common Stock, the “Common Stock”) subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with aan initial Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of aan initial Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the initial Business Combination.

The Company will have only 12 months from the closing of the IPOuntil July 22, 2024 to complete the initial Business Combination or may extend the period of time to complete the initial Business Combination by three additional three-month periods (the “Combination Period”). Pursuant to the terms of the Company’s amendedAmended and restated certificate of incorporationRestated Charter and the trust agreement to beInvestment Management Trust Agreement, dated July 19, 2021 entered into between the Company and Continental, Stock Transfer &as trustee of the Trust Company,Account, in order to extend the time available for the Company to consummate its initial Business Combination, the Sponsor or its affiliates or designees, upon five daysdays’ advance notice prior to the applicable deadline, must deposit into the trust accountTrust Account for each additional three monththree-month period, $1,383,123 ($0.10 per share on or prior to the date of the applicable deadline) for each additional three monththree-month period. Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of an initial business combination.Business Combination. If the Company completes an initial business combination,Business Combination, it will, at the option of the Sponsor, repay such loaned amounts out of the proceeds of the trust accountTrust Account released to the Company or convert a portion or all of the total loan amount into unitsUnits at a price of $10.00 per unit.Unit.

On July 18, 2022, the Company issued a promissory note (the “July 2022 Extension Note”) in the principal amount of $1,383,123 to the Sponsor in connection with the extension of the Combination Period from July 22, 2022 to October 22, 2022 (the “July 2022 Extension”).

On October 19, 2022, the Company held a special meeting of stockholders (the “2022 Special Meeting”). At the 2022 Special Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Charter to extend the date by which the Company must consummate its initial Business Combination from October 22, 2022 to July 22, 2023, or such earlier date as determined by the Company’s board of directors (the “Board”) (the “October 2022 Extension”). In connection with the 2022 Special Meeting, stockholders holding 12,204,072 shares of the Company’s Class A Common Stock issued in the Company’s IPO exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. As a result, approximately $125,587,180.34 (approximately $10.29 per share) was removed from the Company’s Trust Account to pay such holders.

On July 19, 2023, the Company held a special meeting of stockholders in lieu of an annual meeting of stockholders (the “2023 Special Meeting”). At the 2023 Special Meeting, the Company’s stockholders approved an amendment (the “2023 Extension Amendment”) to the Company’s Amended and Restated Charter to extend the date by which the Company must consummate its initial Business Combination from July 22, 2023 to January 22, 2024, or such earlier date as determined by the Company’s Board (the “2023 Extension”). On July 20, 2023, the Company filed the 2023 Extension Amendment with the Secretary of State of the State of Delaware.

In connection with the 2023 Special Meeting, stockholders holding 376,002 shares of the Company’s Class A Common Stock issued in the Company’s IPO exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. As a result, approximately $4,209,931.03 (approximately $11.20 per share after removal of interest to pay taxes) was removed from the Company’s Trust Account to pay such holders, resulting in approximately $14,008,650.13 remaining in the Trust Account.

In connection with the 2023 Extension, the Company will cause up to $360,000 to be deposited into the Trust Account in installments of $60,000 per month, which equates to approximately $0.048 per remaining Public Share, for each calendar month or portion thereof (commencing on July 22, 2023 and on the 22nd of each subsequent month until January 22, 2024), that the Company needs to complete an initial Business Combination, and such amount will be distributed either to: (i) all of the holders of Public Shares upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of the initial Business Combination. As of July 21, 2023, an aggregate of $60,000 had been deposited into the Trust Account to support the 2023 Extension. The Company deposited $360,000 in the Trust Account through December 31, 2023.

On August 31, 2023, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company no longer meets the minimum 300 public holders requirement for The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “Minimum Public Holders Requirement”). The notification received has no immediate effect on the Company’s Nasdaq listing. On October 16, 2023, the Company submitted to Nasdaq a plan to regain compliance with the Minimum Public Holders Requirement. On October 25, 2023, in response to such compliance plan, the Staff granted the Company an extension of time to regain compliance with the Minimum Public Holders Requirement. Pursuant to the extension, on or before February 27, 2024, the Company must have filed with Nasdaq documentation that demonstrated that the Company’s Common Stock has a minimum of 300 public holders. On February 27, 2024, the Company was not able to demonstrate compliance with the Minimum Public Holders Requirement, and as such, on March 1, 2024, the Company received a notice from the Staff of Nasdaq (the “Delisting Notice”) informing the Company that its securities may be subject to suspension and delisting pending the outcome of a hearing before the Nasdaq Hearings Panel (the “Panel”), which the Company requested on March 8, 2024.

On October 4, 2023, the Company issued a press release announcing that the Company had submitted to EDGAR, the SEC’s online portal, a Registration Statement on Form S-4, which includes a preliminary proxy statement/prospectus, with respect to the Company’s proposed initial Business Combination (the “Kustom Entertainment Business Combination”) with Kustom Entertainment, Inc., a Nevada corporation (“Kustom Entertainment”).

If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (1)(i) cease all operations except for the purpose of winding up; (2)(ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares,Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (3)(iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the board of directors,Board, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

F-8

The Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to waive: (1)(i) their redemption rights with respect to any Founder Shares private placement shares(as defined below) (see Note 5), Private Placement Shares and public sharesPublic Shares held by them, as applicable, in connection with the completion of the initial Business Combination; (2)(ii) their redemption rights with respect to any Founder Shares and public sharesPublic Shares held by them in connection with a stockholder vote to amend the Company’s amendedAmended and restated certificate of incorporation (A)Restated Charter (a) to modify the substance or timing of the Company’s obligation to redeem 100% of the public sharesPublic Shares if the Company does not complete the initial Business Combination within the Combination Period or (B)(b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and (3)(iii) their rights to liquidating distributions from the trust accountTrust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public sharesPublic Shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).time. 


The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1)(i) $10.15 per public sharePublic Share or (2)(ii) the actual amount per public sharePublic Share held in the trust accountTrust Account as of the date of the liquidation of the trust account,Trust Account, if less than $10.15 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust accountTrust Account (whether or not such waiver is enforceable), nor will it apply to any claims under ourthe Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.Act of 1933, as amended (the “Securities Act”). The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believebelieves that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations.

Franchise and Income Tax Withdrawals from Trust Account

 

Going Concern

Since completion of its IPO on July 19, 2021, and through December 31, 2023, the Company withdrew $1,017,913 from the Trust Account to pay its liabilities related to the federal and Floria state and Delaware franchise taxes. Through December 31, 2023, the Company remitted $777,312 to the respective tax authorities. Additionally, as of December 31, 2023, the Company had accrued but unpaid income tax liability of $134,428 and was in a credit position of $75,143 for Delaware franchise tax, which resulted in remaining excess of funds withdrawn from the Trust Account, but not remitted to the government authorities of $181,316. As of December 31, 2021,2023, the Company had $680,302$162,933 in its operating account and inadvertently used $77,668 of the funds withdrawn from the Trust Account for payment of taxes for payment of other operating expenses not related to taxes. The Company continues to incur further tax liabilities and intends to cover such liabilities from the funds in its operating account and, if necessary, from the proceeds from the promissory note to Sponsor, without recurring to additional withdrawals from the Trust Account, until the excess of the funds withdrawn from the Trust Account over the amounts remitted to the government authorities is cured.

Going Concern

As of December 31, 2023 and 2022, the Company had $162,933 and $303,449 in cash, respectively, and working capital deficit of $418,498. $4,493,502 and $2,882,521 (net of Delaware franchise and income taxes), respectively.

Prior to the completion of the Initial Public Offering,IPO, the Company’s liquidity needs had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5).

On July 24, 2023, the Company issued a promissory note (the “2023 Working Capital Note”) in the principal amount of up to $300,000 to the Sponsor. The 2023 Working Capital Note was issued in connection with advances the Sponsor may make in the future to the Company for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) completion of the initial Business Combination or (ii) the date the winding up of the Company is effective.

At various dates in the fourth quarter of 2023, the Sponsor advanced to the Company $415,000 for the Company’s working capital needs. On January 22, 2024, the Company issued the a promissory note (the “2024 Working Capital Note”) in the principal amount of up to $1,000,000 to the Sponsor. The 2024 Working Capital Note was issued in connection with advances the Sponsor may make in the future to the Company for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) completion of the initial Business Combination or (ii) the date the winding up of the Company is effective. The funds advanced in the fourth quarter of 2023 were considered advanced under terms of this 2024 Working Capital Note and were outstanding as of December 31, 2023.

In addition, in order to finance transaction costs in connection with aan Initial Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As$715,000 and $0 were outstanding under Working Capital Loans as of December 31, 2021, there were no amounts outstanding under any Working Capital Loans.2023, and 2022, respectively.

Until the consummation of aan initial Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating, and consummating the initial Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders,stockholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.

F-9

The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company’s assessment of going concern considerations in accordance with FinancialFASB’s Accounting Standard Board’s Account Standards Update (“ASU”) Topic 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The Company has until July 22, 20222024 to consummate aan initial Business Combination.Combination, unless otherwise extended. It is uncertain that the Company will be able to consummate aan initial Business Combination by this time. If aan initial Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary, should the Company be unable to continue as a going concern, and also do not include any adjustmentadjustments that might result from the outcome of this uncertainty about should aan initial Business Combination not occur.

Merger Agreement

On June 1, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CL Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), the Sponsor, in the capacity as the representative from and after the Effective Time (as defined in the Merger Agreement) for the stockholders of the Company (other than the Kustom Entertainment Stockholder (as defined below) as of immediately prior to the Effective Time and its successors and assignees) in accordance with the terms and conditions of the Merger Agreement, Kustom Entertainment, which has a focus and mission to own and produce events, festivals, and entertainment alongside its evolving primary and secondary ticketing technologies, and Digital Ally, Inc., a Nevada corporation and the sole stockholder of Kustom Entertainment (the “Kustom Entertainment Stockholder”).

Pursuant to the Merger Agreement, subject to the terms and conditions set forth therein upon the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), Merger Sub will merge with and into Kustom Entertainment (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Merger Transactions”), with Kustom Entertainment continuing as the surviving corporation in the Merger and a wholly-owned subsidiary of the Company. In the Merger, all of the issued and outstanding capital stock of Kustom Entertainment immediately prior to the Effective Time shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right for the Kustom Entertainment Stockholder to receive the Merger Consideration (as defined herein). Upon consummation of the Transactions, the Company will change its name to “Kustom Entertainment, Inc.”

The aggregate merger consideration to be paid pursuant to the Merger Agreement to the Kustom Entertainment Stockholder as of immediately prior to the Effective Time will be an amount equal to (the “Merger Consideration”) (i) $125 million, minus (ii) the estimated consolidated indebtedness of Kustom Entertainment as of the Closing (“Closing Indebtedness”). The Merger Consideration to be paid to the Kustom Entertainment Stockholder will be paid solely by the delivery of new shares of the Company’s Class A Common Stock, each valued at $11.14 per share. The Closing Indebtedness (and the resulting Merger Consideration) is based solely on estimates determined shortly prior to the Closing and is not subject to any post-Closing true-up or adjustment.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with an initial Business Combination, a vote by the stockholders of the Company to extend the period of time to complete the initial Business Combination (“Extension Vote”) or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with an initial Business Combination, Extension Vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the initial Business Combination, extension or otherwise, (ii) the structure of an initial Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with an initial Business Combination (or otherwise issued not in connection with an initial Business Combination but issued within the same taxable year of an initial Business Combination), and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete an initial Business Combination and in the Company’s ability to complete an initial Business Combination.

F-10

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”).


Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart ourOur Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditorindependent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of these financial statements in conformity with US GAAP requires managementManagement to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. TheAs of December 31, 2023 and 2022, the Company had $680,302$162,933 and $303,449 in cash, respectively, and no cash equivalents as of December 31, 2021.equivalents.

Investments Held in Trust Account

As of December 31, 2021,2023 and 2022, the Company had $140,404,628$14,648,926 and $18,276,649 in investments held in the Trust Account.Account, respectively.

As of December 31, 2023, the Company’s investments held in the Trust Account are held in an interest-bearing demand deposit account and are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

The

F-11

Prior to the current reporting period, the Company classifiesclassified its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasuryTreasury securities arewere recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.

A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry in which the investee operates.


Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “Interest and dividends earned on cashinvestment held in Trust”trust” line item in the statements of operations. Interest income is recognized when earned.

The carrying value, excluding gross unrealized holding loss and fair value of held to maturityheld-to-maturity securities on December 31, 20212023 and 2022 are as follows:

  Carrying
Value as of
December 31,
2021
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Fair Value
as of
December 31,
2021
 
U.S. Treasury Securities (matures February 24, 2022)  140,404,628        —   (1,142)  140,403,486 
  $140,404,628  $  $(1,142) $140,403,486 
  Carrying
Value as of
December 31,
2023
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Fair
Value as of
December 31,
2023
 
Money Market Funds  14,648,926         14,648,926 
  $14,648,926  $  $  $14,648,926 

  Carrying
Value as of
December 31,
2022
  Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Fair
Value as of
December 31,
2022
 
U.S. Treasury Securities (matured May 25, 2023)  18,276,649      217   18,276,866 
  $18,276,649  $  $217  $18,276,866 

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts, and managementManagement believes the Company is not exposed to significant risks on such accounts.

Offering Costs Associated with Initial Public Offering

The Company complies with the requirements of the FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the consummation of the Public Offering.IPO. Offering costs amounted to $9,562,126 and were charged to permanent and temporary equity, ratably with the redeemable and non-redeemable shares they are allocated to, upon the completion of the IPO.

F-12

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements and Disclosures,”Disclosures” (“ASC 820”) approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’sManagement’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.


F-13

 

Class A Common Stock Subject to Possible Redemption

All of the 13,831,230 Class A common stockCommon Stock sold as part of the Units in the Initial Public OfferingIPO contain a redemption feature whichthat allows for the redemption of such public sharesPublic Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the initial Business Combination and in connection with certain amendments to the Company’s amendedAmended and restated certificate of incorporation.Restated Charter. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in FASB ASC Topic 480-10-S99, redemption provisions not solely within the control of the Company require common stockCommon Stock subject to redemption to be classified outside of permanent equity. Given that the Class A common stockCommon Stock was issued with other freestanding instruments (i.e., equity rights), the initial carrying value of Class A common stockCommon Stock classified as temporary equity is the allocated proceeds based on the guidance in FASB ASC Topic 470-20, “Debt – “Debt—Debt with Conversion and Other Options.”

If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately.

Immediately upon the closing of the Initial Public Offering,IPO, the Company recognized the accretion from initial book value to redemption amount, which approximates fair value. The change in the carrying value of Class A common stockCommon Stock subject to possible redemption resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit and Class A common stock.Common Stock.

As of December 31, 2021,2023 and 2022, the Class A common stockCommon Stock reflected on the balance sheet areis reconciled in the following table:

Gross Proceeds $138,312,300  $138,312,300 
Proceeds allocated to equity rights  (760,718)  (760,718)
Less:        
Issuance costs related to Class A common stock subject to possible redemption  (9,509,534)  (9,509,534)
Plus:        
Remeasurement of carrying value to redemption value  12,344,937   12,344,937 
Contingently redeemable Class A common stock subject to possible redemption $140,386,985 
Contingently redeemable Class A common stock subject to possible redemption (December 31, 2021)  140,386,985 
Less:    
Redemptions of Class A common stock  (125,587,180)
Plus:    
Remeasurement of carrying value to redemption value  3,483,582 
Contingently redeemable Class A common stock subject to possible redemption (December 31, 2022)  18,283,387 
Plus:    
Remeasurement of carrying value to redemption value  756,785 
Less:    
Redemptions of Class A common stock  (4,209,931)
Contingently redeemable Class A common stock subject to possible redemption (December 31, 2023) $14,830,241 

Net Loss(Loss) Income Per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings“Earnings Per Share. Net loss(loss) income per share is computed by dividing net loss(loss) income by the weighted average number of shares of common stockCommon Stock outstanding during the period. The Company has two classes of shares, redeemable common stockCommon Stock and non-redeemable common stock.Common Stock. The Company’s redeemable common stockCommon Stock is comprised of Class A shares sold in the IPO. The Company’s non-redeemable shares are comprised of Class B shares purchased by the Sponsor as well as Class A shares sold in the Private UnitsPlacement and Representative Shares. Earnings and losses are shared pro rata between the two classes of shares. The Company’s statement of operations applies the two-class method in calculating net loss(loss) income per share. Basic and diluted net loss(loss) income per common share for redeemable common stockCommon Stock and non-redeemable common stockCommon Stock is calculated by dividing net loss,(loss) income, allocated proportionally to each class of common stock,Common Stock, attributable to the Company by the weighted average number of shares of redeemable and non-redeemable stock outstanding.

The calculation of diluted loss(loss) income per share of common stockCommon Stock does not consider the effect of the rights issued in connection with the IPO since exercise of the rights is contingent upon the occurrence of future events and the inclusion of such rights would be anti-dilutive. Accretion of the carrying value of Class A common stockCommon Stock to redemption value is excluded from net loss(loss) income per redeemable share because the redemption value approximates fair value. As a result, diluted lossnet (loss) income per share is the same as basic lossnet (loss) income per share for the periodperiods presented.


F-14

 

The basic and diluted (loss) income per common stock is calculated as follows:

 For the Period 
 From
February 25,
2021
 
 (Inception)
Through
  For the Year Ended
December 31,
 
 December 31,
2021
  2023  2022 
Common stock subject to possible redemption        
Numerator:        
Net loss allocable to Class A common stock subject to possible redemption $(589,818)
Net (loss) income allocable to redeemable Class A common stock $(266,047) $46,938 
Denominator:            
Weighted Average Class A common stock, basic and diluted  7,700,506 
Basic and Diluted net income per share, Class A common stock $(0.08)
Weighted Average redeemable Class A common stock, basic and diluted  1,457,184   12,204,321 
Basic and Diluted net (loss) income per share, redeemable Class A common stock $(0.18) $0.00 
            
Non-redeemable common stock            
Numerator:            
Net loss allocable to Class B common stock $(244,269)
Net (loss) income allocable to non-redeemable Class A and Class B common stock $(779,912) $13,299 
Denominator:            
Weighted Average non-redeemable common stock, basic and diluted  3,189,105 
Basic and diluted net income per share, common stock $(0.08)
Weighted Average non-redeemable Class A and Class B common stock, basic and diluted  4,271,712   3,457,807 
Basic and diluted net (loss) income per share, non-redeemable Class A and Class B common stock $(0.18) $0.00 

Income Taxes

The Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021.2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction.

The Company is subject to income tax examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s managementManagement does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.


F-15

 

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU No.Topic 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. The ASU 2020-06 also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is reviewing what impact, if any, adoption will have on the Company’s financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s Management does not believe the adoption of ASU 2023-09 will have a material impact on its consolidated financial statements and disclosures.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3 — Initial Public Offering

On July 22, 2021, the Company consummated its IPO of 13,831,230 Units at a purchase price of $10.00 per Unit, generating gross proceeds of $138,312,300. This included 1,331,230 unitsUnits due to a partial over-allotment exercised by the underwriters. The underwriters forfeited their remaining over-allotment option on July 28, 2021. Each Unit consists of (i) one share of Class A common stockCommon Stock and (ii) one right to receive one-eighth (1/8) of a share of Class A common stockCommon Stock upon the consummation of the initial Business Combination (the “rights” or “public rights”“Rights”).

The Company paid an underwriting fee at the closing of the IPO of $2,766,246. An additional fee of $4,840,931 was deferred and will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.


Note 4 — Private Placement

Simultaneously with the closing of the IPO and the sale of the Units, the Sponsor purchased an aggregate of 571,859 Private Placement Units at a price of $10.00 per Private Placement Unit ($5,718,590 in the aggregate) and the representativeRepresentative purchased an aggregate of 103,734 Private Placement Units at a price of $10.00 per Private Placement Unit ($1,037,340 in the aggregate) in a private placement.Private Placement. Each Private Placement Unit is identical to the Units offered in the IPO except as described below.

The Private Placement Units and their component securities will not be transferable, assignable or salable until after the completion of the initial Business Combination except to permitted transferees. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Founder Shares, private placement sharesPrivate Placement Shares or private placement rights,the Private Placement Rights, which will expire worthless if the Company does not consummate aan initial Business Combination within the Combination Period.

Note 5 — Related Party Transactions

Founder Shares

In March 2021, the Sponsor paid $25,000 in consideration for 3,593,750 shares of Class B common stockCommon Stock (the “Founder Shares”). The number of Founder Shares issued was determined based on the expectation that the Founder Shares would represent 20% of the outstanding shares after the IPO (excluding shares included in the private placement unitsPrivate Placement Units or the shares of Class A common stockCommon Stock issuable to Maxim)the Representative). Up to 468,750 of the Founder Shares were subject to forfeiture depending on the extent to which the underwriters’ over-allotment is exercised. On July 22, 2021, the underwriters partially exercised their over-allotment option and purchased an additional 1,331,230 of their full 1,875,000 option. The underwriters forfeited the remainder of their over-allotment option as of July 28, 2021, resulting in aggregate Founders Shares outstanding of 3,457,807.


F-16

 

On April 8, 2021, the Sponsor transferred a membership interest (the “Interest”) to 3three of the Company’s officers and the 3 Independent Directorsthree independent directors of 75,000 Founder Shares. The Interest relates solely to the number of Founder Shares laid out in theirthe Company’s officers’ and independent directors’ respective agreements. The transferred shares shall vest upon the Company consummating an initial Business Combination (the “Vesting Date”). If prior to the Vesting Date, any of the grantees ceases to remain in their role, either voluntarily or for a cause (a “Separation Event”), 100% of the shares granted will be automatically and immediately transferred back to the Sponsor upon such Separation Event. Since the stock grants to both directors and to the officers contain the performance condition of consummating aan initial Business Combination, the Company has determined the appropriate accounting treatment is to defer recognition of the compensation costs until the consummation of an initial Business Combination in accordance with FASB ASC Topic 718, – “Compensation – “Compensation—Stock Compensation”.Compensation.”

The Company’s initial stockholders,Sponsor and any other holders of Founder Shares (or their permitted transferees) prior to our IPO (“Initial Stockholders”), including the Interests transferred to the Company’s officers and directors, have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A)(i) six months after the completion of the initial Business Combination; and (B)(ii) subsequent to the initial Business Combination (x)(a) if the closing price of the shares of the Class A common stockCommon Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination or (y)(b) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the public stockholders having the right to exchange their shares of common stockCommon Stock for cash, securities or other property (except with respect to permitted transferees). Any permitted transferees would be subject to the same restrictions and other agreements of the Company’s initial stockholdersInitial Stockholders with respect to any Founder Shares (the “lock-up”“Lock-Up”).

On July 20, 2023, the Company issued an aggregate of 3,457,806 shares of its Class A Common Stock to the Sponsor upon the conversion (the “Founder Share Conversion”) of an equal number of shares of Class B Common Stock of the Company held by the Sponsor. The 3,457,806 shares of Class A Common Stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Common Stock before the Founder Share Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an Initial Business Combination as described in the prospectus for the Company’s IPO. Following the Founder Share Conversion, there were 5,522,867 shares of Class A Common Stock issued and outstanding and 1 share of Class B Common Stock issued and outstanding. As a result of the Founder Share Conversion, the Sponsor holds approximately 73.0% of the Company’s issued and outstanding Class A Common Stock.

Promissory Note — Related Party

On March 4, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the Initial Public Offering,IPO, under a promissory note. These loans are non-interest bearing, unsecured and due at the earlier of September 30, 2021, or the closing of the Initial Public Offering.IPO. These loans were repaid upon the closing of the Initial Public OfferingIPO out of the offering proceeds that hashad been allocated to the payment of offering expenses. As of December 31, 2021,2023 and 2022, there is no amount outstanding under the promissory note.

On July 18, 2022, the Company issued the July 2022 Extension Note in the principal amount of $1,383,123 to the Sponsor in connection with the July 2022 Extension. The July 2022 Extension Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company’s initial Business Combination is consummated and (ii) the liquidation of the Company on or before October 22, 2022 or such liquidation date as may be approved by the Company’s stockholders. At the election of the Sponsor, up to $1,383,123 of the unpaid principal amount of the July 2022 Extension Note may be converted into Units of the Company (the “Conversion Units”) with the total Conversion Units so issued shall be equal to: (i) the portion of the principal amount of the July 2022 Extension Note being converted divided by (ii) the conversion price of ten dollars ($10.00), rounded up to the nearest whole number of Conversion Units. The conversion feature included in the July 2022 Extension Note is closely related to the debt instrument itself and is not bifurcated from the host instrument. As a result, all debt proceeds received have been allocated to debt liability. As of December 31, 2023, and 2022, there was $1,383,892 outstanding under the July 2022 Extension Note.

On October 19, 2022, in connection with the October 2022 Extension, the Company issued a further promissory note (the “October 2022 Extension Note”) in the principal amount of $1,383,123 to the Sponsor pursuant to which the Sponsor loaned to the Company $1,383,123 to deposit into the Company’s Trust Account for each share of the Company’s Class A Common Stock that was not redeemed in connection with the October 2022 Extension. The October 2022 Extension Note bears no interest and is repayable in full upon the earlier of (i) the date of the consummation of the Company’s initial Business Combination, or (ii) the date of the liquidation of the Company. As of December 31, 2023, and 2022, there was $1,383,123 outstanding under the October 2022 Extension Note.

F-17

On July 21, 2023, the Company issued a promissory note (the “2023 Extension Note”) in the aggregate principal amount of up to $360,000 to the Sponsor, pursuant to which the Sponsor agreed to loan to the Company up to $360,000 to deposit into Trust Account for the Company’s Class A Common Stock, held by the Company’s public stockholders that were not redeemed in connection with the 2023 Extension Amendment. On July 21, 2023, the Company deposited $60,000 into the Trust Account, with such amount being treated as the first draw under the 2023 Extension Note, and the Company will continue to deposit $60,000 into the Trust Account for each additional calendar month (promptly following the 22nd of each calendar month), or portion thereof, that is needed by the Company to complete an initial Business Combination until January 22, 2024, and such amount will be distributed either to: (i) all of the holders of Public Shares upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of the initial Business Combination. The 2023 Extension Note bears no interest and is repayable in full upon the earlier of (i) the date of the consummation of the Company’s initial Business Combination or (ii) the date of the liquidation of the Company. The Sponsor deposited $360,000 in the Trust Account under the 2023 Extension Note, which was outstanding as of December 31, 2023.

On July 21, 2023, the Company issued the 2023 Working Capital Note in the principal amount of up to $300,000 to the Sponsor. The 2023 Working Capital Note was issued in connection with advances the Sponsor may make in the future to the Company for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) completion of the initial Business Combination or (ii) the date the winding up of the Company is effective. The Company drew $300,000 under the 2023 Working Capital Note which was outstanding as of December 31, 2023.

At various dates in the fourth quarter of 2023, the Sponsor advanced to the Company $415,000 for the working capital needs. On January 22, 2024, the Company issued the 2024 Working Capital Note in the principal amount of up to $1,000,000 to the Sponsor. The 2024 Working Capital Note was issued in connection with advances the Sponsor may make in the future to the Company for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) completion of the initial Business Combination or (ii) the date the winding up of the Company is effective. The funds advanced in the fourth quarter of 2023 were considered advanced under terms of this note and were outstanding as of December 31, 2023.

Related Party Loans

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but is not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes an initial Business Combination, the Company wouldwill repay such loaned amounts out of the proceeds of the Trust Account released to the Company. Otherwise, such loansWorking Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $1,500,000 of such loansWorking Capital Loans may be convertible into private placement-equivalent unitsPrivate Placement-equivalent Units at a price of $10.00 per unitUnit (which, for example, would result in the holders being issued 150,000 unitsUnits if $1,500,000 of notes were so converted), at the option of the lender. The unitsUnits would be identical to the Private Placement Units issued to the Sponsor. As of December 31, 2021, no$715,000 and $0 were outstanding under such Working Capital Loans were outstanding.as of December 31, 2023 and 2022, respectively.

Administrative Support Agreement

Commencing on the date of the IPO, the Company has agreed to pay an affiliate of the Sponsor for office space, secretarial, and administrative services provided to members of the management team,Management Team, in the amount of $10,000 per month. The administrative support agreement began on the day the Company first listed on theThe Nasdaq Capital Market and continue monthly until the completion of the Company’s initial Business Combination or liquidation of the Company. For the period from February 25, 2021 (inception) throughyear ended December 31, 2021,2023, the Company incurred $54,237$120,000, in administrative support fees, which is included in formation and operating costs in the accompanying statementstatements of operations. For the year ended December 31, 2022, the Company incurred $120,000 in administrative support fees which is included in formation and operating costs in the accompanying statements of operations. As of December 31, 2021,2023 and 2022, there was $2,903$10,000 and $0, respectively, outstanding, which is included on the accompanying balance sheetsheets as “due to related party”.party.”

F-18

Note 6 — Commitments and Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Units and securities that may be issued upon conversion of Working Capital Loans and extension loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. These holders will be entitled to make up to three demands, excluding short formshort-form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back”“piggyback” registration rights to include their securities in other registration statements filed by the Company. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five and seven years, respectively, after the effective date of the registration statement of which the IPO Registration Statement forms a part and may not exercise their demand rights on more than one occasion.


Underwriting Agreement

The Company has granted the underwriters a 30-day option to purchase up to 1,875,000 additional Units to cover any over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On July 22, 2021, the underwriters partially exercised their over-allotment option and purchased an additional 1,331,230 unitsUnits and forfeited the remainder of their over-allotment option as of July 28, 2021.

The Company agreed to pay or reimburse the underwriters for travel, lodging, and other “road show” expenses, expenses of the underwriters’ legal counsel, and certain diligence and other fees, including the preparation, binding and delivery of bound volumes in form and style reasonably satisfactory to the Representative, transaction Lucite cubes, or similar commemorative items in a style as reasonably requested by the Representative, and reimbursement for background checks on the Company’s directors and executive officers, which such fees and expenses are capped at an aggregate of $125,000 (less amounts previously paid).

The underwriters will be entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO held in the Trust Account upon the completion of the Company’s initial Business Combination, subject to the terms of the underwriting agreement.

The Representative’s Common Stock

The Company has agreed to issue to Maximthe Representative and/or its designees, 125,000 shares of common stockCommon Stock (or 143,750 shares if the underwriter’s over-allotment option is exercised in full) upon the consummation of the IPO. On July 22, 2021, the underwriters partially exercised their over-allotment option, resulting in an aggregate issuance of 138,312 representative shares.Representative Shares. These shares were valued at a price of $10.00 which was the sale price of the unitsUnits sold in the IPO. MaximThe Representative has agreed not to transfer, assign, or sell any such shares until the completion of the Company’s initial Business Combination. In addition, Maximthe Representative has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company’s initial Business Combination and (ii) to waive its rights to liquidating distributions from the trust accountTrust Account with respect to such shares if the Company fails to complete an initial Business Combination within 12 months from the closing of the IPO (or up to 21 months from the closing of the IPO if the period of time to consummate a Business Combination is extended, as described herein).applicable period.

The shares have been deemed compensation by FINRAthe Financial Industry Regulatory Authority (“FINRA”) and are therefore subject to a lock-upLock-Up for a period of 180 days immediately following the date of the effectiveness of the registration statement of the IPO Registration Statement pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of the IPO Registration Statement, nor may they be sold, transferred, assigned, pledged, or hypothecated for a period of 180 days immediately following the effective date of the registration statement of the IPO Registration Statement except to any underwriter and selected dealer participating in the offeringIPO and their bona fide officers or partners.

Right of First Refusal

Subject to certain conditions, the Company will grant Maxim,the Representative, for a period beginning on the closing of the IPO and ending 15 months after the date of the consummation of the initial Business Combination, a right of first refusal to act as lead left book-running managing underwriter with at least 75% of the economics; or, in the case of a three-handed deal, 50% of the economics, for any and all future public and private equity, convertible, and debt offerings for the Company or any of its successors or subsidiaries. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement of the IPO.IPO Registration Statement.

F-19

Note 7 — Stockholders’ Deficit

 

Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. As of December 31, 2021,2023 and 2022, there were no shares of preferred stock issued or outstanding.

Class A common stockCommon Stock — The Company is authorized to issue 100,000,000 shares of Class A common stockCommon Stock with a par value of $0.0001 per share. Holders of shares of Class A common stockCommon Stock are entitled to one vote for each share. As of December 31, 20212023 and 2022 there were 4,271,711 and 813,905 shares of Class A common stockCommon Stock issued or outstanding, excluding 13,831,2301,251,156 and 1,627,158 shares of Class A common stockCommon Stock subject to possible redemption.redemption, respectively.


Class B common stock Common Stock— The Company is authorized to issue 10,000,000 shares of Class B common stockCommon Stock with a par value of $0.0001 per share. As of December 31, 2021,2023 and, 2022 there were 1 and 3,457,807 shares of Class B common stockCommon Stock issued and outstanding, respectively, so that the Founder Shares represent, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.IPO.

The Company’s initial stockholdersInitial Stockholders have agreed not to transfer, assign, or sell any of their Founder Shares until the earlier to occur of: (A)(i) six months after the date of the consummation of the initial Business Combination;Combination and (B)(ii) subsequent to the initial Business Combination (x)(a) if the closing price of ourthe Company’s shares of Class A common stockCommon Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any 20 trading days within any 30-trading day period after the initial Business Combination or (y)(b) the date on which the Company consummates a liquidation, merger, stock exchange, or other similar transaction that results in all of the public stockholders having the right to exchange their shares of Class A common stockCommon Stock for cash, securities, or other property (except as described herein). Any permitted transferees would be subject to the same restrictions and other agreements of the Company’s initial stockholdersInitial Stockholders with respect to any Founder Shares.

Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stockCommon Stock and holders of the Class B common stockCommon Stock will vote together as a single class on all matters submitted to a vote of ourthe Company’s stockholders, except as required by law. The shares of Class B common stockCommon Stock will automatically convert into shares of Class A common stockCommon Stock at the time of the initial Business Combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations, and the like), and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock,Common Stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public OfferingIPO and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stockCommon Stock shall convert into shares of Class A common stockCommon Stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stockCommon Stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stockCommon Stock issuable upon conversion of all shares of Class B common stockCommon Stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stockCommon Stock outstanding upon completion of the Initial Public OfferingIPO (excluding shares included in the private placement unitsPrivate Placement Units or the shares of Class A common stockCommon Stock issuable to Maxim)the Representative) plus all shares of Class A common stockCommon Stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination.

Rights

Rights

Each holder of a rightRight will receive one-eighth (1/8) of one Class A common stockCommon Stock upon consummation of the initial Business Combination. In the event the Company will not be the surviving entity upon completion of the initial Business Combination, each holder of a rightRight will be required to affirmatively convert its rightsRights in order to receive the 1/8 share of Class A common stockCommon Stock underlying each rightRight (without paying any additional consideration). If the Company is unable to complete an initial Business Combination within the required time period and the Company redeems the public sharesPublic Shares of Class A common stockCommon Stock for the funds held in the trust account,Trust Account, holders of rightsRights will not receive any such funds in exchange for their rightsRights and the rightsRights will expire worthless. Every eight (8) rightsRights that you holda holder holds will entitle youthe holder to receive one share at the closing of the initial Business Combination. The Company will not issue fractional shares of Class A common stockCommon Stock upon exchange of the rights.Rights. If, upon conversion of the rights,Rights, a holder would be entitled to receive a fractional interest in a share, fractional shares will be rounded up to the nearest whole share.

If the Company is unable to complete an initial Business Combination within the required time period and it liquidates the funds held in the Trust Account, holders of rightsRights will not receive any such funds with respect to any of their rights,Rights, nor will they receive any distribution from the Company’s assets held outside of the trust accountTrust Account with respect to such rights,Rights, and all rightsRights will expire worthless.

 

Note 8 – Income Tax

The Company’s net deferred tax assets are as follows:

 December 31,
2021
  December 31,
2023
  December 31,
2022
 
Deferred tax asset        
Organizational costs/Start-up costs $162,250   748,482   334,531 
Federal net operating loss  38,176 
Total deferred tax asset  200,426   748,482   334,531 
Deferred tax liability            
Unrealized gain/loss  (1,955)     (18,790)
Valuation allowance  (198,471)  (748,482)  (334,531)
Deferred tax asset, net of allowance $ 
Deferred tax asset (liability), net of allowance $  $(18,790)


F-20

 

The income tax provision consists of the following:

December 31,
2021
Federal
Current$
Deferred(175,158)
State
Current
Deferred(23,313)
Change in valuation allowance198,471
Income tax provision$

  December 31,
2023
  December 31,
2022
 
Federal      
Current $177,066  $138,094 
Deferred  (322,849)  (86,506)
State        
Current  38,315   28,540 
Deferred  (109,934)  (30,765)
Change in valuation allowance  413,993   136,060 
Income tax provision $196,591  $185,423 

The Company’s federal and state net operating loss carryforwards as of December 31, 20212023 and 2022 amounted to $160,439,$0 and $0, respectively, and will be carried forward indefinitely and are available to offset future taxable income in the respective tax jurisdictions.

In assessing the realization of the deferred tax assets, managementManagement considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, managementManagement believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2021,2023, the change in the valuation allowance was $198,471.$413,993. For the year ended December 31, 2022, the change in the valuation allowance was $136,060.

Reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2022 and 2021 is as follows:

Statutory federal income tax rate21.00%
State taxes, net of federal tax benefit2.80%
Permanent book/tax differences:
Change in valuation allowance(23.80)%
Other0.00%
Income tax provision
  December 31,
2023
  December 31,
2022
 
Statutory federal income tax rate  21.00%  21.00%
State taxes, net of federal tax benefit  4.34%  4.30%
Prior year true-up  0.25%  (5.23)%
Change in valuation allowance  (48.74)%  55.41%
Income tax provision  (23.15)%  75.48%

The Company’s effective tax rates for the periods presented differ from the expected (statutory) rates due to the recording of full valuation allowances on deferred tax assets.

The Company files income tax returns in the U.S. federal jurisdiction and Florida and is subject to examination by the various taxing authorities, since inception.

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than that identified below, that would have required adjustment or disclosure in the financial statement.statements.

Extension of the Combination Period

On January 17, 2024, the Company held a special meeting of stockholders (the “2024 Special Meeting”). At the 2024 Special Meeting, the Company’s stockholders approved an amendment (the “2024 Extension Amendment”) to the Amended and Restated Charter to extend the date by which the Company must consummate its initial Business Combination from January 22, 2024 to July 22, 2024, or such earlier date as determined by the Company’s Board (the “2024 Extension”).


F-21

 

EXHIBIT INDEXIn connection with the 2024 Special Meeting, Public Stockholders holding 202,360 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $2,374,149 (approximately $11.73 per share) will be removed from the Trust Account to pay such holders.

Following the approval and implementation of the Extension Amendment, on January 22, 2024, the Company issued a promissory note (the “2024 Extension Note”) in the aggregate principal amount of up to $360,000 the Sponsor, pursuant to which the Sponsor agreed to loan to the Company up to $360,000 to deposit into the Company’s Trust Account for each Public Share that was not redeemed in connection with the 2024 Extension Amendment. The 2024 Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial Business Combination, or (b) the date of the liquidation of the Company.

On January 22, 2024, the Company deposited $60,000 into the Trust Account, and the Company will continue to deposit $60,000 into the Trust Account for each additional calendar month (promptly following the 22nd of each calendar month), or portion thereof, that is needed by the Company to complete an initial Business Combination until July 22, 2024, and such amount will be distributed either to: (i) all of the holders of Public Shares upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of the initial Business Combination. As of March 21, 2024, $180,000 of the principal on the 2024 Extension Note has been deposited into the Trust Account.

On January 22, 2024, the Company issued the 2024 Working Capital Note in the principal amount of up to $1,000,000 to the Sponsor. The 2024 Working Capital Note was issued in connection with up to $1,000,000 of advances the Sponsor has made or may make in the future to the Company for working capital expenses. The loan is non-interest bearing and payable upon the earlier of (i) the date of the consummation of the Company’s initial Business Combination or (ii) the date of the liquidation of the Company. As of March 5, 2024, a total of $525,000 had been drawn down on the 2024 Working Capital Note.

Nasdaq Compliance—Minimum Public Holders Requirement and Annual Meeting Requirement

On August 31, 2023, the Company received a deficiency letter from the Staff of Nasdaq notifying us that the Company is no longer meet the Minimum Public Holders Requirement. The notification received has no immediate effect on our Nasdaq listing. On October 16, 2023, we submitted to Nasdaq a plan to regain compliance with the Minimum Public Holders Requirement. On October 25, 2023, in response to such compliance plan, the Staff granted us an extension of time to regain compliance with the Minimum Public Holders Requirement. Pursuant to the extension, on or before February 27, 2024, the Company must have filed with Nasdaq documentation that demonstrated that our Common Stock has a minimum of 300 public holders.

On January 23, 2024, the Company received a deficiency notice from the Staff of Nasdaq notifying the Company that it is not in compliance with the requirement pursuant to Nasdaq Listing Rule 5620(a) that companies listed on Nasdaq hold an annual meeting of shareholders within twelve months of their fiscal year end (the “Annual Meeting Requirement”) because it did not hold an annual meeting of stockholders within twelve months of our fiscal year ended December 31, 2022. The notification received had no immediate effect on our Nasdaq listing. In accordance with Nasdaq rules, the Company had 45 calendar days, or until March 8, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement.

On February 27, 2024, the Company was not able to demonstrate compliance with the Minimum Public Holders Requirement, and as such, on March 1, 2024, we received a notice (the “Delisting Notice”) from the Staff of Nasdaq informing us that our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel. Because the Staff of Nasdaq issued the Delisting Notice to us on March 1, 2024, the Company chose to forego submitting a plan of compliance to Nasdaq related to the Annual Meeting Requirement. Because we were unable to demonstrate compliance with the Minimum Public Holders Requirement and did not submit to Nasdaq a plan of compliance related to the Annual Meeting Requirement, our securities may be subject to suspension and delisting pending the outcome of a hearing before the Panel, which we requested on March 8, 2024. 

Indemnification Agreement with Kustom Entertainment and Digital Ally

On February 1, 2024, we entered in an indemnification agreement with Kustom Entertainment and the Kustom Entertainment Stockholder, pursuant to which, Kustom Entertainment and Kustom Entertainment Stockholder agreed to indemnify us and our officers and directors for liabilities incurred in connection with Kustom Entertainment Stockholder disclosure incorporated by reference into the Kustom Entertainment Registration Statement.

F-22

EXHIBIT INDEX

Exhibit No.Description
1.1    Underwriting Agreement, dated July 19, 2021, by and between the Company and Maxim Group LLC.the representative. (4)
2.1Agreement and Plan of Merger, dated June 1, 2023, by and among the Company, Merger Sub, our Sponsor in the capacity as the Purchase Representative, Kustom Entertainment, and Digital Ally. (8)
3.1  Second Amended and Restated Certificate of Incorporation. (4)
3.2Bylaws. (1)Amendment to Amended and Restated Certificate of Incorporation. (7)
3.3Second Amendment to Amended and Restated Certificate of Incorporation (9)
3.4Third Amendment to Amended and Restated Certificate of Incorporation (12)
3.5  Bylaws. (1)
4.1  Rights Agreement, dated July 19, 2021, by and between the Company and Continental, Stock Transfer & Trust Company, as rights agent. (4)
4.2  Specimen Unit Certificate. (3)
4.3  Specimen Class A Common Stock Certificate. (2)
4.4Specimen Rights Certificate. (3)
4.5  Description of Registered Securities.* (5)
10.1Promissory NotedNote, dated March 4, 2021, Issuedissued to Yntegra Capital Investments, LLC.our Sponsor. (1)
10.2Securities Subscription Agreement, dated March 4, 2021, between the Company and theour Sponsor. (1)
10.3Letter Agreement, dated July 19, 2021, by and among the Company, itsour officers and directors, and theour Sponsor. (4)
10.4Investment Management Trust Agreement, dated July 19, 2021, by and between the Company and Continental, Stock Transfer & Trust Company, as trustee. (4)
10.5

Form of Indemnity Agreement. (2)

10.6Registration Rights Agreement, dated July 19, 2021, by and among the Company and certain security holders. (4)
10.7Maxim Unit Purchase Agreement, dated July 19, 2021, by and between the Company and Maxim.the Representative. (4)
10.8 Sponsor Unit Purchase Agreement, dated July 19, 2021, by and between the Company and theour Sponsor. (4)
10.9Administrative Support Agreement, dated July 19, 2021, by and between the Company and the Sponsor.Yntegra Capital Management, LLC. (4)
10.10Promissory Note, dated July 18, 2022, issued to our Sponsor. (6)
10.11Promissory Note, dated October 19, 2022, issued to our Sponsor. (7)
10.12Lock-up Agreement, by and among the Company, our Sponsor in the capacity as the Purchaser Representative and Digital Ally. (8)
10.13Sponsor Forfeiture Letter, by and among the Company, our Sponsor in the capacity as the Purchaser Representative and Stanton E. Ross. (8)
10.14Extension Promissory Note, dated July 24, 2023, issued to our Sponsor. (10)
10.15Working Capital Promissory Note, dated July 24, 2023, issued to our Sponsor. (10)
10.16Amendment No. 1 to Lock-Up Agreement, by and among the Company, our Sponsor in the capacity as the Purchaser Representative and Digital Ally. (11)
10.17Extension Promissory Note, dated January 22, 2024, issued to our Sponsor. (12)
10.18Working Capital Promissory Note, dated January 22, 2024, issued to our Sponsor. (12)
10.19Indemnification Agreement, dated February 1, 2024, between the Company, Kustom Entertainment and Digital Ally (13)
14Form of Code of Ethics. (2)
19*Insider Trading Policy.
21*List of Subsidiaries.
31.1Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2  Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
97Policy Related to Recovery of Erroneously Awarded Compensation, adopted November 30, 2023.*
99.1Amended and Restated Audit Committee Charter.*
99.2Amended and Restated Compensation Committee Charter.*
101.INSInline XBRL Instance Document.*
101.SCHInline XBRL Taxonomy Extension Schema Document.*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*
104Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).*

*Filed herewith.

**

Furnished herewithherewith.

(1)Incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333-255111), filed with the SEC on April 7, 2021.


(2)Incorporated by reference to the Company’s Registration Statement on Form S-1/A (File No. 333-255111), filed with the SEC on June 7, 2021.

(3)Incorporated by reference to the Company’s Registration Statement on Form S-1/A (File No. 333-255111), filed with the SEC on July 9,12, 2021.

(4)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on July 23, 2021.

(5)Incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on April 15, 2022.

(6)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on July 19, 2022.

(7)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on October 24, 2022.

(8)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on June 6, 2023.

(9)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on July 21, 2023.

(10)  Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on July 28, 2023.

(11)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on December 15, 2023.

(12)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on January 22, 2024.

(13)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on February 7, 2024.


 

SIGNATURES

Pursuant to the requirements of Section13Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

April 15, 2022March 21, 2024Clover Leaf Capital Corp.
By:

/s/ Felipe MacLean

Name: Felipe MacLean
Title:Chief Executive Officer
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

NamePositionDate

/s/ Felipe MacLean

Chief Executive OfficerApril 15, 2022March 21, 2024
Felipe MacLean(Principal Executive Officer)

/s/ Luis A. Guerra

Chief Financial OfficerApril 15, 2022March 21, 2024
Luis A. Guerra(Principal Financial and Accounting Officer)

/s/ Per Bjorkman

DirectorApril 15, 2022March 21, 2024
Per Bjorkman

/s/ Marcos Angelini

DirectorApril 15, 2022March 21, 2024
Marcos Angelini

/s/ Ambassador Manuel Rocha

Luis Derechin
DirectorApril 15, 2022March 21, 2024
Luis Derechin

4152

 

12204321 1457184 0.00 0.18 3457807 4271712 0.00 0.18 12204321 1457184 0.00 0.18 3457807 4271712 0.00 0.18 false FY 0001849058 iso4217:USD xbrli:shares